Targeting epigenetics: A novel promise for Alzheimer’s disease treatment
So far, the search for a cure for Alzheimer Disease (AD) has been unsuccessful. The only approved drugs attenuate some symptoms, but do not halt the progress of this disease, which affects 50 million people worldwide and will increase its incidence in the coming decades. Such scenario demands new th...
Saved in:
| Published in | Ageing research reviews Vol. 90; p. 102003 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
England
Elsevier B.V
01.09.2023
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | So far, the search for a cure for Alzheimer Disease (AD) has been unsuccessful. The only approved drugs attenuate some symptoms, but do not halt the progress of this disease, which affects 50 million people worldwide and will increase its incidence in the coming decades. Such scenario demands new therapeutic approaches to fight against this devastating dementia. In recent years, multi-omics research and the analysis of differential epigenetic marks in AD subjects have contributed to our understanding of AD; however, the impact of epigenetic research is yet to be seen. This review integrates the most recent data on pathological processes and epigenetic changes relevant for aging and AD, as well as current therapies targeting epigenetic machinery in clinical trials. Evidence shows that epigenetic modifications play a key role in gene expression, which could provide multi-target preventative and therapeutic approaches in AD. Both novel and repurposed drugs are employed in AD clinical trials due to their epigenetic effects, as well as increasing number of natural compounds. Given the reversible nature of epigenetic modifications and the complexity of gene-environment interactions, the combination of epigenetic-based therapies with environmental strategies and drugs with multiple targets might be needed to properly help AD patients.
•Epigenetic studies provided numerous data on the role of gene expression changes in AD.•Studies tend to be neuron-centric focused on DNA methylation, histone modification and non-coding RNAs.•Epigenetic should be incorporated in molecular etiology of AD at different levels of biological complexity•Preventative strategies against AD epigenetic factors ought to integrate with future multi-target therapies. |
|---|---|
| AbstractList | So far, the search for a cure for Alzheimer Disease (AD) has been unsuccessful. The only approved drugs attenuate some symptoms, but do not halt the progress of this disease, which affects 50 million people worldwide and will increase its incidence in the coming decades. Such scenario demands new therapeutic approaches to fight against this devastating dementia. In recent years, multi-omics research and the analysis of differential epigenetic marks in AD subjects have contributed to our understanding of AD; however, the impact of epigenetic research is yet to be seen. This review integrates the most recent data on pathological processes and epigenetic changes relevant for aging and AD, as well as current therapies targeting epigenetic machinery in clinical trials. Evidence shows that epigenetic modifications play a key role in gene expression, which could provide multi-target preventative and therapeutic approaches in AD. Both novel and repurposed drugs are employed in AD clinical trials due to their epigenetic effects, as well as increasing number of natural compounds. Given the reversible nature of epigenetic modifications and the complexity of gene-environment interactions, the combination of epigenetic-based therapies with environmental strategies and drugs with multiple targets might be needed to properly help AD patients.
•Epigenetic studies provided numerous data on the role of gene expression changes in AD.•Studies tend to be neuron-centric focused on DNA methylation, histone modification and non-coding RNAs.•Epigenetic should be incorporated in molecular etiology of AD at different levels of biological complexity•Preventative strategies against AD epigenetic factors ought to integrate with future multi-target therapies. So far, the search for a cure for Alzheimer Disease (AD) has been unsuccessful. The only approved drugs attenuate some symptoms, but do not halt the progress of this disease, which affects 50 million people worldwide and will increase its incidence in the coming decades. Such scenario demands new therapeutic approaches to fight against this devastating dementia. In recent years, multi-omics research and the analysis of differential epigenetic marks in AD subjects have contributed to our understanding of AD; however, the impact of epigenetic research is yet to be seen. This review integrates the most recent data on pathological processes and epigenetic changes relevant for aging and AD, as well as current therapies targeting epigenetic machinery in clinical trials. Evidence shows that epigenetic modifications play a key role in gene expression, which could provide multi-target preventative and therapeutic approaches in AD. Both novel and repurposed drugs are employed in AD clinical trials due to their epigenetic effects, as well as increasing number of natural compounds. Given the reversible nature of epigenetic modifications and the complexity of gene-environment interactions, the combination of epigenetic-based therapies with environmental strategies and drugs with multiple targets might be needed to properly help AD patients.So far, the search for a cure for Alzheimer Disease (AD) has been unsuccessful. The only approved drugs attenuate some symptoms, but do not halt the progress of this disease, which affects 50 million people worldwide and will increase its incidence in the coming decades. Such scenario demands new therapeutic approaches to fight against this devastating dementia. In recent years, multi-omics research and the analysis of differential epigenetic marks in AD subjects have contributed to our understanding of AD; however, the impact of epigenetic research is yet to be seen. This review integrates the most recent data on pathological processes and epigenetic changes relevant for aging and AD, as well as current therapies targeting epigenetic machinery in clinical trials. Evidence shows that epigenetic modifications play a key role in gene expression, which could provide multi-target preventative and therapeutic approaches in AD. Both novel and repurposed drugs are employed in AD clinical trials due to their epigenetic effects, as well as increasing number of natural compounds. Given the reversible nature of epigenetic modifications and the complexity of gene-environment interactions, the combination of epigenetic-based therapies with environmental strategies and drugs with multiple targets might be needed to properly help AD patients. So far, the search for a cure for Alzheimer Disease (AD) has been unsuccessful. The only approved drugs attenuate some symptoms, but do not halt the progress of this disease, which affects 50 million people worldwide and will increase its incidence in the coming decades. Such scenario demands new therapeutic approaches to fight against this devastating dementia. In recent years, multi-omics research and the analysis of differential epigenetic marks in AD subjects have contributed to our understanding of AD; however, the impact of epigenetic research is yet to be seen. This review integrates the most recent data on pathological processes and epigenetic changes relevant for aging and AD, as well as current therapies targeting epigenetic machinery in clinical trials. Evidence shows that epigenetic modifications play a key role in gene expression, which could provide multi-target preventative and therapeutic approaches in AD. Both novel and repurposed drugs are employed in AD clinical trials due to their epigenetic effects, as well as increasing number of natural compounds. Given the reversible nature of epigenetic modifications and the complexity of gene-environment interactions, the combination of epigenetic-based therapies with environmental strategies and drugs with multiple targets might be needed to properly help AD patients. |
| ArticleNumber | 102003 |
| Author | Jeremic, Danko Navarro-López, Juan D. Jiménez-Díaz, Lydia |
| Author_xml | – sequence: 1 givenname: Danko surname: Jeremic fullname: Jeremic, Danko – sequence: 2 givenname: Lydia surname: Jiménez-Díaz fullname: Jiménez-Díaz, Lydia email: Lydia.Jimenez@uclm.es – sequence: 3 givenname: Juan D. surname: Navarro-López fullname: Navarro-López, Juan D. email: Juan.Navarro@uclm.es |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37422087$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkDtOAzEQhi0E4n0AGrQlzQY_srYXqgjxFBJNqC1jzwaHXW-wHSSouAbX4yQ4SqCggMpj-_tGM_8OWve9B4QOCB4QTPjxdKBDGFBMWb5TjNka2iZS0LLmw3o91xWXJeFMbKGdGKc4OzWnm2iLiSGlWIptdDPWYQLJ-UkBMzcBn2sTT4pR4fsXaItZ6DsXoWj6UIzat0dwHYTP949Y2Pys808KoFMHPu2hjUa3EfZX5y66vzgfn12Vt3eX12ej29IMMUul0PpB8spYSWtsdUOoZRUxmkIjWV6DDgXWYBlQ2jBJBNFcVBhbboEvOLaLjpZ982zPc4hJ5QkNtK320M-jopJVVGJG64wertD5QwdWzYLrdHhV3_tngCwBE_oYAzQ_CMFqkbGaqpyxWmSslhlnR_xyjEs6ud6noF37p3m6NCHH8-IgqGgceAPWBTBJ2d79ade_bNM674xun-D1H_cL4deozQ |
| CitedBy_id | crossref_primary_10_1080_01932691_2024_2434704 crossref_primary_10_3389_fnut_2024_1483790 crossref_primary_10_3390_life14121555 crossref_primary_10_1021_acsomega_3c07046 crossref_primary_10_1038_s41392_024_02095_6 crossref_primary_10_3390_nu16091288 crossref_primary_10_1007_s00580_024_03603_4 crossref_primary_10_1177_20552173241296726 crossref_primary_10_1021_acs_jmedchem_4c03049 crossref_primary_10_1016_j_sleep_2024_05_010 crossref_primary_10_3389_fnagi_2024_1332845 crossref_primary_10_1016_j_arr_2024_102267 crossref_primary_10_4103_1673_5374_391335 crossref_primary_10_1016_j_inoche_2024_113843 crossref_primary_10_1186_s12967_023_04749_5 |
| Cites_doi | 10.7554/eLife.73420 10.1016/j.expneurol.2014.05.008 10.18632/aging.204196 10.1111/acel.13153 10.3389/fncel.2021.785433 10.1186/s13195-022-01110-8 10.3390/pharmaceutics13091397 10.1007/s12035-021-02385-y 10.1007/0-387-23226-5_12 10.1002/alz.12328 10.1016/j.arr.2020.101050 10.1007/s12192-023-01347-8 10.1016/j.neurobiolaging.2013.12.015 10.3233/JAD-2012-111223 10.1016/j.ejmg.2008.06.004 10.1038/s41598-017-13601-y 10.3389/fnagi.2021.743573 10.3390/cells9020466 10.1038/s41392-021-00646-9 10.1177/1533317513505132 10.1111/nan.12518 10.2217/epi-2016-0009 10.1016/j.coph.2005.09.007 10.1186/s13059-019-1824-y 10.1038/nn.4194 10.1038/ncomms12948 10.3389/fnagi.2018.00083 10.3233/JAD-180592 10.1007/s12035-012-8256-y 10.1016/j.brainres.2018.08.006 10.1001/jamanetworkopen.2020.15428 10.1001/archgenpsychiatry.2011.72 10.1038/s41597-023-01948-z 10.1186/s13195-021-00803-w 10.1155/2021/2031407 10.1007/s11357-019-00061-7 10.1186/s13148-016-0202-9 10.1016/S0092-8674(04)00248-X 10.1155/2018/5642148 10.3389/fnagi.2021.798297 10.1038/nature13163 10.1126/sciadv.aaw2880 10.1002/mds.26820 10.1038/cr.2011.22 10.1016/j.ejmech.2021.113946 10.1038/s41588-020-0696-0 10.1002/mnfr.201600744 10.1111/acel.12689 10.1016/j.neuroimage.2018.03.023 10.1038/npjamd.2016.17 10.1212/WNL.0000000000001617 10.15252/emmm.201606210 10.7326/M17-1529 10.2217/epi.15.39 10.1016/S0169-328X(99)00163-1 10.1038/s41582-018-0056-1 10.1212/WNL.90.15_supplement.S2.006 10.1007/s00018-022-04499-5 10.3389/fgene.2018.00640 10.1002/jez.2465 10.1158/0008-5472.CAN-03-0799 10.1155/2016/5912146 10.1111/jcmm.17411 10.3389/fendo.2018.00402 10.1016/j.ncl.2017.01.001 10.1186/gb-2013-14-10-r115 10.1002/med.21701 10.1098/rsob.210124 10.1007/s00018-015-1988-x 10.1016/j.molcel.2018.08.008 10.1016/j.trci.2018.09.009 10.1007/s12640-014-9508-6 10.3892/etm.2022.11436 10.1126/scitranslmed.aag0481 10.1016/j.jalz.2019.06.4682 10.2174/1570159X19666210609160017 10.1530/JOE-21-0123 10.1002/alz.12192 10.3390/ijms19051315 10.2217/epi-2017-0160 10.1080/15592294.2020.1722917 10.1016/j.molcel.2012.10.016 10.1038/nm1784 10.2174/156720512800617991 10.1001/jamaneurol.2020.1840 10.3389/fragi.2023.1057204 10.3389/fnbeh.2015.00347 10.1007/s10571-017-0572-3 10.1016/j.stem.2018.12.013 10.1523/JNEUROSCI.2107-13.2013 10.1016/j.cell.2014.10.039 10.1261/rna.2414110 10.1021/acschemneuro.8b00620 10.3390/biology11010090 10.3389/fnagi.2019.00244 10.3233/JAD-190120 10.1002/ptr.7176 10.1038/s41582-022-00714-w 10.1159/000503105 10.1038/nrneurol.2012.263 10.1186/2041-2223-3-19 10.18632/aging.101427 10.3389/fgene.2018.00579 10.1002/alz.066866 10.1016/j.jpsychires.2017.04.003 10.1021/acsomega.0c06168 10.1111/bpa.12879 10.1084/jem.20081588 10.4161/psb.11029 10.1101/cshperspect.a017905 10.1136/bmj.p73 10.1038/s41593-018-0194-1 10.1111/joim.12190 10.3390/ijms24032254 10.1016/j.celrep.2018.01.020 10.1101/gad.227439.113 10.1212/WNL.58.12.1791 10.1111/jnc.14946 10.1038/ncb1009-1176 10.1016/j.neurobiolaging.2017.11.007 10.1001/jamaneurol.2021.3310 10.1080/17425247.2022.2063835 10.1002/ctm2.397 10.3389/fnagi.2019.00290 10.1007/s12035-020-02101-2 10.1093/hmg/ddl398 10.1523/JNEUROSCI.5052-10.2011 10.1016/j.neuro.2016.05.022 10.1007/s10571-013-0012-y 10.1016/j.neulet.2020.134919 10.1080/19490976.2021.1994835 10.1038/s41591-018-0013-y 10.3389/fmed.2018.00061 10.1267/ahc.21-00095 10.1016/j.freeradbiomed.2021.02.044 10.3389/fgene.2020.00171 10.1212/WNL.0000000000002035 10.1186/s13148-018-0547-3 10.3389/fnmol.2020.00041 10.1007/s40265-021-01546-6 10.1016/S0304-3940(99)00731-4 10.1101/2022.10.05.22280735 10.1523/JNEUROSCI.1592-12.2012 10.1186/s12974-016-0779-0 10.3390/cells10113064 10.1016/j.mad.2013.08.005 10.1016/S0197-4580(99)00053-6 10.1177/25168657211072499 10.1371/journal.pone.0233468 10.1038/s41467-020-19791-w 10.1016/S0140-6736(20)30367-6 10.1038/s41467-021-23545-7 10.3233/JAD-161118 10.1186/s13148-020-00864-y 10.3389/fnagi.2021.639428 10.1016/j.neurobiolaging.2010.08.017 10.1016/j.nbd.2021.105481 10.1016/j.humpath.2011.10.010 10.1186/s13063-021-05404-4 10.1038/s41583-021-00533-w 10.1016/j.cell.2019.09.001 10.1093/nar/gkm605 10.3389/fnins.2019.00476 10.1007/978-1-4939-8556-2_18 10.1007/s40265-020-01268-1 10.1212/NXG.0000000000000512 10.1038/srep37486 10.3389/fnmol.2016.00140 10.14336/AD.2019.0820 10.14283/jpad.2023.34 10.1016/j.neurol.2022.06.012 10.1177/2633105520942221 10.3233/JAD-170007 10.1016/j.lanepe.2022.100321 10.3389/fimmu.2018.02584 10.1186/s13059-016-1030-0 10.18632/aging.101414 10.1371/journal.pone.0009505 10.1101/gad.1941010 10.1212/01.WNL.0000044400.11317.EC 10.7150/ijbs.57078 10.1212/WNL.0000000000005303 10.3390/molecules27165232 10.1038/nbt.1732 10.3389/fncel.2018.00131 10.1089/neu.2014.3506 10.1016/j.cossms.2020.100872 10.1212/WNL.0000000000200898 10.1016/j.heliyon.2021.e07570 10.1124/jpet.117.244939 10.3390/ijms22115864 10.1016/j.neubiorev.2013.01.017 10.1126/science.aay0793 10.1093/brain/awh559 10.1038/s41380-021-01249-0 10.3233/JAD-190634 10.1186/s13578-021-00700-7 10.1093/hmg/ddt451 10.18632/oncotarget.4695 10.1186/s13045-019-0811-9 10.1038/s41586-021-03542-y 10.2174/1567205013666160930110551 10.1001/jamaneurol.2020.4478 10.3390/biom9110734 10.1073/pnas.1707151114 10.1186/s13578-020-00436-w 10.1186/s40478-022-01470-0 10.1002/mnfr.201600194 10.1186/s13195-017-0294-2 10.1101/cshperspect.a006213 10.3389/fncel.2021.746631 10.1371/journal.pone.0024515 10.1177/1533317512467680 10.1016/S1474-4422(18)30232-1 10.1186/s40035-018-0139-3 10.1080/15384101.2019.1629773 10.1016/j.neurobiolaging.2016.05.003 10.1371/journal.pone.0007176 10.1111/jcmm.13914 10.1038/nature04303 10.1016/j.tips.2021.07.002 10.1016/j.celrep.2016.04.045 10.1101/cshperspect.a025114 10.3390/ijms23158714 10.1016/j.immuni.2018.02.016 10.5213/inj.1938196.098 10.1016/S0891-5849(01)00688-8 10.3233/JAD-201182 10.1007/s11357-022-00558-8 10.1038/s41422-019-0216-x 10.1007/s12031-019-01364-2 10.1002/alz.051871 10.1038/nature11283 10.1111/jnc.14961 10.1111/bcp.14889 10.1038/s41593-018-0101-9 10.3389/fphar.2015.00205 10.1038/s41467-022-28280-1 10.1186/s13072-018-0211-3 10.1371/journal.pone.0002575 10.1016/j.freeradbiomed.2016.11.038 10.1111/ene.12453 10.1038/nature08085 10.1093/brain/awaa334 10.1038/s41467-021-25991-9 10.14336/AD.2020.1202 10.1038/s41467-019-10101-7 10.1016/j.biocel.2020.105747 10.3389/fnagi.2020.00103 10.3389/fnagi.2016.00140 10.1007/s13318-018-0507-5 10.1016/j.yfrne.2022.100986 10.1016/j.mad.2020.111319 10.3390/ijms24043754 10.3233/JAD-220614 10.1186/s13195-022-01151-z 10.1016/j.jalz.2016.02.002 10.1186/s13024-021-00489-6 10.3233/JAD-210090 10.1096/fj.15-282285 10.7150/thno.79535 10.2174/1570159X17666191010094849 10.3389/fneur.2020.00080 10.1186/s13041-016-0237-z 10.1111/j.1747-0285.2009.00781.x 10.5483/BMBRep.2019.52.1.290 10.1016/j.jmb.2006.06.038 10.1038/s41576-019-0106-6 10.1001/jamanetworkopen.2021.25584 10.1523/JNEUROSCI.1165-14.2014 10.1016/j.jalz.2018.01.017 10.1172/jci.insight.131093 10.1002/jcb.28276 10.1001/jamaneurol.2021.5216 10.1021/acs.chemrestox.9b00013 10.1016/j.neubiorev.2019.12.022 10.3389/fnmol.2016.00114 10.1371/journal.pone.0196929 10.1016/j.biopha.2023.114474 10.1016/j.neuron.2017.09.003 10.1016/j.celrep.2018.05.004 10.18632/aging.100742 10.1016/j.eurpsy.2008.12.005 10.1016/j.ejca.2021.08.012 10.1016/j.nut.2021.111499 10.1016/j.cell.2013.08.043 10.1186/s13072-021-00400-z 10.3389/fneur.2020.578720 10.1186/1756-8935-6-10 10.3389/fnagi.2022.837649 10.1016/j.mce.2020.111116 10.18632/aging.101684 10.3389/fendo.2018.00258 10.18632/aging.100864 10.3233/JAD-215217 10.3390/ijms222413647 10.1016/j.tins.2018.05.005 10.1007/s11682-013-9272-x 10.1016/j.bbi.2011.01.017 10.1016/j.bbagrm.2014.02.013 10.1186/s13195-021-00838-z 10.1038/s41380-019-0616-9 10.1016/j.conb.2021.09.009 10.1016/j.arr.2021.101496 10.3233/JAD-180242 10.1038/s41467-022-32475-x 10.1016/j.neulet.2022.136531 10.1111/jcmm.16811 10.4103/1673-5374.332127 10.3390/cells9051215 10.1093/hmg/ddv377 10.3389/fgene.2019.00153 10.1523/JNEUROSCI.2089-12.2012 10.3390/biom11020195 10.1101/cshperspect.a018713 10.1186/s13195-021-00862-z 10.1007/BF00308809 10.1186/s13024-021-00496-7 10.3389/fnagi.2020.00150 10.1007/s00018-017-2527-8 10.1007/s00281-017-0662-9 10.7326/M19-3887 10.1111/bpa.12881 10.1016/j.jnutbio.2021.108817 10.1111/j.1474-9726.2011.00680.x |
| ContentType | Journal Article |
| Copyright | 2023 Elsevier B.V. Copyright © 2023. Published by Elsevier B.V. Copyright © 2023 Elsevier B.V. All rights reserved. |
| Copyright_xml | – notice: 2023 Elsevier B.V. – notice: Copyright © 2023. Published by Elsevier B.V. – notice: Copyright © 2023 Elsevier B.V. All rights reserved. |
| DBID | AAYXX CITATION NPM 7X8 |
| DOI | 10.1016/j.arr.2023.102003 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Anatomy & Physiology |
| EISSN | 1872-9649 |
| ExternalDocumentID | 37422087 10_1016_j_arr_2023_102003 S1568163723001629 |
| Genre | Journal Article Review |
| GroupedDBID | --- --K --M -~X .1- .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 23M 4.4 457 4G. 53G 5GY 5VS 6J9 7-5 71M 8P~ AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AATTM AAXKI AAXUO AAYWO ABFNM ABFRF ABGSF ABJNI ABMAC ABUDA ABWVN ABXDB ACDAQ ACGFO ACGFS ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADUVX AEBSH AEFWE AEHWI AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGRDE AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU APXCP AXJTR BKOJK BLXMC CS3 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W KOM M41 MO0 N9A O-L O9- OAUVE OD~ OO0 OZT P-8 P-9 P2P PC. Q38 ROL RPZ SCC SDF SDG SDP SES SEW SPCBC SSU SSZ T5K UNMZH Z5R ~G- AACTN AAIAV ABYKQ AFCTW AFKWA AJBFU AJOXV AMFUW DOVZS EFLBG RIG AAYXX AGRNS BNPGV CITATION SSH NPM 7X8 |
| ID | FETCH-LOGICAL-c403t-7aab865cd8290daf12d351ca2ef831022470aed3e22f38171a67500d6de651ca3 |
| IEDL.DBID | .~1 |
| ISSN | 1568-1637 1872-9649 |
| IngestDate | Fri Jul 11 04:10:56 EDT 2025 Thu Apr 03 06:52:15 EDT 2025 Tue Jul 01 02:57:22 EDT 2025 Thu Apr 24 23:02:18 EDT 2025 Fri Feb 23 02:34:58 EST 2024 Tue Aug 26 20:09:24 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Epigenetics Clinical trials Aging Mild cognitive impairment Alzheimer’s clinical trials mild cognitive impairment aging |
| Language | English |
| License | Copyright © 2023. Published by Elsevier B.V. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c403t-7aab865cd8290daf12d351ca2ef831022470aed3e22f38171a67500d6de651ca3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| PMID | 37422087 |
| PQID | 2835280329 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2835280329 pubmed_primary_37422087 crossref_primary_10_1016_j_arr_2023_102003 crossref_citationtrail_10_1016_j_arr_2023_102003 elsevier_sciencedirect_doi_10_1016_j_arr_2023_102003 elsevier_clinicalkey_doi_10_1016_j_arr_2023_102003 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2023-09-01 |
| PublicationDateYYYYMMDD | 2023-09-01 |
| PublicationDate_xml | – month: 09 year: 2023 text: 2023-09-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Ageing research reviews |
| PublicationTitleAlternate | Ageing Res Rev |
| PublicationYear | 2023 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| References | Turner, Thomas, Craft, van Dyck, Mintzer, Reynolds, Brewer, Rissman, Raman, Aisen (bib327) 2015; 85 Alsadany, Shehata, Mohamad, Mahfouz (bib3) 2013; 28 Lythgoe, Prasad (bib211) 2021; 157 Cui, Xu (bib73) 2018; 19 Banerjee, Muralidharan, Hakim Mohammed, Malik (bib19) 2020; 12 Thal, Rüb, Orantes, Braak (bib320) 2002; 58 Xie, Liu, Liu, Jiang, Zhang, Cui, Zhang, Xu (bib352) 2017; 58 Hou, Zhou, Zhu, Wang, Pang, Wang, Liuyang, Man, Lu, Zhu, Liu (bib143) 2020; 154 Gorbunova, Seluanov, Mita, McKerrow, Fenyö, Boeke, Linker, Gage, Kreiling, Petrashen, Woodham, Taylor, Helfand, Sedivy (bib125) 2021; 596 Ji, Sigurdsson (bib157) 2021; 81 Pittaluga, Roggeri, Vallarino, Olivero (bib263) 2021; 22 Zheng, Prescott, Maksimovic, David (bib374) 2019; 32 Fink, Jutkowitz, McCarten, Hemmy, Butler, Davila, Ratner, Calvert, Barclay, Brasure, Nelson, Kane (bib107) 2018; 168 Kanach, Blusztajn, Fischer, Delalle (bib162) 2021; 7 Sanchez-Mut, Heyn, Silva, Dixsaut, Garcia-Esparcia, Vidal, Sayols, Glauser, Monteagudo-Sánchez, Perez-Tur, Ferrer, Monk, Schneider, Esteller, Gräff (bib288) 2018; 24 Kim, Lee, Choi, Yang, Hwang, Park, LaFerla, Han, Lee, Kim (bib171) 2017; 61 Bakulski, Dolinoy, Sartor, Paulson, Konen, Lieberman, Albin, Hu, Rozek (bib18) 2012; 29 Zhao, Liu, Van Ingelgom, Martens, Linares, Knight, Painter, Sullivan, Bu (bib371) 2017; 96 Sugden, Caspi, Elliott, Bourassa, Chamarti, Corcoran, Hariri, Houts, Kothari, Kritchevsky, Kuchel, Mill, Williams, Belsky, Moffitt (bib310) 2022; 99 Braak, Braak (bib36) 1991; 82 ClinicalTrials.gov, 2022h. Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease Participants. Shah, Kishore, Shastri (bib297) 2021; 22 Chen, Liu, Ji, Wu, Ji, Zhou, Zheng, Zhang, Xu, Huang (bib49) 2016; 2016 ClinicalTrials.gov, 2021b. Study to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's Disease (PEGASUS). Bollati, Galimberti, Pergoli, Dalla Valle, Barretta, Cortini, Scarpini, Bertazzi, Baccarelli (bib32) 2011; 25 Mahady, Nadeem, Malek-Ahmadi, Chen, Perez, Mufson (bib216) 2019; 45 Mummery, Junge, Kordasiewicz, Mignon, Moore, Yun, Baumann, Li, Norris, Crean (bib239) 2021; 17 Field, Robertson, Wang, Havas, Ideker, Adams (bib105) 2018; 71 Becker, Workman (bib23) 2013; 5 . Bateman, Cummings, Schobel, Salloway, Vellas, Boada, Black, Blennow, Fontoura, Klein, Assunção, Smith, Doody (bib22) 2022; 14 Cercillieux, Ciarlo, Canto (bib46) 2022; 79 He, Hui, Xu, Bai, Gao, Wang, Xie, Ye (bib135) 2022; 227 Zimmer-Bensch, Zempel (bib377) 2021; 10 Paparazzo, Lagani, Geracitano, Citrigno, Aceto, Malvaso, Bruno, Passarino, Montesanto (bib252) 2023; 24 Blanco-Luquin, Altuna, Sánchez-Ruiz de Gordoa, Urdánoz-Casado, Roldán, Cámara, Zelaya, Erro, Echavarri, Mendioroz (bib31) 2018; 10 Chen, Ge, Li, Yu, Wu, Zhao, He, Cai (bib47) 2022; 24 Monti, Cavallaro, Stoccoro, Nicolia, Scarpa, Kovacs, Fiorenza, Lucarelli, Aronica, Ferrer, Coppedè, Troen, Fuso (bib234) 2020; 15 Hampel, Hardy, Blennow, Chen, Perry, Kim, Villemagne, Aisen, Vendruscolo, Iwatsubo, Masters, Cho, Lannfelt, Cummings, Vergallo (bib132) 2021; 26 Finch, Sapolsky (bib106) 1999; 20 Khokale, Kang, Buchanan-Peart, Nelson, Awolumate, Cancarevic (bib168) 2020; 12 Arbo, André-Miral, Nasre-Nasser, Schimith, Santos, Costa-Silva, Muccillo-Baisch, Hort (bib10) 2020; 12 ClinicalTrials.gov, 2022g. Sirtuin-NAD Activator in Alzheimer's Disease. Phipps, Vickers, Taberlay, Woodhouse (bib262) 2016; 45 Imai, Guarente (bib150) 2016; 2 Li, Zhao, Tang, Zhang, Wang, Zhang, Hao, Bai, Lu (bib194) 2021; 25 Levine, Lu, Quach, Chen, Assimes, Bandinelli, Hou, Baccarelli, Stewart, Li, Whitsel, Wilson, Reiner, Aviv, Lohman, Liu, Ferrucci, Horvath (bib191) 2018; 10 Frisoni, Altomare, Thal, Ribaldi, van der Kant, Ossenkoppele, Blennow, Cummings, van Duijn, Nilsson, Dietrich, Scheltens, Dubois (bib113) 2022; 23 Zangerolamo, Vettorazzi, Solon, Bronczek, Engel, Kurauti, Soares, Rodrigues, Velloso, Boschero, Carneiro, Barbosa (bib358) 2021; 521 Lu, Quach, Wilson, Reiner, Aviv, Raj, Hou, Baccarelli, Li, Stewart, Whitsel, Assimes, Ferrucci, Horvath (bib208) 2019; 11 Ishida, Selaru (bib152) 2013; 1 Poly, Islam, Walther, Yang, Wu, Lin, Li (bib265) 2020; 54 Zhang, Zhao, Ao, Yu, Zhang, Wang, Chang (bib367) 2021; 13 Koh, Kwon, Choi, Jeong, Na, Lee, Yang, Lee, Lee, Park, Han, Kim, Park, Lee, Kim, Lee (bib176) 2021; 13 DeVos, Miller, Schoch, Holmes, Kebodeaux, Wegener, Chen, Shen, Tran, Nichols, Zanardi, Kordasiewicz, Swayze, Bennett, Diamond, Miller (bib87) 2017; 9 Zhao, Huai (bib368) 2023; 13 Bondarev, Attwood, Jonsson, Chubarev, Tarasov, Schiöth (bib33) 2021; 87 Kornicka, Szłapka-Kosarzewska, Śmieszek, Marycz (bib180) 2019; 23 Torgersen, Bellamy, Ratshaa, Han, Mosepele, Zuppa, Vujkovic, Steenhoff, Bisson, Gross (bib324) 2019; 44 Feng, Hou, Pieper, Leverenz, Cummings, Cheng (bib100) 2022; 18 Silva, Young, Zhang, Gomez, Schmidt, Varma, Chen, Martin, Wang (bib300) 2022; 13 Aron, Zullo, Yankner (bib14) 2022; 72 Faghihi, Modarresi, Khalil, Wood, Sahagan, Morgan, Finch, St Laurent, Kenny, Wahlestedt (bib98) 2008; 14 Ljubenkov, Edwards, Iaccarino, La Joie, Rojas, Koestler, Harris, Boeve, Borroni, van Swieten, Grossman, Pasquier, Frisoni, Mummery, Vandenberghe, Le Ber, Hannequin, McGinnis, Auriacombe, Onofrj, Goodman, Riordan, Wisniewski, Hesterman, Marek, Haynes, Patzke, Koenig, Hilt, Moebius, Boxer (bib204) 2021; 4 Vanderweyde, Apicco, Youmans-Kidder, Ash, Cook, Lummertz da Rocha, Jansen-West, Frame, Citro, Leszyk, Ivanov, Abisambra, Steffen, Li, Petrucelli, Wolozin (bib330) 2016; 15 Killingsworth, Sawmiller, Shytle (bib169) 2020; 12 Zhu, Grossman, Neugroschl, Parker, Burden, Luo, Sano (bib375) 2018; 4 Petersen, Caracciolo, Brayne, Gauthier, Jelic, Fratiglioni (bib259) 2014; 275 Bitto, Wang, Bennett, Kaeberlein (bib30) 2015; 5 Stefanelli, Azam, Walters, Brimble, Gettens, Bouchard-Cannon, Cheng, Davidoff, Narkaj, Day, Kennedy, Zovkic (bib309) 2018; 22 Zhang, Silva, Young, Gomez, Schmidt, Hamilton-Nelson, Kunkle, Chen, Martin, Wang (bib362) 2020; 11 Long, Holtzman (bib207) 2019; 179 Swygert, Peterson (bib312) 2014; 1839 Belsky, Caspi, Corcoran, Sugden, Poulton, Arseneault, Baccarelli, Chamarti, Gao, Hannon, Harrington, Houts, Kothari, Kwon, Mill, Schwartz, Vokonas, Wang, Williams, Moffitt (bib25) 2022; 11 Datta, Staszewski, Raschi, Frosch, Hagemeyer, Tay, Blank, Kreutzfeldt, Merkler, Ziegler-Waldkirch, Matthias, Meyer-Luehmann, Prinz (bib79) 2018; 48 Ionescu-Tucker, Butler, Berchtold, Matheos, Wood, Cotman (bib151) 2021; 13 Roy, Wong, Aquili, Uddin, Heng, Tipoe, Wong, Fung, Lim (bib282) 2022; 65 Guo, Jeong, Hsieh, Klein, Bennett, De Jager, Liu, Shulman (bib128) 2018; 23 Cummings, Lee, Zhong, Fonseca, Taghva (bib74) 2021; 7 Zhu, Chen, Shen, Huang, Sedivy, Wang, Ju (bib376) 2021; 6 Bufill, Blesa, Augustí (bib38) 2013; 91 Klungland, Robertson (bib174) 2017; 107 Zhang, Hu, Teng, Tang, Chen (bib361) 2014; 34 Vasanthakumar, Davis, Idler, Waring, Asque, Riley-Gillis, Grosskurth, Srivastava, Kim, Nho, Nudelman, Faber, Sun, Foroud, Estrada, Apostolova, Li, Saykin (bib332) 2020; 12 Du, Zheng (bib90) 2021; 11 Akhter, Shao, Shaw, Formica, Khrestian, Leverenz, Bekris (bib2) 2018; 63 Li, Marshall, Oh, Jakubowski, Groot, He, Wang, Petronis, Labrie (bib195) 2019; 10 Wang, Qin, Tang (bib339) 2019; 10 ClinicalTrials.gov, 2022e. Pilot Study to Investigate the Safety and Feasibility of AntiRetroviral Therapy for Alzheimer's Disease (ART-AD) Villain, Planche, Levy (bib333) 2022; 178 Bernstein (bib28) 2022; 15 Yen, Vinayachandran, Pugh (bib356) 2013; 154 Panegyres, Chen (bib251) 2014; 21 Modarresi, Pedram Fatemi, Razavipour, Ricciardi, Makhmutova, Khoury, Magistri, Volmar, Wahlestedt, Faghihi (bib233) 2021; 7 Wei, Zhang, Zeng (bib345) 2020; 191 García-González, Pilat, Baranger, Rivera (bib118) 2019; 11 Purushotham, Tashrifwala, Jena, Vudugula, Patil, Agrawal (bib270) 2022; 14 Talevi (bib314) 2015; 6 Yuen, Liang, Zhu, Jia, Leung (bib357) 2021; 13 Meshorer, Gruenbaum (bib229) 2009; 11 Lang, Eulalio, Fox, Yakabi, Bukhari, Kawas, Corrada, Montgomery, Heppner, Capper, Nachun, Montine (bib186) 2022; 10 Jansen, Janssen, Tijms, Vos, Ossenkoppele, Visser, Aarsland, Alcolea, Altomare, von Arnim, Baiardi, Baldeiras, Barthel, Bateman, Van Berckel, Binette, Blennow, Boada, Boecker, Bottlaender, den Braber, Brooks, Van Buchem, Camus, Carill, Cerman, Chen, Chételat, Chipi, Cohen, Daniels, Delarue, Didic, Drzezga, Dubois, Eckerström, Ekblad, Engelborghs, Epelbaum, Fagan, Fan, Fladby, Fleisher, Van der Flier, Förster, Fortea, Frederiksen, Freund-Levi, Frings, Frisoni, Fröhlich, Gabryelewicz, Gertz, Gill, Gkatzima, Gómez-Tortosa, Grimmer, Guedj, Habeck, Hampel, Handels, Hansson, Hausner, Hellwig, Heneka, Herukka, Hildebrandt, Hodges, Hort, Huang, Iriondo, Itoh, Ivanoiu, Jagust, Jessen, Johannsen, Johnson, Kandimalla, Kapaki, Kern, Kilander, Klimkowicz-Mrowiec, Klunk, Koglin, Kornhuber, Kramberger, Kuo, Van Laere, Landau, Landeau, Lee, de Leon, Leyton, Lin, Lleó, Löwenmark, Madsen, Maier, Marcusson, Marquié, Martinez-Lage, Maserejian, Mattsson, de Mendonça, Meyer, Miller, Minatani, Mintun, Mok, Molinuevo, Morbelli, Morris, Mroczko, Na, Newberg, Nobili, Nordberg, Olde Rikkert, de Oliveira, Olivieri, Orellana, Paraskevas, Parchi, Pardini, Parnetti, Peters, Poirier, Popp, Prabhakar, Rabinovici, Ramakers, Rami, Reiman, Rinne, Rodrigue, Rodríguez-Rodriguez, Roe, Rosa-Neto, Rosen, Rot, Rowe, Rüther, Ruiz, Sabri, Sakhardande, Sánchez-Juan, Sando, Santana, Sarazin, Scheltens, Schröder, Selnes, Seo, Silva, Skoog, Snyder, Soininen, Sollberger, Sperling, Spiru, Stern, Stomrud, Takeda, Teichmann, Teunissen, Thompson, Tomassen, Tsolaki, Vandenberghe, Verbeek, Verhey, Villemagne, Villeneuve, Vogelgsang, Waldemar, Wallin, Wallin, Wiltfang, Wolk, Fleisher, Zboch, Zetterberg (bib155) 2022 Ozaki, Yoshino, Yamazaki, Sao, Mori, Ochi, Yoshida, Mori, Iga, Ueno (bib249) 2017; 92 Fleischman, Wilson, Gabrieli, Schneider, Bienias, Bennett (bib110) 2005; 128 Yao, Liang, Liu, Zhang, Zhu, Huang, Qin (bib354) 2014; 34 Zhao, Zhou, Guo, Yue, Chen, Liang, Xu (bib369) 2020; 10 Gong, Dai, Liu, Iqbal (bib123) 2022; 14 Johnson, K Andrés-Benito (10.1016/j.arr.2023.102003_bib8) 2018; 12 Churchland (10.1016/j.arr.2023.102003_bib54) 2012 Butchart (10.1016/j.arr.2023.102003_bib40) 2015; 84 Hannum (10.1016/j.arr.2023.102003_bib133) 2013; 49 Jeremic (10.1016/j.arr.2023.102003_bib156) 2021; 72 Cuajungco (10.1016/j.arr.2023.102003_bib72) 2005; 38 Walgrave (10.1016/j.arr.2023.102003_bib336) 2021; 16 Proskovec (10.1016/j.arr.2023.102003_bib269) 2020; 3 Chen (10.1016/j.arr.2023.102003_bib50) 2022; 85 Cummings (10.1016/j.arr.2023.102003_bib75) 2021; 13 Halder (10.1016/j.arr.2023.102003_bib131) 2016 Press (10.1016/j.arr.2023.102003_bib268) 2023 Phipps (10.1016/j.arr.2023.102003_bib262) 2016; 45 Shireby (10.1016/j.arr.2023.102003_bib298) 2020; 143 Cui (10.1016/j.arr.2023.102003_bib73) 2018; 19 Bakulski (10.1016/j.arr.2023.102003_bib17) 2012; 9 Talevi (10.1016/j.arr.2023.102003_bib314) 2015; 6 Paluvai (10.1016/j.arr.2023.102003_bib250) 2020; 9 Poon (10.1016/j.arr.2023.102003_bib266) 2020; 111 Mercorio (10.1016/j.arr.2023.102003_bib228) 2018; 65 Li (10.1016/j.arr.2023.102003_bib192) 2018; 7 Zhang (10.1016/j.arr.2023.102003_bib360) 2021; 17 Fotuhi (10.1016/j.arr.2023.102003_bib111) 2019; 69 Hillary (10.1016/j.arr.2023.102003_bib139) 2021; 26 Monti (10.1016/j.arr.2023.102003_bib234) 2020; 15 Roda (10.1016/j.arr.2023.102003_bib279) 2022; 17 10.1016/j.arr.2023.102003_bib272 VandeVrede (10.1016/j.arr.2023.102003_bib331) 2020; 731 Torgersen (10.1016/j.arr.2023.102003_bib324) 2019; 44 Lombardi (10.1016/j.arr.2023.102003_bib206) 2020; 3 Yao (10.1016/j.arr.2023.102003_bib354) 2014; 34 Zhang (10.1016/j.arr.2023.102003_bib362) 2020; 11 Fink (10.1016/j.arr.2023.102003_bib108) 2020; 172 Ridler (10.1016/j.arr.2023.102003_bib277) 2018; 14 Kölsch (10.1016/j.arr.2023.102003_bib177) 2009; 24 Kontush (10.1016/j.arr.2023.102003_bib179) 2001; 31 Scheyer (10.1016/j.arr.2023.102003_bib292) 2018; 5 Rafii (10.1016/j.arr.2023.102003_bib273) 2023 Rodrigues (10.1016/j.arr.2023.102003_bib280) 2020; 40 Dang (10.1016/j.arr.2023.102003_bib77) 2009; 459 Meng (10.1016/j.arr.2023.102003_bib227) 2023; 10 Li (10.1016/j.arr.2023.102003_bib197) 2020; 123 Vasanthakumar (10.1016/j.arr.2023.102003_bib332) 2020; 12 Qing (10.1016/j.arr.2023.102003_bib271) 2008; 205 DeVos (10.1016/j.arr.2023.102003_bib86) 2013; 33 Belsky (10.1016/j.arr.2023.102003_bib25) 2022; 11 Sanchez-Mut (10.1016/j.arr.2023.102003_bib287) 2015; 9 Yassine (10.1016/j.arr.2023.102003_bib355) 2020; 12 Franceschi (10.1016/j.arr.2023.102003_bib112) 2018; 5 Sen (10.1016/j.arr.2023.102003_bib295) 2021 Cheng (10.1016/j.arr.2023.102003_bib53) 2015; 268 Wang (10.1016/j.arr.2023.102003_bib342) 2019; 29 Wang (10.1016/j.arr.2023.102003_bib338) 2022; 7 Tasaki (10.1016/j.arr.2023.102003_bib318) 2022; 13 Li (10.1016/j.arr.2023.102003_bib195) 2019; 10 De Plano (10.1016/j.arr.2023.102003_bib81) 2022; 23 Tohgi (10.1016/j.arr.2023.102003_bib322) 1999; 70 Datta (10.1016/j.arr.2023.102003_bib79) 2018; 48 Esopenko (10.1016/j.arr.2023.102003_bib95) 2015; 32 Mummery (10.1016/j.arr.2023.102003_bib239) 2021; 17 Roichman (10.1016/j.arr.2023.102003_bib281) 2021; 12 Hsieh (10.1016/j.arr.2023.102003_bib145) 2010; 5 Liu (10.1016/j.arr.2023.102003_bib201) 2013; 9 Sánchez-Rodríguez (10.1016/j.arr.2023.102003_bib289) 2020; 153 Shah (10.1016/j.arr.2023.102003_bib297) 2021; 22 Asakiya (10.1016/j.arr.2023.102003_bib16) 2022; 19 Lang (10.1016/j.arr.2023.102003_bib186) 2022; 10 Madrid (10.1016/j.arr.2023.102003_bib214) 2018; 66 Akhter (10.1016/j.arr.2023.102003_bib2) 2018; 63 Smith (10.1016/j.arr.2023.102003_bib303) 2020; 30 Ljubenkov (10.1016/j.arr.2023.102003_bib204) 2021; 4 Petkovic (10.1016/j.arr.2023.102003_bib260) 2021; 98 Maes (10.1016/j.arr.2023.102003_bib215) 2020; 15 Alzheimer's_Association (10.1016/j.arr.2023.102003_bib6) 2021; 17 Musiek (10.1016/j.arr.2023.102003_bib240) 2021; 78 Kumar (10.1016/j.arr.2023.102003_bib183) 2022; 20 Chen (10.1016/j.arr.2023.102003_bib51) 2020; 11 DeVos (10.1016/j.arr.2023.102003_bib87) 2017; 9 Bufill (10.1016/j.arr.2023.102003_bib38) 2013; 91 Gorbunova (10.1016/j.arr.2023.102003_bib125) 2021; 596 Arqué (10.1016/j.arr.2023.102003_bib15) 2008; 3 Frisoni (10.1016/j.arr.2023.102003_bib113) 2022; 23 Iwata (10.1016/j.arr.2023.102003_bib154) 2014; 23 Decourt (10.1016/j.arr.2023.102003_bib82) 2017; 14 Finch (10.1016/j.arr.2023.102003_bib106) 1999; 20 Galkin (10.1016/j.arr.2023.102003_bib116) 2020; 60 Martinez de Lagran (10.1016/j.arr.2023.102003_bib224) 2022; 26 Mastroeni (10.1016/j.arr.2023.102003_bib225) 2011; 32 Zhang (10.1016/j.arr.2023.102003_bib359) 2018; 10 Higaki (10.1016/j.arr.2023.102003_bib138) 2018; 13 Celarain (10.1016/j.arr.2023.102003_bib45) 2016; 8 Tariot (10.1016/j.arr.2023.102003_bib317) 2011; 68 Du (10.1016/j.arr.2023.102003_bib88) 2003; 60 Craft (10.1016/j.arr.2023.102003_bib71) 2020; 77 Park (10.1016/j.arr.2023.102003_bib254) 2014; 35 Bell (10.1016/j.arr.2023.102003_bib24) 2019; 20 Jicha (10.1016/j.arr.2023.102003_bib158) 2019; 15 Yen (10.1016/j.arr.2023.102003_bib356) 2013; 154 Wattmo (10.1016/j.arr.2023.102003_bib344) 2017; 9 Eyileten (10.1016/j.arr.2023.102003_bib97) 2021; 58 Wang (10.1016/j.arr.2023.102003_bib343) 2018; 10 Mahady (10.1016/j.arr.2023.102003_bib216) 2019; 45 Reitz (10.1016/j.arr.2023.102003_bib276) 2020; 6 Smith (10.1016/j.arr.2023.102003_bib305) 2018; 14 Huin (10.1016/j.arr.2023.102003_bib147) 2016; 31 Hou (10.1016/j.arr.2023.102003_bib143) 2020; 154 Thrush (10.1016/j.arr.2023.102003_bib321) 2022; 14 Zangerolamo (10.1016/j.arr.2023.102003_bib358) 2021; 521 Tamaru (10.1016/j.arr.2023.102003_bib316) 2010; 24 Salameh (10.1016/j.arr.2023.102003_bib286) 2020; 11 van der Kant (10.1016/j.arr.2023.102003_bib85) 2019; 24 Arnsten (10.1016/j.arr.2023.102003_bib13) 2021; 17 Fernando (10.1016/j.arr.2023.102003_bib102) 2020; 74 Fitz (10.1016/j.arr.2023.102003_bib109) 2021; 159 Levine (10.1016/j.arr.2023.102003_bib190) 2015; 7 Zhang (10.1016/j.arr.2023.102003_bib361) 2014; 34 Chen (10.1016/j.arr.2023.102003_bib49) 2016; 2016 Du (10.1016/j.arr.2023.102003_bib90) 2021; 11 Esposito (10.1016/j.arr.2023.102003_bib96) 2019; 13 Zhao (10.1016/j.arr.2023.102003_bib371) 2017; 96 Zhao (10.1016/j.arr.2023.102003_bib369) 2020; 10 Hrit (10.1016/j.arr.2023.102003_bib144) 2018 Sanchez-Mut (10.1016/j.arr.2023.102003_bib288) 2018; 24 Jansen (10.1016/j.arr.2023.102003_bib155) 2022 Koenig (10.1016/j.arr.2023.102003_bib175) 2018; 16 Dubois (10.1016/j.arr.2023.102003_bib92) 2016; 12 Meshorer (10.1016/j.arr.2023.102003_bib229) 2009; 11 Bradley-Whitman (10.1016/j.arr.2023.102003_bib37) 2013; 134 Wei (10.1016/j.arr.2023.102003_bib345) 2020; 191 Zhang (10.1016/j.arr.2023.102003_bib363) 2023; 161 Fuller (10.1016/j.arr.2023.102003_bib114) 2019; 10 Modarresi (10.1016/j.arr.2023.102003_bib233) 2021; 7 Nunes (10.1016/j.arr.2023.102003_bib245) 2012; 45 Li (10.1016/j.arr.2023.102003_bib194) 2021; 25 Gauthier (10.1016/j.arr.2023.102003_bib121) 2021 Tohgi (10.1016/j.arr.2023.102003_bib323) 1999; 275 Zhang (10.1016/j.arr.2023.102003_bib364) 2023 Cao (10.1016/j.arr.2023.102003_bib42) 2021; 2021 Bergsma (10.1016/j.arr.2023.102003_bib27) 2020; 15 Horvath (10.1016/j.arr.2023.102003_bib141) 2015; 7 Syed (10.1016/j.arr.2023.102003_bib313) 2020; 80 Nott (10.1016/j.arr.2023.102003_bib244) 2019; 366 Marchesi (10.1016/j.arr.2023.102003_bib222) 2016; 30 Xia (10.1016/j.arr.2023.102003_bib351) 2021; 58 Carmona (10.1016/j.arr.2023.102003_bib43) 2018; 17 Ozaki (10.1016/j.arr.2023.102003_bib249) 2017; 92 Panegyres (10.1016/j.arr.2023.102003_bib251) 2014; 21 Wu (10.1016/j.arr.2023.102003_bib348) 2016; 9 Bateman (10.1016/j.arr.2023.102003_bib22) 2022; 14 Long (10.1016/j.arr.2023.102003_bib207) 2019; 179 10.1016/j.arr.2023.102003_bib63 10.1016/j.arr.2023.102003_bib62 Ionescu-Tucker (10.1016/j.arr.2023.102003_bib151) 2021; 13 10.1016/j.arr.2023.102003_bib61 10.1016/j.arr.2023.102003_bib60 Sierra (10.1016/j.arr.2023.102003_bib299) 2020; 7 Wiley (10.1016/j.arr.2023.102003_bib347) 2011; 10 10.1016/j.arr.2023.102003_bib67 Hwang (10.1016/j.arr.2023.102003_bib148) 2017; 74 Blanco-Luquin (10.1016/j.arr.2023.102003_bib31) 2018; 10 10.1016/j.arr.2023.102003_bib66 Daruich (10.1016/j.arr.2023.102003_bib78) 2019; 25 10.1016/j.arr.2023.102003_bib65 10.1016/j.arr.2023.102003_bib64 Horvath (10.1016/j.arr.2023.102003_bib142) 2016; 17 Liang (10.1016/j.arr.2023.102003_bib199) 2021; 15 10.1016/j.arr.2023.102003_bib59 10.1016/j.arr.2023.102003_bib58 Braak (10.1016/j.arr.2023.102003_bib36) 1991; 82 10.1016/j.arr.2023.102003_bib57 Horvath (10.1016/j.arr.2023.102003_bib140) 2013; 14 Maiques-Diaz (10.1016/j.arr.2023.102003_bib218) 2016; 8 Migliore (10.1016/j.arr.2023.102003_bib230) 2022; 18 Sáez-Orellana (10.1016/j.arr.2023.102003_bib284) 2020; 9 Aron (10.1016/j.arr.2023.102003_bib14) 2022; 72 Huhn (10.1016/j.arr.2023.102003_bib146) 2018; 174 Kong (10.1016/j.arr.2023.102003_bib178) 2020; 18 Vanderweyde (10.1016/j.arr.2023.102003_bib330) 2016; 15 Mahase (10.1016/j.arr.2023.102003_bib217) 2023; 380 Iatrou (10.1016/j.arr.2023.102003_bib149) 2021; 16 Ma (10.1016/j.arr.2023.102003_bib213) 2016; 6 Lee (10.1016/j.arr.2023.102003_bib188) 2019; 52 Liu (10.1016/j.arr.2023.102003_bib202) 2018; 9 10.1016/j.arr.2023.102003_bib56 10.1016/j.arr.2023.102003_bib55 Poly (10.1016/j.arr.2023.102003_bib265) 2020; 54 10.1016/j.arr.2023.102003_bib5 Du (10.1016/j.arr.2023.102003_bib91) 2021; 13 Song (10.1016/j.arr.2023.102003_bib306) 2011; 29 10.1016/j.arr.2023.102003_bib4 Kim (10.1016/j.arr.2023.102003_bib171) 2017; 61 Boscher (10.1016/j.arr.2023.102003_bib34) 2020; 11 García-González (10.1016/j.arr.2023.102003_bib118) 2019; 11 Sim (10.1016/j.arr.2023.102003_bib301) 2006; 15 Bitto (10.1016/j.arr.2023.102003_bib30) 2015; 5 Kornicka (10.1016/j.arr.2023.102003_bib180) 2019; 23 Field (10.1016/j.arr.2023.102003_bib105) 2018; 71 Mano (10.1016/j.arr.2023.102003_bib220) 2021; 8 Kanach (10.1016/j.arr.2023.102003_bib162) 2021; 7 Zhang (10.1016/j.arr.2023.102003_bib366) 2012 Hampel (10.1016/j.arr.2023.102003_bib132) 2021; 26 Schrauben (10.1016/j.arr.2023.102003_bib293) 2020; 30 Zhao (10.1016/j.arr.2023.102003_bib368) 2023; 13 Andrade-Guerrero (10.1016/j.arr.2023.102003_bib7) 2023; 24 Zheng (10.1016/j.arr.2023.102003_bib374) 2019; 32 Garcia (10.1016/j.arr.2023.102003_bib117) 2021; 42 García-Martínez (10.1016/j.arr.2023.1 |
| References_xml | – volume: 396 start-page: 413 year: 2020 end-page: 446 ident: bib203 article-title: Dementia prevention, intervention, and care: 2020 report of the Lancet Commission publication-title: Lancet – reference: Qiu, W., Chen, H., Kaeberlein, M., Lee, S.-I., 2022. An explainable AI framework for interpretable biological age. medRxiv, 2022.2010.2005.22280735. – volume: 9 start-page: 258 year: 2018 ident: bib274 article-title: Aging hallmarks: the benefits of physical exercise publication-title: Front. Endocrinol. – volume: 13 start-page: 126 year: 2021 ident: bib357 article-title: Prediction of differentially expressed microRNAs in blood as potential biomarkers for Alzheimer's disease by meta-analysis and adaptive boosting ensemble learning publication-title: Alzheimers Res Ther. – volume: 154 start-page: 1246 year: 2013 end-page: 1256 ident: bib356 article-title: SWR-C and INO80 chromatin remodelers recognize nucleosome-free regions near +1 nucleosomes publication-title: Cell – volume: 30 start-page: 503 year: 2016 end-page: 506 ident: bib222 article-title: Gain-of-function somatic mutations contribute to inflammation and blood vessel damage that lead to Alzheimer dementia: a hypothesis publication-title: Faseb J. – volume: 34 start-page: 14919 year: 2014 end-page: 14933 ident: bib361 article-title: Synaptic and cognitive improvements by inhibition of 2-AG metabolism are through upregulation of microRNA-188-3p in a mouse model of Alzheimer's disease publication-title: J. Neurosci. – year: 2023 ident: bib373 article-title: ROS inhibition increases KDM6A-mediated NOX2 transcription and promotes macrophages oxidative stress and M1 polarization publication-title: Cell Stress Chaperon-.-. – volume: 12 start-page: 3208 year: 2021 ident: bib281 article-title: Restoration of energy homeostasis by SIRT6 extends healthy lifespan publication-title: Nat. Commun. – volume: 23 year: 2022 ident: bib81 article-title: Applications of CRISPR-Cas9 in Alzheimer's disease and related disorders publication-title: Int J. Mol. Sci. – volume: 41 start-page: 655 year: 2019 end-page: 670 ident: bib290 article-title: Sulforaphane - role in aging and neurodegeneration publication-title: Geroscience – volume: 337 start-page: 70 year: 2022 end-page: 74 ident: bib337 article-title: Challenging dogmas: how transgenerational epigenetics reshapes our views on life publication-title: J. Exp. Zool. A Ecol. Integr. Physiol. – volume: 12 start-page: 1252 year: 2021 end-page: 1262 ident: bib115 article-title: DeepMAge: a methylation aging clock developed with deep learning publication-title: Aging Dis. – volume: 10 start-page: 775 year: 2018 end-page: 788 ident: bib343 article-title: Identifying circRNA-associated-ceRNA networks in the hippocampus of Aβ1-42-induced Alzheimer's disease-like rats using microarray analysis publication-title: Aging (Albany NY) – volume: 16 start-page: 1 year: 2021 end-page: 15 ident: bib149 article-title: Nuclear dynamics and stress responses in Alzheimer’s disease publication-title: Mol. Neurodegener. – reference: Oryzon ORYZON presents vafidemstat 12-month clinical data from its Phase IIa clinical trials ETHERAL and REIMAGINE-AD in Alzheimer’s at the virtual AD/PD-2021 conference 2021. – volume: 13 start-page: 197 year: 2023 end-page: 230 ident: bib368 article-title: Role of primary aging hallmarks in Alzheimer´s disease publication-title: Theranostics – volume: 24 year: 2020 ident: bib307 article-title: Mechanical regulation of histone modifications and cell plasticity publication-title: Curr. Opin. Solid State Mater. Sci. – volume: 24 start-page: 1 year: 2022 end-page: 10 ident: bib47 article-title: TUDCA protects against tunicamycin‑induced apoptosis of dorsal root ganglion neurons by suppressing activation of ER stress publication-title: Exp. Ther. Med – volume: 82 start-page: 965 year: 2021 end-page: 974 ident: bib185 article-title: Time to diagnosis in young onset Alzheimer's disease: a population-based study from central norway publication-title: J. Alzheimers Dis. – volume: 15 start-page: 781 year: 2020 end-page: 799 ident: bib234 article-title: CpG and non-CpG Presenilin1 methylation pattern in course of neurodevelopment and neurodegeneration is associated with gene expression in human and murine brain publication-title: Epigenetics – volume: 9 start-page: 579 year: 2018 ident: bib202 article-title: The epigenetics of Alzheimer's disease: factors and therapeutic implications publication-title: Front Genet – volume: 37 start-page: 501 year: 2022 end-page: 502 ident: bib11 article-title: Experience with subcutaneous levetiracetam in palliative care patients: prognostic and pharmacological considerations publication-title: Neurol. (Engl. Ed. ) – volume: 438 start-page: 685 year: 2005 end-page: 689 ident: bib181 article-title: Silencing of microRNAs in vivo with 'antagomirs' publication-title: Nature – volume: 45 start-page: 440 year: 2012 end-page: 454 ident: bib245 article-title: TUDCA, a bile acid, attenuates amyloid precursor protein processing and amyloid-β deposition in APP/PS1 mice publication-title: Mol. Neurobiol. – start-page: 7 year: 2018 ident: bib144 article-title: OGT binds a conserved C-terminal domain of TET1 to regulate TET1 activity and function in development publication-title: Elife – volume: 11 year: 2021 ident: bib285 article-title: A glitch in the snitch: the role of linker histone H1 in shaping the epigenome in normal and diseased cells publication-title: Open Biol. – volume: 17 start-page: 171 year: 2016 ident: bib142 article-title: An epigenetic clock analysis of race/ethnicity, sex, and coronary heart disease publication-title: Genome Biol. – volume: 167 start-page: 125 year: 2021 end-page: 140 ident: bib340 article-title: Nanodelivery of natural isothiocyanates as a cancer therapeutic publication-title: Free Radic. Biol. Med – volume: 44 start-page: 179 year: 2019 end-page: 187 ident: bib324 article-title: Impact of efavirenz metabolism on loss to care in older HIV+ africans publication-title: Eur. J. Drug Metab. Pharm. – volume: 20 start-page: 407 year: 1999 end-page: 428 ident: bib106 article-title: The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms☆ publication-title: Neurobiol. Aging – volume: 14 start-page: 412 year: 2017 end-page: 425 ident: bib82 article-title: Targeting tumor necrosis factor alpha for Alzheimer's disease publication-title: Curr. Alzheimer Res – volume: 9 start-page: 61 year: 2016 ident: bib200 article-title: Altered DNA base excision repair profile in brain tissue and blood in Alzheimer’s disease publication-title: Mol. Brain – volume: 17 start-page: 721 year: 2018 end-page: 730 ident: bib43 article-title: The role of TREM2 in Alzheimer's disease and other neurodegenerative disorders publication-title: Lancet Neurol. – volume: 24 start-page: 363 year: 2019 end-page: 375.e369 ident: bib85 article-title: Cholesterol metabolism is a druggable axis that independently regulates tau and amyloid-β in iPSC-derived Alzheimer's disease neurons publication-title: Cell Stem Cell – volume: 6 start-page: 5739 year: 2021 end-page: 5753 ident: bib129 article-title: Computational analysis indicates that PARP1 acts as a histone deacetylases interactor sharing common lysine residues for acetylation, ubiquitination, and SUMOylation in Alzheimer's and Parkinson's disease publication-title: ACS Omega – volume: 13 start-page: 41 year: 2020 ident: bib164 article-title: Oxidative stress in cognitive and epigenetic aging: a retrospective glance publication-title: Front Mol. Neurosci. – volume: 40 start-page: 2177 year: 2020 end-page: 2211 ident: bib280 article-title: Histone deacetylases as targets for the treatment of neurodegenerative disorders: challenges and future opportunities publication-title: Med Res Rev. – volume: 10 start-page: 418 year: 2011 end-page: 428 ident: bib347 article-title: Phenylbutyric acid reduces amyloid plaques and rescues cognitive behavior in AD transgenic mice publication-title: Aging Cell – volume: 376 year: 2022 ident: bib212 article-title: Regulatory decisions diverge over aducanumab for Alzheimer’s disease publication-title: BMJ – year: 2023 ident: bib364 article-title: Distinct CSF biomarker-associated DNA methylation in Alzheimer's disease and cognitively normal subjects publication-title: Res Sq. – volume: 9 start-page: 563 year: 2012 end-page: 573 ident: bib17 article-title: Alzheimer's disease and environmental exposure to lead: the epidemiologic evidence and potential role of epigenetics publication-title: Curr. Alzheimer Res – volume: 87 start-page: 4577 year: 2021 end-page: 4597 ident: bib33 article-title: Recent developments of HDAC inhibitors: emerging indications and novel molecules publication-title: Br. J. Clin. Pharm. – volume: 5 year: 2015 ident: bib30 article-title: Biochemical genetic pathways that modulate aging in multiple species publication-title: Cold Spring Harb. Perspect. Med – reference: ClinicalTrials.gov, 2022d. GV1001 Subcutaneous(SC) for the Treatment of Mild to Moderate Alzheimer's Disease (AD). – volume: 11 start-page: 171 year: 2020 ident: bib286 article-title: DNA methylation biomarkers in aging and age-related diseases publication-title: Front Genet – volume: 154 start-page: 441 year: 2020 end-page: 457 ident: bib143 article-title: Correcting abnormalities in miR-124/PTPN1 signaling rescues tau pathology in Alzheimer's disease publication-title: J. Neurochem. – volume: 11 year: 2021 ident: bib243 article-title: Epigenetics of Alzheimer's disease publication-title: Biomolecules – volume: 12 start-page: 84 year: 2020 ident: bib332 article-title: Harnessing peripheral DNA methylation differences in the Alzheimer's Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease publication-title: Clin. Epigenetics – volume: 25 start-page: 610 year: 2019 end-page: 624 ident: bib78 article-title: Review: the bile acids urso- and tauroursodeoxycholic acid as neuroprotective therapies in retinal disease publication-title: Mol. Vis. – volume: 116 start-page: 779 year: 2004 end-page: 793 ident: bib184 article-title: A small modulatory dsRNA specifies the fate of adult neural stem cells publication-title: Cell – volume: 8 start-page: 1103 year: 2016 end-page: 1116 ident: bib218 article-title: LSD1: biologic roles and therapeutic targeting publication-title: Epigenomics – volume: 35 start-page: 5545 year: 2007 end-page: 5555 ident: bib346 article-title: Defective DNA base excision repair in brain from individuals with Alzheimer's disease and amnestic mild cognitive impairment publication-title: Nucleic Acids Res – volume: 14 start-page: 5641 year: 2022 end-page: 5668 ident: bib321 article-title: Aging the brain: multi-region methylation principal component based clock in the context of Alzheimer's disease publication-title: Aging (Albany NY) – volume: 69 start-page: 351 year: 2019 end-page: 359 ident: bib111 article-title: Long Non-coding RNA BACE1-AS may serve as an Alzheimer's disease blood-based biomarker publication-title: J. Mol. Neurosci. – volume: 35 start-page: 5440 year: 2021 end-page: 5458 ident: bib219 article-title: Sulforaphane: A review of its therapeutic potentials, advances in its nanodelivery, recent patents, and clinical trials publication-title: Phytother. Res. – start-page: 228 year: 2022 end-page: 243 ident: bib155 article-title: Prevalence estimates of amyloid abnormality across the alzheimer disease clinical spectrum publication-title: JAMA Neurol – volume: 16 start-page: 76 year: 2021 ident: bib336 article-title: The promise of microRNA-based therapies in Alzheimer's disease: challenges and perspectives publication-title: Mol. Neurodegener. – volume: 58 start-page: 4038 year: 2021 end-page: 4050 ident: bib351 article-title: The protective A673T mutation of amyloid precursor protein (APP) in Alzheimer's disease publication-title: Mol. Neurobiol. – reference: ClinicalTrials.gov, 2019. Modulation of Micro-RNA Pathways by Gemfibrozil in Predementia Alzheimer Disease. – volume: 22 year: 2021 ident: bib297 article-title: Complement system in Alzheimer's disease publication-title: Int. J. Mol. Sci. – volume: 159 start-page: 709 year: 2014 end-page: 713 ident: bib166 article-title: Geroscience: linking aging to chronic disease publication-title: Cell – volume: 12 start-page: 5711 year: 2021 ident: bib291 article-title: Unraveling the functional role of DNA demethylation at specific promoters by targeted steric blockage of DNA methyltransferase with CRISPR/dCas9 publication-title: Nat. Commun. – volume: 380 start-page: 73 year: 2023 ident: bib217 article-title: Alzheimer's disease: FDA approves lecanemab amid cost and safety concerns publication-title: Bmj – volume: 68 start-page: 853 year: 2011 end-page: 861 ident: bib317 article-title: Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease publication-title: Arch. Gen. Psychiatry – volume: 41 start-page: 587 year: 2018 end-page: 598 ident: bib29 article-title: Epigenetic regulation in neurodegenerative diseases publication-title: Trends Neurosci. – volume: 4 year: 2009 ident: bib350 article-title: Human telomerase reverse transcriptase (hTERT) Q169 is essential for telomerase function in vitro and in vivo publication-title: PLoS One – volume: 61 year: 2017 ident: bib122 article-title: Targeting the epigenome: screening bioactive compounds that regulate histone deacetylase activity publication-title: Mol. Nutr. Food Res – volume: 3 year: 2020 ident: bib269 article-title: Association of epigenetic metrics of biological age with cortical thickness publication-title: JAMA Netw. Open – volume: 30 start-page: 992 year: 2020 end-page: 1004 ident: bib293 article-title: Applying gene-editing technology to elucidate the functional consequence of genetic and epigenetic variation in Alzheimer's disease publication-title: Brain Pathol. – volume: 90 start-page: 695 year: 2018 end-page: 703 ident: bib12 article-title: Resistance vs resilience to Alzheimer disease: clarifying terminology for preclinical studies publication-title: Neurology – reference: ClinicalTrials.gov, 2021a. Nicotinamide as an Early Alzheimer's Disease Treatment (NEAT). – volume: 19 year: 2018 ident: bib73 article-title: DNA methyltransferases, DNA methylation, and age-associated cognitive function publication-title: Int J. Mol. Sci. – volume: 85 start-page: 573 year: 2022 end-page: 585 ident: bib50 article-title: 5-hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for late-onset Alzheimer's disease publication-title: J. Alzheimers Dis. – volume: 6 start-page: 37486 year: 2016 ident: bib213 article-title: Folic acid supplementation improves cognitive function by reducing the levels of peripheral inflammatory cytokines in elderly Chinese subjects with MCI publication-title: Sci. Rep. – volume: 9 start-page: 402 year: 2018 ident: bib246 article-title: Overview of MicroRNA biogenesis, mechanisms of actions, and circulation publication-title: Front Endocrinol. (Lausanne) – volume: 7 start-page: 13537 year: 2017 ident: bib334 article-title: Gut microbiome alterations in Alzheimer's disease publication-title: Sci. Rep. – volume: 459 start-page: 802 year: 2009 end-page: 807 ident: bib77 article-title: Histone H4 lysine 16 acetylation regulates cellular lifespan publication-title: Nature – volume: 78 start-page: 1345 year: 2021 end-page: 1354 ident: bib335 article-title: Effect of levetiracetam on cognition in patients with alzheimer disease with and without epileptiform activity: a randomized clinical trial publication-title: JAMA Neurol. – volume: 123 year: 2020 ident: bib197 article-title: Circular RNA expression profile of Alzheimer's disease and its clinical significance as biomarkers for the disease risk and progression publication-title: Int. J. Biochem Cell Biol. – volume: 24 start-page: 1465 year: 2010 end-page: 1478 ident: bib316 article-title: Confining euchromatin/heterochromatin territory: jumonji crosses the line publication-title: Genes Dev. – volume: 776 year: 2022 ident: bib196 article-title: Circular RNA AXL increases neuron injury and inflammation through targeting microRNA-328 mediated BACE1 in Alzheimer's disease publication-title: Neurosci. Lett. – volume: 7 start-page: 2 year: 2020 end-page: 3 ident: bib299 article-title: Editorial: geroscience and the role of aging in the etiology and management of Alzheimer's disease publication-title: J. Prev. Alzheimers Dis. – volume: 37 start-page: 384 year: 2013 end-page: 400 ident: bib103 article-title: Resting-state functional connectivity in normal brain aging publication-title: Neurosci. Biobehav Rev. – volume: 21 start-page: 381 year: 2011 end-page: 395 ident: bib20 article-title: Regulation of chromatin by histone modifications publication-title: Cell Res – volume: 10 year: 2021 ident: bib377 article-title: DNA methylation in genetic and sporadic forms of neurodegeneration: lessons from Alzheimer's, related tauopathies and genetic tauopathies publication-title: Cells – volume: 25 start-page: 1078 year: 2011 end-page: 1083 ident: bib32 article-title: DNA methylation in repetitive elements and Alzheimer disease publication-title: Brain Behav. Immun. – volume: 19 year: 2020 ident: bib187 article-title: Epigenome signatures landscaped by histone H3K9me3 are associated with the synaptic dysfunction in Alzheimer's disease publication-title: Aging Cell – volume: 13 year: 2021 ident: bib257 article-title: A meta-analysis of Brain DNA methylation across sex, age, and Alzheimer's disease points for accelerated epigenetic aging in neurodegeneration publication-title: Front Aging Neurosci. – volume: 11 start-page: 290 year: 2019 ident: bib315 article-title: Systemic immune dyshomeostasis model and pathways in Alzheimer's disease publication-title: Front Aging Neurosci. – volume: 2016 start-page: 5912146 year: 2016 ident: bib49 article-title: Folic acid supplementation mitigates Alzheimer's disease by reducing inflammation: a randomized controlled trial publication-title: Mediat. Inflamm. – volume: 4 start-page: 1057204 year: 2023 ident: bib223 article-title: Towards AI-driven longevity research: an overview publication-title: Front Aging – volume: 52 start-page: 24 year: 2019 end-page: 34 ident: bib188 article-title: Sirtuin signaling in cellular senescence and aging publication-title: BMB Rep. – volume: 51 start-page: 679 year: 2008 end-page: 684 ident: bib153 article-title: Complex constitutional subtelomeric 1p36.3 deletion/duplication in a mentally retarded child with neonatal neuroblastoma publication-title: Eur. J. Med. Genet – volume: 11 start-page: 244 year: 2019 ident: bib118 article-title: Emerging alternative proteinases in APP metabolism and Alzheimer's disease pathogenesis: a focus on MT1-MMP and MT5-MMP publication-title: Front Aging Neurosci. – volume: 70 start-page: 288 year: 1999 end-page: 292 ident: bib322 article-title: Reduction with age in methylcytosine in the promoter region -224 approximately -101 of the amyloid precursor protein gene in autopsy human cortex publication-title: Brain Res Mol. Brain Res. – volume: 18 start-page: 2197 year: 2019 end-page: 2214 ident: bib353 article-title: Circular RNA circ_0000950 promotes neuron apoptosis, suppresses neurite outgrowth and elevates inflammatory cytokines levels via directly sponging miR-103 in Alzheimer's disease publication-title: Cell Cycle – volume: 16 start-page: 1219 year: 2017 end-page: 1233 ident: bib9 article-title: TOR-mediated regulation of metabolism in aging publication-title: Aging Cell – volume: 11 start-page: 303 year: 2019 end-page: 327 ident: bib208 article-title: DNA methylation GrimAge strongly predicts lifespan and healthspan publication-title: Aging (Albany NY) – volume: 22 year: 2021 ident: bib263 article-title: Somatostatin, a presynaptic modulator of glutamatergic signal in the central nervous system publication-title: Int J. Mol. Sci. – volume: 9 year: 2020 ident: bib284 article-title: Alzheimer's disease, a lipid story: involvement of peroxisome proliferator-activated receptor α publication-title: Cells – volume: 21 start-page: 1149 year: 2014 end-page: 1154 ident: bib251 article-title: Early-onset Alzheimer's disease: a global cross-sectional analysis publication-title: Eur. J. Neurol. – volume: 4 start-page: 976 year: 2012 end-page: 997 ident: bib21 article-title: Sex hormones, aging, and Alzheimer's disease publication-title: Front Biosci. (Elite Ed. ) – volume: 54 start-page: 214 year: 2020 end-page: 226 ident: bib265 article-title: Association between use of statin and risk of dementia: a meta-analysis of observational studies publication-title: Neuroepidemiology – volume: 24 year: 2023 ident: bib7 article-title: Alzheimer's disease: an updated overview of its genetics publication-title: Int J. Mol. Sci. – volume: 15 year: 2020 ident: bib27 article-title: DNA methylation clocks and their predictive capacity for aging phenotypes and healthspan publication-title: Neurosci. Insights – volume: 731 year: 2020 ident: bib331 article-title: Targeting tau: clinical trials and novel therapeutic approaches publication-title: Neurosci. Lett. – reference: ClinicalTrials.gov, 2022a. Efavirenz for Patients With Alzheimer's Disease (EPAD). – volume: 38 start-page: 1021 year: 2018 end-page: 1031 ident: bib264 article-title: Up-regulated pro-inflammatory microRNAs (miRNAs) in Alzheimer's disease (AD) and age-related macular degeneration (AMD) publication-title: Cell Mol. Neurobiol. – volume: 15 start-page: 1455 year: 2016 end-page: 1466 ident: bib330 article-title: Interaction of tau with the RNA-binding protein TIA1 regulates tau pathophysiology and toxicity publication-title: Cell Rep. – volume: 5 start-page: 225 year: 2018 end-page: 230 ident: bib292 article-title: Female sex and Alzheimer's risk: the menopause connection publication-title: J. Prev. Alzheimers Dis. – volume: 11 year: 2022 ident: bib165 article-title: DNA methylation: a promising approach in management of Alzheimer's disease and other neurodegenerative disorders publication-title: Biology – volume: 111 start-page: 57 year: 2020 end-page: 68 ident: bib266 article-title: Memory and neuromodulation: a perspective of DNA methylation publication-title: Neurosci. Biobehav Rev. – volume: 45 start-page: 380 year: 2019 end-page: 397 ident: bib216 article-title: HDAC2 dysregulation in the nucleus basalis of Meynert during the progression of Alzheimer's disease publication-title: Neuropathol. Appl. Neurobiol. – volume: 9 year: 2019 ident: bib167 article-title: Elevated plasma microRNA-206 levels predict cognitive decline and progression to dementia from mild cognitive impairment publication-title: Biomolecules – volume: 60 year: 2020 ident: bib116 article-title: Biohorology and biomarkers of aging: current state-of-the-art, challenges and opportunities publication-title: Ageing Res Rev. – volume: 13 start-page: 66 year: 2021 ident: bib176 article-title: Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer's disease already receiving donepezil: a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trial publication-title: Alzheimers Res Ther. – start-page: 508 year: 2021 ident: bib295 article-title: An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study publication-title: Trials – volume: 58 start-page: 263 year: 2017 end-page: 274 ident: bib352 article-title: DNA methylation and tag SNPs of the BDNF gene in conversion of amnestic mild cognitive impairment into Alzheimer's disease: a cross-sectional cohort study publication-title: J. Alzheimers Dis. – volume: 2021 start-page: 2031407 year: 2021 ident: bib42 article-title: MiR-29c-3p may promote the progression of Alzheimer's disease through BACE1 publication-title: J. Health Eng. – volume: 3 start-page: 19 year: 2012 ident: bib70 article-title: High throughput DNA sequencing to detect differences in the subgingival plaque microbiome in elderly subjects with and without dementia publication-title: Invest. Genet – volume: 191 year: 2020 ident: bib345 article-title: DNA methylation in Alzheimer's disease: in brain and peripheral blood publication-title: Mech. Ageing Dev. – volume: 7 year: 2021 ident: bib74 article-title: Alzheimer's disease drug development pipeline: 2021 publication-title: Alzheimers Dement – volume: 35 start-page: 175 year: 2017 end-page: 190 ident: bib124 article-title: Tau spread, apolipoprotein E, inflammation, and more: rapidly evolving basic science in Alzheimer disease publication-title: Neurol. Clin. – volume: 275 start-page: 214 year: 2014 end-page: 228 ident: bib259 article-title: Mild cognitive impairment: a concept in evolution publication-title: J. Intern Med – volume: 65 year: 2022 ident: bib282 article-title: Role of melatonin in Alzheimer's disease: from preclinical studies to novel melatonin-based therapies publication-title: Front. Neuroendocr. – volume: 11 start-page: 6114 year: 2020 ident: bib362 article-title: Epigenome-wide meta-analysis of DNA methylation differences in prefrontal cortex implicates the immune processes in Alzheimer's disease publication-title: Nat. Commun. – volume: 43 start-page: 1300 year: 2012 end-page: 1307 ident: bib26 article-title: Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma publication-title: Hum. Pathol. – volume: 73 start-page: 355 year: 2009 end-page: 364 ident: bib80 article-title: Histone deacetylase inhibition activity and molecular docking of (e)-resveratrol: its therapeutic potential in spinal muscular atrophy publication-title: Chem. Biol. Drug Des. – volume: 11 start-page: 80 year: 2020 ident: bib51 article-title: Imaging biomarkers for neurodegeneration in presymptomatic familial frontotemporal lobar degeneration publication-title: Front. Neurol. – volume: 26 start-page: 5481 year: 2021 end-page: 5503 ident: bib132 article-title: The amyloid-β pathway in Alzheimer's disease publication-title: Mol. Psychiatry – volume: 9 start-page: 221 year: 2022 end-page: 230 ident: bib76 article-title: Aducanumab: appropriate use recommendations update publication-title: J. Prev. Alzheimers Dis. – volume: 15 year: 2022 ident: bib28 article-title: DNA methylation and establishing memory publication-title: Epigenet Insights – volume: 159 year: 2021 ident: bib109 article-title: Small nucleolar RNAs in plasma extracellular vesicles and their discriminatory power as diagnostic biomarkers of Alzheimer's disease publication-title: Neurobiol. Dis. – volume: 10 start-page: 1365 year: 2018 end-page: 1382 ident: bib137 article-title: Alzheimer's disease DNA methylome of pyramidal layers in frontal cortex: laser-assisted microdissection study publication-title: Epigenomics – volume: 74 start-page: 91 year: 2020 end-page: 99 ident: bib102 article-title: Sodium butyrate reduces brain amyloid-β levels and improves cognitive memory performance in an Alzheimer's disease transgenic mouse model at an early disease stage publication-title: J. Alzheimers Dis. – volume: 268 start-page: 3 year: 2015 end-page: 9 ident: bib53 article-title: 5-Hydroxymethylcytosine: a new player in brain disorders? publication-title: Exp. Neurol. – volume: 34 start-page: 805 year: 2014 end-page: 812 ident: bib354 article-title: Valproate improves memory deficits in an Alzheimer's disease mouse model: investigation of possible mechanisms of action publication-title: Cell Mol. Neurobiol. – volume: 9 start-page: 114 year: 2016 ident: bib349 article-title: Aberrant expression of histone deacetylases 4 in cognitive disorders: molecular mechanisms and a potential target publication-title: Front Mol. Neurosci. – volume: 6 start-page: 24797 year: 2015 end-page: 24822 ident: bib319 article-title: Dissecting tRNA-derived fragment complexities using personalized transcriptomes reveals novel fragment classes and unexpected dependencies publication-title: Oncotarget – volume: 23 start-page: S72 year: 2019 end-page: S81 ident: bib170 article-title: Methyl-CpG binding protein 2 in Alzheimer dementia publication-title: Int Neurourol. J. – volume: 120 start-page: 9936 year: 2019 end-page: 9946 ident: bib193 article-title: miR-219-5p inhibits tau phosphorylation by targeting TTBK1 and GSK-3β in Alzheimer's disease publication-title: J. Cell Biochem – volume: 18 year: 2022 ident: bib100 article-title: A multimodal genomic analysis framework identifies transposable element (TE) activation in Alzheimer’s disease publication-title: Alzheimers Dement. – volume: 48 start-page: 514 year: 2018 end-page: 529.e516 ident: bib79 article-title: Histone deacetylases 1 and 2 regulate microglia function during development, homeostasis, and neurodegeneration in a context-dependent manner publication-title: Immunity – volume: 10 start-page: 174 year: 2022 ident: bib186 article-title: Methylation differences in Alzheimer's disease neuropathologic change in the aged human brain publication-title: Acta Neuropathol. Commun. – volume: 80 start-page: 441 year: 2020 end-page: 444 ident: bib313 article-title: Sodium oligomannate: first approval publication-title: Drugs – volume: 17 start-page: 327 year: 2021 end-page: 406 ident: bib6 article-title: 2021 Alzheimer's disease facts and figures publication-title: Alzheimers Dement – volume: 13 start-page: 4852 year: 2022 ident: bib300 article-title: Cross-tissue analysis of blood and brain epigenome-wide association studies in Alzheimer's disease publication-title: Nat. Commun. – volume: 24 start-page: 6721 year: 2015 end-page: 6735 ident: bib304 article-title: miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo publication-title: Hum. Mol. Genet – volume: 65 start-page: 283 year: 2018 end-page: 292 ident: bib228 article-title: PICALM gene methylation in blood of Alzheimer's disease patients is associated with cognitive decline publication-title: J. Alzheimers Dis. – volume: 17 start-page: 2181 year: 2021 end-page: 2192 ident: bib360 article-title: Interaction between Aβ and tau in the pathogenesis of Alzheimer's disease publication-title: Int J. Biol. Sci. – volume: 11 year: 2020 ident: bib34 article-title: Advances and challenges in understanding MicroRNA function in tauopathies: a case study of miR-132/212 publication-title: Front Neurol. – volume: 5 year: 2010 ident: bib308 article-title: The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide publication-title: PLoS One – volume: 134 start-page: 486 year: 2013 end-page: 495 ident: bib37 article-title: Epigenetic changes in the progression of Alzheimer's disease publication-title: Mech. Ageing Dev. – reference: Alzforum Antisense Therapy Stifles CSF Tau in Mild Alzheimer’s Disease. – volume: 4 year: 2021 ident: bib204 article-title: Effect of the histone deacetylase inhibitor FRM-0334 on progranulin levels in patients with progranulin gene haploinsufficiency: a randomized clinical trial publication-title: JAMA Netw. Open – volume: 66 start-page: 927 year: 2018 end-page: 934 ident: bib214 article-title: DNA Hypomethylation in Blood Links B3GALT4 and ZADH2 to Alzheimer's Disease publication-title: J. Alzheimers Dis. – volume: 9 start-page: 70 year: 2017 ident: bib344 article-title: Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years publication-title: Alzheimers Res. Ther. – reference: ClinicalTrials.gov, 2022b. Effects of Nicotinamide Riboside on Bioenergetics and Oxidative Stress in Mild Cognitive Impairment/Alzheimer's Dementia. – volume: 45 start-page: 30 year: 2016 end-page: 42 ident: bib262 article-title: Neurofilament-labeled pyramidal neurons and astrocytes are deficient in DNA methylation marks in Alzheimer's disease publication-title: Neurobiol. Aging – volume: 1 start-page: 63 year: 2013 end-page: 70 ident: bib152 article-title: miRNa-based therapeutic strategies publication-title: Curr. Anesth. Rep. – volume: 15 year: 2020 ident: bib215 article-title: Modulation of KDM1A with vafidemstat rescues memory deficit and behavioral alterations publication-title: PLoS One – volume: 25 start-page: 8490 year: 2021 end-page: 8503 ident: bib194 article-title: Lamivudine improves cognitive decline in SAMP8 mice: Integrating in vivo pharmacological evaluation and network pharmacology publication-title: J. Cell Mol. Med. – volume: 32 start-page: 1161 year: 2011 end-page: 1180 ident: bib225 article-title: Epigenetic mechanisms in Alzheimer's disease publication-title: Neurobiol. Aging – volume: 12 start-page: 129 year: 2019 ident: bib99 article-title: LSD1/KDM1A inhibitors in clinical trials: advances and prospects publication-title: J. Hematol. Oncol. – volume: 7 start-page: 12948 year: 2016 ident: bib325 article-title: Nicotinamide riboside is uniquely and orally bioavailable in mice and humans publication-title: Nat. Commun. – volume: 14 start-page: 723 year: 2008 end-page: 730 ident: bib98 article-title: Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase publication-title: Nat. Med – volume: 9 start-page: 140 year: 2016 ident: bib348 article-title: The protective role of microRNA-200c in Alzheimer's disease pathologies is induced by beta amyloid-triggered endoplasmic reticulum stress publication-title: Front Mol. Neurosci. – volume: 9 start-page: 347 year: 2015 ident: bib287 article-title: Epigenetic alterations in Alzheimer's disease publication-title: Front Behav. Neurosci. – volume: 15 start-page: 3251 year: 2006 end-page: 3262 ident: bib301 article-title: C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1 publication-title: Hum. Mol. Genet – volume: 93 year: 2022 ident: bib48 article-title: Multiple roles of short-chain fatty acids in Alzheimer disease publication-title: Nutrition – reference: ClinicalTrials.gov, 2022h. Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease Participants. – volume: 16 start-page: 164 year: 2018 end-page: 172 ident: bib175 article-title: Biomarkers in Alzheimer's, frontotemporal, lewy body, and vascular dementias publication-title: Focus (Am. Psychiatr. Publ. ) – volume: 205 start-page: 2781 year: 2008 end-page: 2789 ident: bib271 article-title: Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models publication-title: J. Exp. Med – volume: 10 start-page: 153 year: 2019 ident: bib339 article-title: MicroRNAs in Alzheimer's disease publication-title: Front Genet – year: 2021 ident: bib121 article-title: World Alzheimer Report 2021: journey through the diagnosis of dementia publication-title: Alzheimer’s Dis. Int. – volume: 73 start-page: 201 year: 2016 end-page: 215 ident: bib126 article-title: Sex hormone-related neurosteroids differentially rescue bioenergetic deficits induced by amyloid-β or hyperphosphorylated tau protein publication-title: Cell Mol. Life Sci. – volume: 55 start-page: 131 year: 2016 end-page: 141 ident: bib255 article-title: Neural stem cells injured by oxidative stress can be rejuvenated by GV1001, a novel peptide, through scavenging free radicals and enhancing survival signals publication-title: Neurotoxicology – volume: 12 year: 2020 ident: bib169 article-title: Propionate and Alzheimer's disease publication-title: Front Aging Neurosci. – volume: 85 start-page: 1383 year: 2015 end-page: 1391 ident: bib327 article-title: A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease publication-title: Neurology – volume: 161 year: 2023 ident: bib363 article-title: Therapeutic potential of natural molecules against Alzheimer's disease via SIRT1 modulation publication-title: Biomed. Pharm. – volume: 143 start-page: 3763 year: 2020 end-page: 3775 ident: bib298 article-title: Recalibrating the epigenetic clock: implications for assessing biological age in the human cortex publication-title: Brain – volume: 32 start-page: 8270 year: 2012 end-page: 8283 ident: bib329 article-title: Contrasting pathology of the stress granule proteins TIA-1 and G3BP in tauopathies publication-title: J. Neurosci. – volume: 2 start-page: 135 year: 2014 ident: bib237 article-title: Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease publication-title: Acta Neuropathol. Commun. – volume: 11 start-page: 188 year: 2021 ident: bib90 article-title: Role of FoxO transcription factors in aging and age-related metabolic and neurodegenerative diseases publication-title: Cell Biosci. – volume: 9 start-page: 640 year: 2018 ident: bib182 article-title: Epigenetics of modified DNA bases: 5-methylcytosine and beyond publication-title: Front Genet – volume: 1839 start-page: 728 year: 2014 end-page: 736 ident: bib312 article-title: Chromatin dynamics: interplay between remodeling enzymes and histone modifications publication-title: Biochim Biophys. Acta – reference: . – volume: 15 year: 2021 ident: bib199 article-title: Inflamma-MicroRNAs in Alzheimer's disease: from disease pathogenesis to therapeutic potentials publication-title: Front Cell Neurosci. – volume: 11 start-page: 1176 year: 2009 end-page: 1177 ident: bib229 article-title: NURD keeps chromatin young publication-title: Nat. Cell Biol. – volume: 7 start-page: 294 year: 2015 end-page: 306 ident: bib141 article-title: The cerebellum ages slowly according to the epigenetic clock publication-title: Aging (Albany NY) – volume: 90 year: 2018 ident: bib231 article-title: Design of the first-in-human study of IONIS-MAPTRx, a tau-lowering antisense oligonucleotide, in patients with Alzheimer disease (S2.006) publication-title: Neurology – volume: 10 start-page: 77 year: 2020 ident: bib369 article-title: MicroRNA-7: expression and function in brain physiological and pathological processes publication-title: Cell Biosci. – volume: 31 start-page: 764 year: 2011 end-page: 774 ident: bib226 article-title: HDAC3 is a critical negative regulator of long-term memory formation publication-title: J. Neurosci. – volume: 2018 start-page: 5642148 year: 2018 ident: bib134 article-title: Sulforaphane delays fibroblast senescence by curbing cellular glucose uptake, increased glycolysis, and oxidative damage publication-title: Oxid. Med Cell Longev. – volume: 174 start-page: 177 year: 2018 end-page: 190 ident: bib146 article-title: Effects of resveratrol on memory performance, hippocampus connectivity and microstructure in older adults - a randomized controlled trial publication-title: Neuroimage – volume: 15 start-page: P910 year: 2019 ident: bib158 article-title: Modulation of microRNA pathways by gemfibrozil in predementia Alzheimer disease: a randomized, placebo-controlled, double-blind clinical trial publication-title: Alzheimers Dement. – volume: 178 start-page: 1011 year: 2022 end-page: 1030 ident: bib333 article-title: High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects publication-title: Rev. Neurol. (Paris) – volume: 15 year: 2021 ident: bib101 article-title: Sirtuins as potential therapeutic targets for mitigating neuroinflammation associated With Alzheimer's disease publication-title: Front Cell Neurosci. – volume: 9 year: 2017 ident: bib87 article-title: Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy publication-title: Sci. Transl. Med – volume: 26 start-page: 4210 year: 2022 end-page: 4215 ident: bib224 article-title: Lamivudine, a reverse transcriptase inhibitor, rescues cognitive deficits in a mouse model of down syndrome publication-title: J. Cell Mol. Med. – volume: 366 start-page: 1134 year: 2019 end-page: 1139 ident: bib244 article-title: Brain cell type-specific enhancer-promoter interactome maps and disease-risk association publication-title: Science – volume: 5 start-page: 61 year: 2018 ident: bib112 article-title: The continuum of aging and age-related diseases: common mechanisms but different rates publication-title: Front Med (Lausanne) – volume: 31 start-page: 1883 year: 2016 end-page: 1890 ident: bib147 article-title: The MAPT gene is differentially methylated in the progressive supranuclear palsy brain publication-title: Mov. Disord. – volume: 63 start-page: 110 year: 2018 end-page: 119 ident: bib2 article-title: Regulation of ADAM10 by miR-140-5p and potential relevance for Alzheimer's disease publication-title: Neurobiol. Aging – volume: 24 start-page: 598 year: 2018 end-page: 603 ident: bib288 article-title: PM20D1 is a quantitative trait locus associated with Alzheimer's disease publication-title: Nat. Med – volume: 521 year: 2021 ident: bib358 article-title: The bile acid TUDCA improves glucose metabolism in streptozotocin-induced Alzheimer's disease mice model publication-title: Mol. Cell Endocrinol. – volume: 20 start-page: 158 year: 2022 end-page: 178 ident: bib183 article-title: Understanding the role of histone deacetylase and their inhibitors in neurodegenerative disorders: current targets and future perspective publication-title: Curr. Neuropharmacol. – volume: 14 year: 2022 ident: bib270 article-title: The association between Alzheimer's disease and epilepsy: a narrative review publication-title: Cureus – volume: 72 year: 2021 ident: bib156 article-title: Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: a systematic review publication-title: Ageing Res Rev. – year: 2022 ident: bib341 article-title: Alzheimer's disease and progressive supranuclear palsy share similar transcriptomic changes in distinct brain regions publication-title: J Clin Invest. – volume: 24 start-page: 183 year: 2009 end-page: 190 ident: bib177 article-title: CYP46A1 variants influence Alzheimer's disease risk and brain cholesterol metabolism publication-title: Eur. Psychiatry – volume: 33 start-page: 12887 year: 2013 end-page: 12897 ident: bib86 article-title: Antisense reduction of tau in adult mice protects against seizures publication-title: J. Neurosci. – volume: 14 start-page: 25 year: 2021 ident: bib253 article-title: Losing DNA methylation at repetitive elements and breaking bad publication-title: Epigenetics Chromatin – volume: 29 start-page: 787 year: 2019 end-page: 803 ident: bib342 article-title: Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression publication-title: Cell Res – volume: 7 year: 2022 ident: bib338 article-title: Epigenetic regulation of aging: implications for interventions of aging and diseases publication-title: Signal Transduct. Target Ther. – volume: 14 start-page: R115 year: 2013 ident: bib140 article-title: DNA methylation age of human tissues and cell types publication-title: Genome Biol. – volume: 14 year: 2022 ident: bib123 article-title: Multi-targets: an unconventional drug development strategy for Alzheimer's disease publication-title: Front Aging Neurosci. – volume: 13 year: 2021 ident: bib151 article-title: Exercise reduces H3K9me3 and regulates brain derived neurotrophic factor and GABRA2 in an age dependent manner publication-title: Front Aging Neurosci. – volume: 27 start-page: 172 year: 2015 end-page: 197 ident: bib283 article-title: A comprehensive view of the epigenetic landscape. Part II: Histone post-translational modification, nucleosome level, and chromatin regulation by ncRNAs publication-title: Neurotox. Res. – volume: 9 year: 2020 ident: bib250 article-title: The histone code of senescence publication-title: Cells – volume: 7 start-page: 1198 year: 2015 end-page: 1211 ident: bib190 article-title: Epigenetic age of the pre-frontal cortex is associated with neuritic plaques, amyloid load, and Alzheimer's disease related cognitive functioning publication-title: Aging (Albany NY) – year: 2022 ident: bib258 article-title: MIB-626, an oral formulation of a microcrystalline unique polymorph of β-nicotinamide mononucleotide, increases circulating nicotinamide adenine dinucleotide and its metabolome in middle-aged and older adults publication-title: J. Gerontol. A Biol. Sci. Med Sci. – volume: 7 start-page: 1051 year: 2015 end-page: 1073 ident: bib89 article-title: Methyl-CpG-binding domain proteins: readers of the epigenome publication-title: Epigenomics – volume: 11 start-page: 41 year: 2018 ident: bib120 article-title: DNA methylation analysis on purified neurons and glia dissects age and Alzheimer's disease-specific changes in the human cortex publication-title: Epigenetics Chromatin – volume: 58 start-page: 1791 year: 2002 end-page: 1800 ident: bib320 article-title: Phases of A beta-deposition in the human brain and its relevance for the development of AD publication-title: Neurology – volume: 12 year: 2020 ident: bib19 article-title: Neuroimaging in dementia: a brief review publication-title: Cureus – volume: 11 year: 2021 ident: bib302 article-title: Alzheimer's disease: an evolving understanding of noradrenergic involvement and the promising future of electroceutical therapies publication-title: Clin. Transl. Med – volume: 251 start-page: 111 year: 2021 end-page: 123 ident: bib44 article-title: Nicotinamide riboside has minimal impact on energy metabolism in mouse models of mild obesity publication-title: J. Endocrinol. – year: 2012 ident: bib366 article-title: Ageing and cancer: Mi-2, mTOR and metabolism publication-title: Enzym. Eng. – volume: 84 start-page: 2161 year: 2015 end-page: 2168 ident: bib40 article-title: Etanercept in Alzheimer disease: a randomized, placebo-controlled, double-blind, phase 2 trial publication-title: Neurology – volume: 6 year: 2011 ident: bib267 article-title: CHD5, a brain-specific paralog of Mi2 chromatin remodeling enzymes, regulates expression of neuronal genes publication-title: PLoS One – volume: 10 start-page: 51 year: 2023 ident: bib227 article-title: Three-dimensional chromatin architecture datasets for aging and Alzheimer’s disease publication-title: Sci. Data – volume: 49 start-page: 359 year: 2013 end-page: 367 ident: bib133 article-title: Genome-wide methylation profiles reveal quantitative views of human aging rates publication-title: Mol. Cell – volume: 40 start-page: 113 year: 2018 end-page: 124 ident: bib235 article-title: Complement in the pathogenesis of Alzheimer's disease publication-title: Semin Immunopathol. – volume: 14 start-page: 1580 year: 2018 end-page: 1588 ident: bib305 article-title: Elevated DNA methylation across a 48-kb region spanning the HOXA gene cluster is associated with Alzheimer's disease neuropathology publication-title: Alzheimers Dement – volume: 13 year: 2021 ident: bib367 article-title: The role of non-coding RNAs in Alzheimer's disease: from regulated mechanism to therapeutic targets and diagnostic biomarkers publication-title: Front Aging Neurosci. – volume: 6 start-page: 205 year: 2015 ident: bib314 article-title: Multi-target pharmacology: possibilities and limitations of the "skeleton key approach" from a medicinal chemist perspective publication-title: Front Pharm. – volume: 13 start-page: 655 year: 2022 ident: bib318 article-title: Inferring protein expression changes from mRNA in Alzheimer's dementia using deep neural networks publication-title: Nat. Commun. – volume: 98 year: 2021 ident: bib260 article-title: Dietary supplementation with sulforaphane ameliorates skin aging through activation of the Keap1-Nrf2 pathway publication-title: J. Nutr. Biochem – year: 2022 ident: bib35 article-title: Dementia risk in a diverse population: a single-region nested case-control study in the East End of London publication-title: Lancet Reg. Health Eur. – volume: 13 year: 2021 ident: bib41 article-title: P-tau/Aβ42 and Aβ42/40 ratios in CSF are equally predictive of amyloid PET status publication-title: Alzheimers Dement (Amst. ) – volume: 18 start-page: 643 year: 2022 end-page: 660 ident: bib230 article-title: Gene-environment interactions in Alzheimer disease: the emerging role of epigenetics publication-title: Nat. Rev. Neurol. – volume: 8 start-page: 262 year: 2014 end-page: 273 ident: bib328 article-title: Apolipoprotein E, gender, and Alzheimer's disease: an overlooked, but potent and promising interaction publication-title: Brain Imaging Behav. – volume: 15 year: 2021 ident: bib365 article-title: The association between folate and Alzheimer's disease: a systematic review and meta-analysis publication-title: Front. Neurosci. – volume: 71 start-page: 882 year: 2018 end-page: 895 ident: bib105 article-title: DNA methylation clocks in aging: categories, causes, and consequences publication-title: Mol. Cell – volume: 74 start-page: 3347 year: 2017 end-page: 3362 ident: bib148 article-title: Nicotinamide is an inhibitor of SIRT1 in vitro, but can be a stimulator in cells publication-title: Cell Mol. Life Sci. – volume: 10 start-page: 2246 year: 2019 ident: bib195 article-title: Epigenetic dysregulation of enhancers in neurons is associated with Alzheimer's disease pathology and cognitive symptoms publication-title: Nat. Commun. – volume: 81 start-page: 1135 year: 2021 end-page: 1152 ident: bib157 article-title: Current Status of Clinical Trials on Tau Immunotherapies publication-title: Drugs – volume: 507 start-page: 448 year: 2014 end-page: 454 ident: bib209 article-title: REST and stress resistance in ageing and Alzheimer's disease publication-title: Nature – volume: 78 start-page: 141 year: 2021 end-page: 142 ident: bib240 article-title: Possible consequences of the approval of a disease-modifying therapy for Alzheimer disease publication-title: JAMA Neurol. – volume: 29 start-page: 68 year: 2011 end-page: 72 ident: bib306 article-title: Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine publication-title: Nat. Biotechnol. – volume: 32 start-page: 10879 year: 2012 end-page: 10886 ident: bib172 article-title: An essential role for histone deacetylase 4 in synaptic plasticity and memory formation publication-title: J. Neurosci. – volume: 10 start-page: 116 year: 2018 ident: bib31 article-title: PLD3 epigenetic changes in the hippocampus of Alzheimer's disease publication-title: Clin. Epigenetics – reference: ClinicalTrials.gov, 2022i. A Study to Assess if BIIB080 Can Change Clinical Dementia Rating-Sum of Boxes Scores, and BIIB080 Safety and Tolerability When Injected Into the Cerebrospinal Fluid of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age (CELIA). – volume: 21 start-page: 1038 year: 2018 end-page: 1048 ident: bib311 article-title: Pathogenic tau-induced piRNA depletion promotes neuronal death through transposable element dysregulation in neurodegenerative tauopathies publication-title: Nat. Neurosci. – volume: 23 start-page: 2874 year: 2018 end-page: 2880 ident: bib128 article-title: Tau activates transposable elements in Alzheimer's disease publication-title: Cell Rep. – volume: 3 start-page: Cd009628 year: 2020 ident: bib206 article-title: Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment publication-title: Cochrane Database Syst. Rev. – volume: 32 start-page: 796 year: 2019 end-page: 807 ident: bib374 article-title: (De)Toxifying the epigenetic code publication-title: Chem. Res Toxicol. – volume: 96 start-page: 115 year: 2017 end-page: 129.e115 ident: bib371 article-title: Apolipoprotein E4 impairs neuronal insulin signaling by trapping insulin receptor in the endosomes publication-title: Neuron – volume: 26 start-page: 3806 year: 2021 end-page: 3816 ident: bib139 article-title: An epigenetic predictor of death captures multi-modal measures of brain health publication-title: Mol. Psychiatry – volume: 10 start-page: 1729 year: 2019 end-page: 1743 ident: bib114 article-title: CoREST complex-selective histone deacetylase inhibitors show prosynaptic effects and an improved safety profile to enable treatment of synaptopathies publication-title: ACS Chem. Neurosci. – volume: 12 year: 2020 ident: bib168 article-title: Alzheimer's gone viral: could herpes simplex virus type-1 be stealing your memories? publication-title: Cureus – reference: ClinicalTrials.gov, 2022c. GV1001 Subcutaneous for the Treatment of Moderate to Severe Alzheimer's Disease(AD). – volume: 8 start-page: 595 year: 2016 end-page: 608 ident: bib294 article-title: The amyloid hypothesis of Alzheimer's disease at 25 years publication-title: EMBO Mol. Med – volume: 14 start-page: 198 year: 2022 ident: bib189 article-title: CYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer’s disease publication-title: Alzheimers Res Ther – volume: 596 start-page: 43 year: 2021 end-page: 53 ident: bib125 article-title: The role of retrotransposable elements in ageing and age-associated diseases publication-title: Nature – reference: ClinicalTrials.gov, 2020a. Effects of Sulforaphane in Patients With Prodromal to Mild Alzheimer's Disease. – volume: 27 year: 2022 ident: bib119 article-title: Influence of age and dose on the effect of resveratrol for glycemic control in type 2 diabetes mellitus: systematic review and meta-analysis publication-title: Molecules – volume: 80 start-page: 1 year: 2021 end-page: 27 ident: bib205 article-title: Modifiable, non-modifiable, and clinical factors associated with progression of Alzheimer's disease publication-title: J. Alzheimers Dis. – volume: 157 start-page: 68 year: 2021 end-page: 70 ident: bib211 article-title: How the US Food and Drug Administration’s approval of aducanumab for Alzheimer’s disease has implication for oncology and beyond publication-title: Eur J Cancer – volume: 12 start-page: 292 year: 2016 end-page: 323 ident: bib92 article-title: Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria publication-title: Alzheimers Dement – volume: 20 start-page: 249 year: 2019 ident: bib24 article-title: DNA methylation aging clocks: challenges and recommendations publication-title: Genome Biol. – volume: 19 start-page: 435 year: 2022 end-page: 450 ident: bib16 article-title: Current progress of miRNA-derivative nucleotide drugs: modifications, delivery systems, applications publication-title: Expert Opin. Drug Deliv. – volume: 22 start-page: 1124 year: 2018 end-page: 1131 ident: bib309 article-title: Learning and age-related changes in genome-wide H2A.Z binding in the mouse hippocampus publication-title: Cell Rep. – volume: 17 start-page: 115 year: 2021 end-page: 124 ident: bib13 article-title: Hypothesis: tau pathology is an initiating factor in sporadic Alzheimer's disease publication-title: Alzheimers Dement – volume: 77 start-page: 1099 year: 2020 end-page: 1109 ident: bib71 article-title: Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and Alzheimer disease dementia: a randomized clinical trial publication-title: JAMA Neurol. – volume: 52 start-page: 1024 year: 2020 end-page: 1035 ident: bib242 article-title: An integrated multi-omics approach identifies epigenetic alterations associated with Alzheimer's disease publication-title: Nat. Genet – volume: 6 year: 2020 ident: bib276 article-title: Late-onset vs nonmendelian early-onset Alzheimer disease: a distinction without a difference? publication-title: Neurol. Genet – reference: ClinicalTrials.gov, 2022e. Pilot Study to Investigate the Safety and Feasibility of AntiRetroviral Therapy for Alzheimer's Disease (ART-AD), – volume: 7 year: 2021 ident: bib162 article-title: MicroRNAs as candidate biomarkers for Alzheimer's disease publication-title: Nanocoding RNA – volume: 6 start-page: a018713 year: 2014 ident: bib296 article-title: Erasers of histone acetylation: the histone deacetylase enzymes publication-title: Cold Spring Harb. Perspect. Biol. – volume: 13 year: 2018 ident: bib138 article-title: Defensive effect of microRNA-200b/c against amyloid-beta peptide-induced toxicity in Alzheimer's disease models publication-title: PLoS One – volume: 7 start-page: 34 year: 2018 ident: bib192 article-title: Amyloid, tau, pathogen infection and antimicrobial protection in Alzheimer's disease -conformist, nonconformist, and realistic prospects for AD pathogenesis publication-title: Transl. Neurodegener. – volume: 12 start-page: 103 year: 2020 ident: bib10 article-title: Resveratrol derivatives as potential treatments for Alzheimer's and Parkinson's disease publication-title: Front Aging Neurosci. – volume: 58 start-page: 329 year: 2021 end-page: 347 ident: bib97 article-title: The relation of the brain-derived neurotrophic factor with MicroRNAs in neurodegenerative diseases and ischemic stroke publication-title: Mol. Neurobiol. – volume: 72 start-page: 91 year: 2022 end-page: 100 ident: bib14 article-title: The adaptive aging brain publication-title: Curr. Opin. Neurobiol. – volume: 27 start-page: 2072 year: 2013 end-page: 2085 ident: bib127 article-title: Calorie restriction and sirtuins revisited publication-title: Genes Dev. – volume: 55 start-page: 1 year: 2022 end-page: 7 ident: bib173 article-title: Histochemistry, cytochemistry and epigenetics publication-title: Acta Histochem Cytochem – volume: 30 start-page: 964 year: 2020 end-page: 965 ident: bib303 article-title: The molecular etiology of Alzheimer's disease publication-title: Brain Pathol. – volume: 23 start-page: 237 year: 2019 end-page: 259 ident: bib180 article-title: 5-Azacytydine and resveratrol reverse senescence and ageing of adipose stem cells via modulation of mitochondrial dynamics and autophagy publication-title: J. Cell Mol. Med – volume: 227 year: 2022 ident: bib135 article-title: Medicinal chemistry updates of novel HDACs inhibitors (2020 to present) publication-title: Eur. J. Med Chem. – volume: 14 start-page: 1 year: 2017 ident: bib238 article-title: Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease publication-title: J. Neuroinflamm. – volume: 13 start-page: 476 year: 2019 ident: bib96 article-title: Epigenetic modifications in Alzheimer's neuropathology and therapeutics publication-title: Front Neurosci. – volume: 23 start-page: 53 year: 2022 end-page: 66 ident: bib113 article-title: The probabilistic model of Alzheimer disease: the amyloid hypothesis revised publication-title: Nat. Rev. Neurosci. – volume: 14 start-page: 569 year: 2018 ident: bib277 article-title: Does tau pathology activate jumping genes? publication-title: Nat. Rev. Neurol. – reference: ClinicalTrials.gov, 2020b. Single and Multiple Ascending Dose and Food Effect PK Study in Healthy Adult and Elderly Subjects. – volume: 4 start-page: 609 year: 2018 end-page: 616 ident: bib375 article-title: A randomized, double-blind, placebo-controlled trial of resveratrol with glucose and malate (RGM) to slow the progression of Alzheimer's disease: a pilot study publication-title: Alzheimers Dement (N. Y) – volume: 18 start-page: 153 year: 2020 end-page: 166 ident: bib178 article-title: Epigenetic effects mediated by antiepileptic drugs and their potential application publication-title: Curr. Neuropharmacol. – volume: 168 start-page: 39 year: 2018 end-page: 51 ident: bib107 article-title: Pharmacologic interventions to prevent cognitive decline, mild cognitive impairment, and clinical alzheimer-type dementia: a systematic review publication-title: Ann. Intern Med – reference: ClinicalTrials.gov, 2022f. Probiotics in Dementia (PIDE). ClinicalTrials.gov. – volume: 16 start-page: 2043 year: 2010 end-page: 2050 ident: bib94 article-title: MicroRNA sponges: progress and possibilities publication-title: Rna – volume: 44 start-page: 1807 year: 2022 end-page: 1823 ident: bib232 article-title: Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume publication-title: Geroscience – reference: Alzforum, 2022. Mutations/APP. – volume: 172 start-page: 656 year: 2020 end-page: 668 ident: bib108 article-title: Benefits and harms of prescription drugs and supplements for treatment of clinical alzheimer-type dementia publication-title: Ann. Intern Med – volume: 1698 start-page: 179 year: 2018 end-page: 186 ident: bib326 article-title: Glia-specific APOE epigenetic changes in the Alzheimer's disease brain publication-title: Brain Res. – year: 2020 ident: bib39 article-title: The therapeutic potential of epigenetic modifications in Alzheimer’s disease publication-title: Alzheimer’s Disease: Drug Discovery – volume: 179 start-page: 312 year: 2019 end-page: 339 ident: bib207 article-title: Alzheimer disease: an update on pathobiology and treatment strategies publication-title: Cell – volume: 7 year: 2021 ident: bib233 article-title: A novel knockout mouse model of the noncoding antisense Brain-Derived Neurotrophic Factor (Bdnf) gene displays increased endogenous Bdnf protein and improved memory function following exercise publication-title: Heliyon – volume: 17 start-page: 1666 year: 2022 end-page: 1674 ident: bib279 article-title: Amyloid-beta peptide and tau protein crosstalk in Alzheimer's disease publication-title: Neural Regen. Res – volume: 21 start-page: 497 year: 2018 end-page: 505 ident: bib241 article-title: Dysregulation of the epigenetic landscape of normal aging in Alzheimer's disease publication-title: Nat. Neurosci. – volume: 6 start-page: 61 year: 2006 end-page: 67 ident: bib159 article-title: Mechanism of action of memantine publication-title: Curr. Opin. Pharm. – volume: 13 start-page: 1994835 year: 2021 ident: bib91 article-title: Effects of anti-aging interventions on intestinal microbiota publication-title: Gut Microbes – volume: 72 start-page: 733 year: 2019 end-page: 749 ident: bib256 article-title: Genome-wide methylation of mild cognitive impairment in mexican americans highlights genes involved in synaptic transport, Alzheimer's disease-precursor phenotypes, and metabolic morbidities publication-title: J. Alzheimers Dis. – volume: 31 start-page: 1120 year: 2001 end-page: 1131 ident: bib179 article-title: Amyloid-beta: an antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer's disease publication-title: Free Radic. Biol. Med – volume: 9 start-page: 2584 year: 2018 ident: bib198 article-title: Sulforaphane inhibits inflammatory responses of primary human T-cells by increasing ROS and depleting glutathione publication-title: Front. Immunol. – volume: 12 start-page: 150 year: 2020 ident: bib355 article-title: APOE alleles and diet in brain aging and Alzheimer's disease publication-title: Front Aging Neurosci. – year: 2012 ident: bib54 article-title: Neurophilosophy and Alzheimer's disease – volume: 5 year: 2020 ident: bib83 article-title: Human endogenous retrovirus HERV-K(HML-2) RNA causes neurodegeneration through Toll-like receptors publication-title: JCI Insight – volume: 2 start-page: a006213 year: 2012 ident: bib160 article-title: Brain imaging in Alzheimer disease publication-title: Cold Spring Harb. Perspect. Med. – volume: 61 year: 2017 ident: bib171 article-title: Sulforaphane epigenetically enhances neuronal BDNF expression and TrkB signaling pathways publication-title: Mol. Nutr. Food Res – volume: 1 year: 2022 ident: bib236 article-title: Blood MAPT expression and methylation status in Alzheimer's disease publication-title: Psychiatry Clin. Neurosci. Rep. – volume: 35 start-page: 1255 year: 2014 end-page: 1274 ident: bib254 article-title: Novel vaccine peptide GV1001 effectively blocks β-amyloid toxicity by mimicking the extra-telomeric functions of human telomerase reverse transcriptase publication-title: Neurobiol. Aging – volume: 8 start-page: 140 year: 2016 ident: bib372 article-title: Over-expressed pathogenic miRNAs in Alzheimer's disease (AD) and prion disease (PrD) drive deficits in TREM2-mediated Aβ42 peptide clearance publication-title: Front. Aging Neurosci. – volume: 9 start-page: 106 year: 2013 end-page: 118 ident: bib201 article-title: Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy publication-title: Nat. Rev. Neurol. – reference: ClinicalTrials.gov, 2021c. Testing the Safety and Preliminary Efficacy of the New Drug ORY-2001 in Mild to Moderate Alzheimer's Disease (ETHERAL-US). – year: 2023 ident: bib268 article-title: Levetiracetam increases hippocampal blood flow in Alzheimer's disease as measured by arterial spin labelling MRI publication-title: J. Alzheimers Dis. – volume: 38 start-page: 235 year: 2005 end-page: 254 ident: bib72 article-title: Amyloid-beta metal interaction and metal chelation publication-title: Subcell. Biochem – volume: 5 year: 2013 ident: bib23 article-title: Nucleosome remodeling and epigenetics publication-title: Cold Spring Harb. Perspect. Biol. – volume: 10 start-page: 83 year: 2018 ident: bib359 article-title: NSAID exposure and risk of Alzheimer's disease: an updated meta-analysis from cohort studies publication-title: Front. Aging Neurosci. – volume: 91 start-page: 135 year: 2013 end-page: 157 ident: bib38 article-title: Alzheimer's disease: an evolutionary approach publication-title: J. Anthr. Sci. – volume: 114 start-page: E9645 year: 2017 end-page: E9654 ident: bib221 article-title: Neuron-specific methylome analysis reveals epigenetic regulation and tau-related dysfunction of BRCA1 in Alzheimer's disease publication-title: Proc. Natl. Acad. Sci. USA – volume: 6 start-page: 245 year: 2021 ident: bib376 article-title: Inflammation, epigenetics, and metabolism converge to cell senescence and ageing: the regulation and intervention publication-title: Signal Transduct. Target Ther. – volume: 16 year: 2022 ident: bib52 article-title: Epigenetic regulation of synaptic disorder in Alzheimer's disease publication-title: Front Neurosci. – reference: ClinicalTrials.gov, 2022g. Sirtuin-NAD Activator in Alzheimer's Disease. – volume: 488 start-page: 96 year: 2012 end-page: 99 ident: bib161 article-title: A mutation in APP protects against Alzheimer's disease and age-related cognitive decline publication-title: Nature – volume: 1805 start-page: 349 year: 2018 end-page: 370 ident: bib210 article-title: Remodeling and repositioning of nucleosomes in nucleosomal arrays publication-title: Methods Mol. Biol. – volume: 8 start-page: 37 year: 2016 ident: bib45 article-title: TREM2 upregulation correlates with 5-hydroxymethycytosine enrichment in Alzheimer's disease hippocampus publication-title: Clin. Epigenetics – volume: 79 start-page: 463 year: 2022 ident: bib46 article-title: Balancing NAD(+) deficits with nicotinamide riboside: therapeutic possibilities and limitations publication-title: Cell Mol. Life Sci. – volume: 5 start-page: 537 year: 2010 end-page: 539 ident: bib145 article-title: Abundance of tRNA-derived small RNAs in phosphate-starved Arabidopsis roots publication-title: Plant Signal Behav. – volume: 14 start-page: 178 year: 2022 ident: bib22 article-title: Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer's disease publication-title: Alzheimers Res Ther. – volume: 6 start-page: 10 year: 2013 ident: bib261 article-title: 5-hydroxymethylcytosine and its potential roles in development and cancer publication-title: Epigenetics Chromatin – volume: 10 start-page: 573 year: 2018 end-page: 591 ident: bib191 article-title: An epigenetic biomarker of aging for lifespan and healthspan publication-title: Aging (Albany NY) – reference: Oryzon Vafidemstat in Alzheimer’s disease - Oryzon 2020. – volume: 29 start-page: 50 year: 2014 end-page: 53 ident: bib136 article-title: Global long interspersed nuclear element 1 DNA methylation in a Colombian sample of patients with late-onset Alzheimer's disease publication-title: Am. J. Alzheimers Dis. Other Demen – volume: 92 start-page: 74 year: 2017 end-page: 80 ident: bib249 article-title: DNA methylation changes at TREM2 intron 1 and TREM2 mRNA expression in patients with Alzheimer's disease publication-title: J. Psychiatr. Res – volume: 24 year: 2023 ident: bib252 article-title: An ELOVL2-based epigenetic clock for forensic age prediction: a systematic review publication-title: Int J. Mol. Sci. – volume: 128 start-page: 2006 year: 2005 end-page: 2015 ident: bib110 article-title: Implicit memory and Alzheimer's disease neuropathology publication-title: Brain – volume: 28 start-page: 54 year: 2013 end-page: 61 ident: bib3 article-title: Histone deacetylases enzyme, copper, and IL-8 levels in patients with Alzheimer's disease publication-title: Am. J. Alzheimers Dis. Other Demen – volume: 5 start-page: eaaw2880 year: 2019 ident: bib104 article-title: Epigenetic signatures of methylated DNA cytosine in Alzheimer's disease publication-title: Sci. Adv. – volume: 364 start-page: 97 year: 2018 end-page: 109 ident: bib275 article-title: Epigenetic histone deacetylation inhibition prevents the development and persistence of temporal lobe epilepsy publication-title: J. Pharm. Exp. Ther. – volume: 60 start-page: 481 year: 2003 end-page: 486 ident: bib88 article-title: Atrophy rates of entorhinal cortex in AD and normal aging publication-title: Neurology – volume: 11 start-page: 927 year: 2020 end-page: 945 ident: bib370 article-title: Sirtuins and their biological relevance in aging and age-related diseases publication-title: Aging Dis. – volume: 8 start-page: 477 year: 2021 end-page: 482 ident: bib220 article-title: Peripheral blood BRCA1 methylation positively correlates with major Alzheimer’s disease risk factors publication-title: J. Prev. Alzheimers Dis. – volume: 17 year: 2021 ident: bib239 article-title: Results of the first‐in‐human, randomized, double‐blind, placebo‐controlled phase 1b study of lumbar intrathecal bolus administrations of antisense oligonucleotide (ISIS 814907; BIIB080) targeting tau mRNA in patients with mild Alzheimer’s disease publication-title: Alzheimers Dement. – volume: 29 start-page: 571 year: 2012 end-page: 588 ident: bib18 article-title: Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex publication-title: J. Alzheimers Dis. – volume: 64 start-page: 1079 year: 2004 end-page: 1086 ident: bib130 article-title: Histone deacetylase is a target of valproic acid-mediated cellular differentiation publication-title: Cancer Res – volume: 23 start-page: 648 year: 2014 end-page: 656 ident: bib154 article-title: Altered CpG methylation in sporadic Alzheimer's disease is associated with APP and MAPT dysregulation publication-title: Hum. Mol. Genet – volume: 13 year: 2021 ident: bib278 article-title: New RNA-based breakthroughs in Alzheimer's disease diagnosis and therapeutics publication-title: Pharmaceutics – volume: 32 start-page: 209 year: 2015 end-page: 220 ident: bib95 article-title: Aging, neurodegenerative disease, and traumatic brain injury: the role of neuroimaging publication-title: J. Neurotrauma – volume: 82 start-page: 239 year: 1991 end-page: 259 ident: bib36 article-title: Neuropathological stageing of Alzheimer-related changes publication-title: Acta Neuropathol. – reference: ClinicalTrials.gov, 2021b. Study to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's Disease (PEGASUS). – volume: 13 start-page: 98 year: 2021 ident: bib75 article-title: Aducanumab produced a clinically meaningful benefit in association with amyloid lowering publication-title: Alzheimers Res. Ther. – volume: 20 start-page: 417 year: 2019 end-page: 431 ident: bib84 article-title: Regulation of transposable elements by DNA modifications publication-title: Nat. Rev. Genet – volume: 42 start-page: 829 year: 2021 end-page: 844 ident: bib117 article-title: Treatment strategies for glucose-6-phosphate dehydrogenase deficiency: past and future perspectives publication-title: Trends Pharm. Sci. – volume: 2 start-page: 16017 year: 2016 ident: bib150 article-title: It takes two to tango: NAD(+) and sirtuins in aging/longevity control publication-title: NPJ Aging Mech. Dis. – volume: 13 year: 2021 ident: bib1 article-title: MicroRNAs as potential orchestrators of Alzheimer's disease-related pathologies: insights on current status and future possibilities publication-title: Front Aging Neurosci. – volume: 12 year: 2018 ident: bib8 article-title: Altered regulation of KIAA0566, and katanin signaling expression in the locus coeruleus with neurofibrillary tangle pathology publication-title: Front Cell Neurosci. – volume: 275 start-page: 89 year: 1999 end-page: 92 ident: bib323 article-title: The methylation status of cytosines in a tau gene promoter region alters with age to downregulate transcriptional activity in human cerebral cortex publication-title: Neurosci. Lett. – start-page: 102 year: 2016 end-page: 110 ident: bib131 article-title: DNA methylation changes in plasticity genes accompany the formation and maintenance of memory publication-title: Nat Neurosci. – volume: 107 start-page: 62 year: 2017 end-page: 68 ident: bib174 article-title: Oxidized C5-methyl cytosine bases in DNA: 5-Hydroxymethylcytosine; 5-formylcytosine; and 5-carboxycytosine publication-title: Free Radic. Biol. Med – volume: 99 start-page: e1402 year: 2022 end-page: e1413 ident: bib310 article-title: Association of pace of aging measured by blood-based dna methylation with age-related cognitive impairment and dementia publication-title: Neurology – volume: 57 start-page: 1049 year: 2017 end-page: 1069 ident: bib163 article-title: Therapeutics of neurotransmitters in Alzheimer's Disease publication-title: J. Alzheimers Dis. – volume: 153 start-page: 362 year: 2020 end-page: 376 ident: bib289 article-title: Hippocampal long-term synaptic depression and memory deficits induced in early amyloidopathy are prevented by enhancing G-protein-gated inwardly rectifying potassium channel activity publication-title: J. Neurochem – volume: 3 year: 2008 ident: bib15 article-title: Impaired spatial learning strategies and novel object recognition in mice haploinsufficient for the dual specificity tyrosine-regulated kinase-1A (Dyrk1A) publication-title: PLoS One – volume: 361 start-page: 493 year: 2006 end-page: 505 ident: bib93 article-title: Linker histone H1 binds to disease associated amyloid-like fibrils publication-title: J. Mol. Biol. – year: 2023 ident: bib273 article-title: Appropriate use recommendations for lecanemab publication-title: J. Prev. Alzheimers Dis. – volume: 11 year: 2022 ident: bib25 article-title: DunedinPACE, a DNA methylation biomarker of the pace of aging publication-title: Elife – volume: 11 year: 2022 ident: 10.1016/j.arr.2023.102003_bib25 article-title: DunedinPACE, a DNA methylation biomarker of the pace of aging publication-title: Elife doi: 10.7554/eLife.73420 – volume: 268 start-page: 3 year: 2015 ident: 10.1016/j.arr.2023.102003_bib53 article-title: 5-Hydroxymethylcytosine: a new player in brain disorders? publication-title: Exp. Neurol. doi: 10.1016/j.expneurol.2014.05.008 – volume: 8 start-page: 477 year: 2021 ident: 10.1016/j.arr.2023.102003_bib220 article-title: Peripheral blood BRCA1 methylation positively correlates with major Alzheimer’s disease risk factors publication-title: J. Prev. Alzheimers Dis. – volume: 14 start-page: 5641 year: 2022 ident: 10.1016/j.arr.2023.102003_bib321 article-title: Aging the brain: multi-region methylation principal component based clock in the context of Alzheimer's disease publication-title: Aging (Albany NY) doi: 10.18632/aging.204196 – volume: 19 year: 2020 ident: 10.1016/j.arr.2023.102003_bib187 article-title: Epigenome signatures landscaped by histone H3K9me3 are associated with the synaptic dysfunction in Alzheimer's disease publication-title: Aging Cell doi: 10.1111/acel.13153 – volume: 15 year: 2021 ident: 10.1016/j.arr.2023.102003_bib199 article-title: Inflamma-MicroRNAs in Alzheimer's disease: from disease pathogenesis to therapeutic potentials publication-title: Front Cell Neurosci. doi: 10.3389/fncel.2021.785433 – volume: 14 start-page: 178 year: 2022 ident: 10.1016/j.arr.2023.102003_bib22 article-title: Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer's disease publication-title: Alzheimers Res Ther. doi: 10.1186/s13195-022-01110-8 – volume: 13 year: 2021 ident: 10.1016/j.arr.2023.102003_bib278 article-title: New RNA-based breakthroughs in Alzheimer's disease diagnosis and therapeutics publication-title: Pharmaceutics doi: 10.3390/pharmaceutics13091397 – volume: 58 start-page: 4038 year: 2021 ident: 10.1016/j.arr.2023.102003_bib351 article-title: The protective A673T mutation of amyloid precursor protein (APP) in Alzheimer's disease publication-title: Mol. Neurobiol. doi: 10.1007/s12035-021-02385-y – volume: 38 start-page: 235 year: 2005 ident: 10.1016/j.arr.2023.102003_bib72 article-title: Amyloid-beta metal interaction and metal chelation publication-title: Subcell. Biochem doi: 10.1007/0-387-23226-5_12 – volume: 17 start-page: 327 year: 2021 ident: 10.1016/j.arr.2023.102003_bib6 article-title: 2021 Alzheimer's disease facts and figures publication-title: Alzheimers Dement doi: 10.1002/alz.12328 – volume: 60 year: 2020 ident: 10.1016/j.arr.2023.102003_bib116 article-title: Biohorology and biomarkers of aging: current state-of-the-art, challenges and opportunities publication-title: Ageing Res Rev. doi: 10.1016/j.arr.2020.101050 – year: 2023 ident: 10.1016/j.arr.2023.102003_bib373 article-title: ROS inhibition increases KDM6A-mediated NOX2 transcription and promotes macrophages oxidative stress and M1 polarization publication-title: Cell Stress Chaperon-.-. doi: 10.1007/s12192-023-01347-8 – volume: 35 start-page: 1255 year: 2014 ident: 10.1016/j.arr.2023.102003_bib254 article-title: Novel vaccine peptide GV1001 effectively blocks β-amyloid toxicity by mimicking the extra-telomeric functions of human telomerase reverse transcriptase publication-title: Neurobiol. Aging doi: 10.1016/j.neurobiolaging.2013.12.015 – volume: 29 start-page: 571 year: 2012 ident: 10.1016/j.arr.2023.102003_bib18 article-title: Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-2012-111223 – ident: 10.1016/j.arr.2023.102003_bib59 – volume: 51 start-page: 679 year: 2008 ident: 10.1016/j.arr.2023.102003_bib153 article-title: Complex constitutional subtelomeric 1p36.3 deletion/duplication in a mentally retarded child with neonatal neuroblastoma publication-title: Eur. J. Med. Genet doi: 10.1016/j.ejmg.2008.06.004 – volume: 7 start-page: 13537 year: 2017 ident: 10.1016/j.arr.2023.102003_bib334 article-title: Gut microbiome alterations in Alzheimer's disease publication-title: Sci. Rep. doi: 10.1038/s41598-017-13601-y – volume: 5 start-page: 225 year: 2018 ident: 10.1016/j.arr.2023.102003_bib292 article-title: Female sex and Alzheimer's risk: the menopause connection publication-title: J. Prev. Alzheimers Dis. – volume: 13 year: 2021 ident: 10.1016/j.arr.2023.102003_bib1 article-title: MicroRNAs as potential orchestrators of Alzheimer's disease-related pathologies: insights on current status and future possibilities publication-title: Front Aging Neurosci. doi: 10.3389/fnagi.2021.743573 – volume: 9 year: 2020 ident: 10.1016/j.arr.2023.102003_bib250 article-title: The histone code of senescence publication-title: Cells doi: 10.3390/cells9020466 – volume: 6 start-page: 245 year: 2021 ident: 10.1016/j.arr.2023.102003_bib376 article-title: Inflammation, epigenetics, and metabolism converge to cell senescence and ageing: the regulation and intervention publication-title: Signal Transduct. Target Ther. doi: 10.1038/s41392-021-00646-9 – ident: 10.1016/j.arr.2023.102003_bib65 – volume: 29 start-page: 50 year: 2014 ident: 10.1016/j.arr.2023.102003_bib136 article-title: Global long interspersed nuclear element 1 DNA methylation in a Colombian sample of patients with late-onset Alzheimer's disease publication-title: Am. J. Alzheimers Dis. Other Demen doi: 10.1177/1533317513505132 – volume: 45 start-page: 380 year: 2019 ident: 10.1016/j.arr.2023.102003_bib216 article-title: HDAC2 dysregulation in the nucleus basalis of Meynert during the progression of Alzheimer's disease publication-title: Neuropathol. Appl. Neurobiol. doi: 10.1111/nan.12518 – volume: 8 start-page: 1103 year: 2016 ident: 10.1016/j.arr.2023.102003_bib218 article-title: LSD1: biologic roles and therapeutic targeting publication-title: Epigenomics doi: 10.2217/epi-2016-0009 – volume: 6 start-page: 61 year: 2006 ident: 10.1016/j.arr.2023.102003_bib159 article-title: Mechanism of action of memantine publication-title: Curr. Opin. Pharm. doi: 10.1016/j.coph.2005.09.007 – volume: 20 start-page: 249 year: 2019 ident: 10.1016/j.arr.2023.102003_bib24 article-title: DNA methylation aging clocks: challenges and recommendations publication-title: Genome Biol. doi: 10.1186/s13059-019-1824-y – volume: 376 year: 2022 ident: 10.1016/j.arr.2023.102003_bib212 article-title: Regulatory decisions diverge over aducanumab for Alzheimer’s disease publication-title: BMJ – start-page: 102 year: 2016 ident: 10.1016/j.arr.2023.102003_bib131 article-title: DNA methylation changes in plasticity genes accompany the formation and maintenance of memory publication-title: Nat Neurosci. doi: 10.1038/nn.4194 – volume: 7 start-page: 12948 year: 2016 ident: 10.1016/j.arr.2023.102003_bib325 article-title: Nicotinamide riboside is uniquely and orally bioavailable in mice and humans publication-title: Nat. Commun. doi: 10.1038/ncomms12948 – volume: 10 start-page: 83 year: 2018 ident: 10.1016/j.arr.2023.102003_bib359 article-title: NSAID exposure and risk of Alzheimer's disease: an updated meta-analysis from cohort studies publication-title: Front. Aging Neurosci. doi: 10.3389/fnagi.2018.00083 – ident: 10.1016/j.arr.2023.102003_bib60 – volume: 66 start-page: 927 year: 2018 ident: 10.1016/j.arr.2023.102003_bib214 article-title: DNA Hypomethylation in Blood Links B3GALT4 and ZADH2 to Alzheimer's Disease publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-180592 – volume: 45 start-page: 440 year: 2012 ident: 10.1016/j.arr.2023.102003_bib245 article-title: TUDCA, a bile acid, attenuates amyloid precursor protein processing and amyloid-β deposition in APP/PS1 mice publication-title: Mol. Neurobiol. doi: 10.1007/s12035-012-8256-y – volume: 1698 start-page: 179 year: 2018 ident: 10.1016/j.arr.2023.102003_bib326 article-title: Glia-specific APOE epigenetic changes in the Alzheimer's disease brain publication-title: Brain Res. doi: 10.1016/j.brainres.2018.08.006 – volume: 3 year: 2020 ident: 10.1016/j.arr.2023.102003_bib269 article-title: Association of epigenetic metrics of biological age with cortical thickness publication-title: JAMA Netw. Open doi: 10.1001/jamanetworkopen.2020.15428 – volume: 68 start-page: 853 year: 2011 ident: 10.1016/j.arr.2023.102003_bib317 article-title: Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease publication-title: Arch. Gen. Psychiatry doi: 10.1001/archgenpsychiatry.2011.72 – volume: 10 start-page: 51 year: 2023 ident: 10.1016/j.arr.2023.102003_bib227 article-title: Three-dimensional chromatin architecture datasets for aging and Alzheimer’s disease publication-title: Sci. Data doi: 10.1038/s41597-023-01948-z – volume: 13 start-page: 66 year: 2021 ident: 10.1016/j.arr.2023.102003_bib176 article-title: Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer's disease already receiving donepezil: a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trial publication-title: Alzheimers Res Ther. doi: 10.1186/s13195-021-00803-w – volume: 2021 start-page: 2031407 year: 2021 ident: 10.1016/j.arr.2023.102003_bib42 article-title: MiR-29c-3p may promote the progression of Alzheimer's disease through BACE1 publication-title: J. Health Eng. doi: 10.1155/2021/2031407 – volume: 41 start-page: 655 year: 2019 ident: 10.1016/j.arr.2023.102003_bib290 article-title: Sulforaphane - role in aging and neurodegeneration publication-title: Geroscience doi: 10.1007/s11357-019-00061-7 – volume: 8 start-page: 37 year: 2016 ident: 10.1016/j.arr.2023.102003_bib45 article-title: TREM2 upregulation correlates with 5-hydroxymethycytosine enrichment in Alzheimer's disease hippocampus publication-title: Clin. Epigenetics doi: 10.1186/s13148-016-0202-9 – volume: 116 start-page: 779 year: 2004 ident: 10.1016/j.arr.2023.102003_bib184 article-title: A small modulatory dsRNA specifies the fate of adult neural stem cells publication-title: Cell doi: 10.1016/S0092-8674(04)00248-X – volume: 2018 start-page: 5642148 year: 2018 ident: 10.1016/j.arr.2023.102003_bib134 article-title: Sulforaphane delays fibroblast senescence by curbing cellular glucose uptake, increased glycolysis, and oxidative damage publication-title: Oxid. Med Cell Longev. doi: 10.1155/2018/5642148 – volume: 13 year: 2021 ident: 10.1016/j.arr.2023.102003_bib151 article-title: Exercise reduces H3K9me3 and regulates brain derived neurotrophic factor and GABRA2 in an age dependent manner publication-title: Front Aging Neurosci. doi: 10.3389/fnagi.2021.798297 – volume: 507 start-page: 448 year: 2014 ident: 10.1016/j.arr.2023.102003_bib209 article-title: REST and stress resistance in ageing and Alzheimer's disease publication-title: Nature doi: 10.1038/nature13163 – volume: 5 start-page: eaaw2880 year: 2019 ident: 10.1016/j.arr.2023.102003_bib104 article-title: Epigenetic signatures of methylated DNA cytosine in Alzheimer's disease publication-title: Sci. Adv. doi: 10.1126/sciadv.aaw2880 – volume: 31 start-page: 1883 year: 2016 ident: 10.1016/j.arr.2023.102003_bib147 article-title: The MAPT gene is differentially methylated in the progressive supranuclear palsy brain publication-title: Mov. Disord. doi: 10.1002/mds.26820 – volume: 21 start-page: 381 year: 2011 ident: 10.1016/j.arr.2023.102003_bib20 article-title: Regulation of chromatin by histone modifications publication-title: Cell Res doi: 10.1038/cr.2011.22 – volume: 227 year: 2022 ident: 10.1016/j.arr.2023.102003_bib135 article-title: Medicinal chemistry updates of novel HDACs inhibitors (2020 to present) publication-title: Eur. J. Med Chem. doi: 10.1016/j.ejmech.2021.113946 – volume: 52 start-page: 1024 year: 2020 ident: 10.1016/j.arr.2023.102003_bib242 article-title: An integrated multi-omics approach identifies epigenetic alterations associated with Alzheimer's disease publication-title: Nat. Genet doi: 10.1038/s41588-020-0696-0 – volume: 61 year: 2017 ident: 10.1016/j.arr.2023.102003_bib122 article-title: Targeting the epigenome: screening bioactive compounds that regulate histone deacetylase activity publication-title: Mol. Nutr. Food Res doi: 10.1002/mnfr.201600744 – volume: 16 start-page: 1219 year: 2017 ident: 10.1016/j.arr.2023.102003_bib9 article-title: TOR-mediated regulation of metabolism in aging publication-title: Aging Cell doi: 10.1111/acel.12689 – volume: 174 start-page: 177 year: 2018 ident: 10.1016/j.arr.2023.102003_bib146 article-title: Effects of resveratrol on memory performance, hippocampus connectivity and microstructure in older adults - a randomized controlled trial publication-title: Neuroimage doi: 10.1016/j.neuroimage.2018.03.023 – volume: 2 start-page: 16017 year: 2016 ident: 10.1016/j.arr.2023.102003_bib150 article-title: It takes two to tango: NAD(+) and sirtuins in aging/longevity control publication-title: NPJ Aging Mech. Dis. doi: 10.1038/npjamd.2016.17 – volume: 84 start-page: 2161 year: 2015 ident: 10.1016/j.arr.2023.102003_bib40 article-title: Etanercept in Alzheimer disease: a randomized, placebo-controlled, double-blind, phase 2 trial publication-title: Neurology doi: 10.1212/WNL.0000000000001617 – volume: 8 start-page: 595 year: 2016 ident: 10.1016/j.arr.2023.102003_bib294 article-title: The amyloid hypothesis of Alzheimer's disease at 25 years publication-title: EMBO Mol. Med doi: 10.15252/emmm.201606210 – volume: 168 start-page: 39 year: 2018 ident: 10.1016/j.arr.2023.102003_bib107 article-title: Pharmacologic interventions to prevent cognitive decline, mild cognitive impairment, and clinical alzheimer-type dementia: a systematic review publication-title: Ann. Intern Med doi: 10.7326/M17-1529 – volume: 7 start-page: 1051 year: 2015 ident: 10.1016/j.arr.2023.102003_bib89 article-title: Methyl-CpG-binding domain proteins: readers of the epigenome publication-title: Epigenomics doi: 10.2217/epi.15.39 – volume: 70 start-page: 288 year: 1999 ident: 10.1016/j.arr.2023.102003_bib322 article-title: Reduction with age in methylcytosine in the promoter region -224 approximately -101 of the amyloid precursor protein gene in autopsy human cortex publication-title: Brain Res Mol. Brain Res. doi: 10.1016/S0169-328X(99)00163-1 – volume: 14 start-page: 569 year: 2018 ident: 10.1016/j.arr.2023.102003_bib277 article-title: Does tau pathology activate jumping genes? publication-title: Nat. Rev. Neurol. doi: 10.1038/s41582-018-0056-1 – volume: 90 year: 2018 ident: 10.1016/j.arr.2023.102003_bib231 article-title: Design of the first-in-human study of IONIS-MAPTRx, a tau-lowering antisense oligonucleotide, in patients with Alzheimer disease (S2.006) publication-title: Neurology doi: 10.1212/WNL.90.15_supplement.S2.006 – volume: 79 start-page: 463 year: 2022 ident: 10.1016/j.arr.2023.102003_bib46 article-title: Balancing NAD(+) deficits with nicotinamide riboside: therapeutic possibilities and limitations publication-title: Cell Mol. Life Sci. doi: 10.1007/s00018-022-04499-5 – volume: 7 year: 2021 ident: 10.1016/j.arr.2023.102003_bib74 article-title: Alzheimer's disease drug development pipeline: 2021 publication-title: Alzheimers Dement – volume: 9 start-page: 640 year: 2018 ident: 10.1016/j.arr.2023.102003_bib182 article-title: Epigenetics of modified DNA bases: 5-methylcytosine and beyond publication-title: Front Genet doi: 10.3389/fgene.2018.00640 – volume: 337 start-page: 70 year: 2022 ident: 10.1016/j.arr.2023.102003_bib337 article-title: Challenging dogmas: how transgenerational epigenetics reshapes our views on life publication-title: J. Exp. Zool. A Ecol. Integr. Physiol. doi: 10.1002/jez.2465 – volume: 64 start-page: 1079 year: 2004 ident: 10.1016/j.arr.2023.102003_bib130 article-title: Histone deacetylase is a target of valproic acid-mediated cellular differentiation publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-03-0799 – volume: 2016 start-page: 5912146 year: 2016 ident: 10.1016/j.arr.2023.102003_bib49 article-title: Folic acid supplementation mitigates Alzheimer's disease by reducing inflammation: a randomized controlled trial publication-title: Mediat. Inflamm. doi: 10.1155/2016/5912146 – volume: 26 start-page: 4210 year: 2022 ident: 10.1016/j.arr.2023.102003_bib224 article-title: Lamivudine, a reverse transcriptase inhibitor, rescues cognitive deficits in a mouse model of down syndrome publication-title: J. Cell Mol. Med. doi: 10.1111/jcmm.17411 – volume: 9 start-page: 402 year: 2018 ident: 10.1016/j.arr.2023.102003_bib246 article-title: Overview of MicroRNA biogenesis, mechanisms of actions, and circulation publication-title: Front Endocrinol. (Lausanne) doi: 10.3389/fendo.2018.00402 – volume: 35 start-page: 175 year: 2017 ident: 10.1016/j.arr.2023.102003_bib124 article-title: Tau spread, apolipoprotein E, inflammation, and more: rapidly evolving basic science in Alzheimer disease publication-title: Neurol. Clin. doi: 10.1016/j.ncl.2017.01.001 – volume: 14 start-page: R115 year: 2013 ident: 10.1016/j.arr.2023.102003_bib140 article-title: DNA methylation age of human tissues and cell types publication-title: Genome Biol. doi: 10.1186/gb-2013-14-10-r115 – volume: 40 start-page: 2177 year: 2020 ident: 10.1016/j.arr.2023.102003_bib280 article-title: Histone deacetylases as targets for the treatment of neurodegenerative disorders: challenges and future opportunities publication-title: Med Res Rev. doi: 10.1002/med.21701 – volume: 11 year: 2021 ident: 10.1016/j.arr.2023.102003_bib285 article-title: A glitch in the snitch: the role of linker histone H1 in shaping the epigenome in normal and diseased cells publication-title: Open Biol. doi: 10.1098/rsob.210124 – volume: 73 start-page: 201 year: 2016 ident: 10.1016/j.arr.2023.102003_bib126 article-title: Sex hormone-related neurosteroids differentially rescue bioenergetic deficits induced by amyloid-β or hyperphosphorylated tau protein publication-title: Cell Mol. Life Sci. doi: 10.1007/s00018-015-1988-x – volume: 71 start-page: 882 year: 2018 ident: 10.1016/j.arr.2023.102003_bib105 article-title: DNA methylation clocks in aging: categories, causes, and consequences publication-title: Mol. Cell doi: 10.1016/j.molcel.2018.08.008 – volume: 4 start-page: 609 year: 2018 ident: 10.1016/j.arr.2023.102003_bib375 article-title: A randomized, double-blind, placebo-controlled trial of resveratrol with glucose and malate (RGM) to slow the progression of Alzheimer's disease: a pilot study publication-title: Alzheimers Dement (N. Y) doi: 10.1016/j.trci.2018.09.009 – volume: 27 start-page: 172 year: 2015 ident: 10.1016/j.arr.2023.102003_bib283 article-title: A comprehensive view of the epigenetic landscape. Part II: Histone post-translational modification, nucleosome level, and chromatin regulation by ncRNAs publication-title: Neurotox. Res. doi: 10.1007/s12640-014-9508-6 – volume: 24 start-page: 1 year: 2022 ident: 10.1016/j.arr.2023.102003_bib47 article-title: TUDCA protects against tunicamycin‑induced apoptosis of dorsal root ganglion neurons by suppressing activation of ER stress publication-title: Exp. Ther. Med doi: 10.3892/etm.2022.11436 – volume: 9 year: 2017 ident: 10.1016/j.arr.2023.102003_bib87 article-title: Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy publication-title: Sci. Transl. Med doi: 10.1126/scitranslmed.aag0481 – volume: 12 year: 2020 ident: 10.1016/j.arr.2023.102003_bib19 article-title: Neuroimaging in dementia: a brief review publication-title: Cureus – volume: 15 start-page: P910 year: 2019 ident: 10.1016/j.arr.2023.102003_bib158 article-title: Modulation of microRNA pathways by gemfibrozil in predementia Alzheimer disease: a randomized, placebo-controlled, double-blind clinical trial publication-title: Alzheimers Dement. doi: 10.1016/j.jalz.2019.06.4682 – volume: 20 start-page: 158 year: 2022 ident: 10.1016/j.arr.2023.102003_bib183 article-title: Understanding the role of histone deacetylase and their inhibitors in neurodegenerative disorders: current targets and future perspective publication-title: Curr. Neuropharmacol. doi: 10.2174/1570159X19666210609160017 – volume: 251 start-page: 111 year: 2021 ident: 10.1016/j.arr.2023.102003_bib44 article-title: Nicotinamide riboside has minimal impact on energy metabolism in mouse models of mild obesity publication-title: J. Endocrinol. doi: 10.1530/JOE-21-0123 – volume: 17 start-page: 115 year: 2021 ident: 10.1016/j.arr.2023.102003_bib13 article-title: Hypothesis: tau pathology is an initiating factor in sporadic Alzheimer's disease publication-title: Alzheimers Dement doi: 10.1002/alz.12192 – volume: 19 year: 2018 ident: 10.1016/j.arr.2023.102003_bib73 article-title: DNA methyltransferases, DNA methylation, and age-associated cognitive function publication-title: Int J. Mol. Sci. doi: 10.3390/ijms19051315 – volume: 10 start-page: 1365 year: 2018 ident: 10.1016/j.arr.2023.102003_bib137 article-title: Alzheimer's disease DNA methylome of pyramidal layers in frontal cortex: laser-assisted microdissection study publication-title: Epigenomics doi: 10.2217/epi-2017-0160 – volume: 15 start-page: 781 year: 2020 ident: 10.1016/j.arr.2023.102003_bib234 article-title: CpG and non-CpG Presenilin1 methylation pattern in course of neurodevelopment and neurodegeneration is associated with gene expression in human and murine brain publication-title: Epigenetics doi: 10.1080/15592294.2020.1722917 – volume: 49 start-page: 359 year: 2013 ident: 10.1016/j.arr.2023.102003_bib133 article-title: Genome-wide methylation profiles reveal quantitative views of human aging rates publication-title: Mol. Cell doi: 10.1016/j.molcel.2012.10.016 – volume: 14 start-page: 723 year: 2008 ident: 10.1016/j.arr.2023.102003_bib98 article-title: Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase publication-title: Nat. Med doi: 10.1038/nm1784 – volume: 9 start-page: 563 year: 2012 ident: 10.1016/j.arr.2023.102003_bib17 article-title: Alzheimer's disease and environmental exposure to lead: the epidemiologic evidence and potential role of epigenetics publication-title: Curr. Alzheimer Res doi: 10.2174/156720512800617991 – volume: 77 start-page: 1099 year: 2020 ident: 10.1016/j.arr.2023.102003_bib71 article-title: Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and Alzheimer disease dementia: a randomized clinical trial publication-title: JAMA Neurol. doi: 10.1001/jamaneurol.2020.1840 – volume: 4 start-page: 1057204 year: 2023 ident: 10.1016/j.arr.2023.102003_bib223 article-title: Towards AI-driven longevity research: an overview publication-title: Front Aging doi: 10.3389/fragi.2023.1057204 – volume: 9 start-page: 347 year: 2015 ident: 10.1016/j.arr.2023.102003_bib287 article-title: Epigenetic alterations in Alzheimer's disease publication-title: Front Behav. Neurosci. doi: 10.3389/fnbeh.2015.00347 – volume: 38 start-page: 1021 year: 2018 ident: 10.1016/j.arr.2023.102003_bib264 article-title: Up-regulated pro-inflammatory microRNAs (miRNAs) in Alzheimer's disease (AD) and age-related macular degeneration (AMD) publication-title: Cell Mol. Neurobiol. doi: 10.1007/s10571-017-0572-3 – volume: 24 start-page: 363 year: 2019 ident: 10.1016/j.arr.2023.102003_bib85 article-title: Cholesterol metabolism is a druggable axis that independently regulates tau and amyloid-β in iPSC-derived Alzheimer's disease neurons publication-title: Cell Stem Cell doi: 10.1016/j.stem.2018.12.013 – volume: 33 start-page: 12887 year: 2013 ident: 10.1016/j.arr.2023.102003_bib86 article-title: Antisense reduction of tau in adult mice protects against seizures publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.2107-13.2013 – volume: 159 start-page: 709 year: 2014 ident: 10.1016/j.arr.2023.102003_bib166 article-title: Geroscience: linking aging to chronic disease publication-title: Cell doi: 10.1016/j.cell.2014.10.039 – volume: 16 start-page: 2043 year: 2010 ident: 10.1016/j.arr.2023.102003_bib94 article-title: MicroRNA sponges: progress and possibilities publication-title: Rna doi: 10.1261/rna.2414110 – volume: 10 start-page: 1729 year: 2019 ident: 10.1016/j.arr.2023.102003_bib114 article-title: CoREST complex-selective histone deacetylase inhibitors show prosynaptic effects and an improved safety profile to enable treatment of synaptopathies publication-title: ACS Chem. Neurosci. doi: 10.1021/acschemneuro.8b00620 – volume: 11 year: 2022 ident: 10.1016/j.arr.2023.102003_bib165 article-title: DNA methylation: a promising approach in management of Alzheimer's disease and other neurodegenerative disorders publication-title: Biology doi: 10.3390/biology11010090 – volume: 11 start-page: 244 year: 2019 ident: 10.1016/j.arr.2023.102003_bib118 article-title: Emerging alternative proteinases in APP metabolism and Alzheimer's disease pathogenesis: a focus on MT1-MMP and MT5-MMP publication-title: Front Aging Neurosci. doi: 10.3389/fnagi.2019.00244 – volume: 74 start-page: 91 year: 2020 ident: 10.1016/j.arr.2023.102003_bib102 article-title: Sodium butyrate reduces brain amyloid-β levels and improves cognitive memory performance in an Alzheimer's disease transgenic mouse model at an early disease stage publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-190120 – volume: 35 start-page: 5440 year: 2021 ident: 10.1016/j.arr.2023.102003_bib219 article-title: Sulforaphane: A review of its therapeutic potentials, advances in its nanodelivery, recent patents, and clinical trials publication-title: Phytother. Res. doi: 10.1002/ptr.7176 – volume: 18 start-page: 643 year: 2022 ident: 10.1016/j.arr.2023.102003_bib230 article-title: Gene-environment interactions in Alzheimer disease: the emerging role of epigenetics publication-title: Nat. Rev. Neurol. doi: 10.1038/s41582-022-00714-w – volume: 54 start-page: 214 year: 2020 ident: 10.1016/j.arr.2023.102003_bib265 article-title: Association between use of statin and risk of dementia: a meta-analysis of observational studies publication-title: Neuroepidemiology doi: 10.1159/000503105 – ident: 10.1016/j.arr.2023.102003_bib61 – year: 2021 ident: 10.1016/j.arr.2023.102003_bib121 article-title: World Alzheimer Report 2021: journey through the diagnosis of dementia publication-title: Alzheimer’s Dis. Int. – volume: 9 start-page: 106 year: 2013 ident: 10.1016/j.arr.2023.102003_bib201 article-title: Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy publication-title: Nat. Rev. Neurol. doi: 10.1038/nrneurol.2012.263 – ident: 10.1016/j.arr.2023.102003_bib55 – volume: 3 start-page: 19 year: 2012 ident: 10.1016/j.arr.2023.102003_bib70 article-title: High throughput DNA sequencing to detect differences in the subgingival plaque microbiome in elderly subjects with and without dementia publication-title: Invest. Genet doi: 10.1186/2041-2223-3-19 – volume: 10 start-page: 775 year: 2018 ident: 10.1016/j.arr.2023.102003_bib343 article-title: Identifying circRNA-associated-ceRNA networks in the hippocampus of Aβ1-42-induced Alzheimer's disease-like rats using microarray analysis publication-title: Aging (Albany NY) doi: 10.18632/aging.101427 – volume: 9 start-page: 579 year: 2018 ident: 10.1016/j.arr.2023.102003_bib202 article-title: The epigenetics of Alzheimer's disease: factors and therapeutic implications publication-title: Front Genet doi: 10.3389/fgene.2018.00579 – volume: 18 year: 2022 ident: 10.1016/j.arr.2023.102003_bib100 article-title: A multimodal genomic analysis framework identifies transposable element (TE) activation in Alzheimer’s disease publication-title: Alzheimers Dement. doi: 10.1002/alz.066866 – volume: 92 start-page: 74 year: 2017 ident: 10.1016/j.arr.2023.102003_bib249 article-title: DNA methylation changes at TREM2 intron 1 and TREM2 mRNA expression in patients with Alzheimer's disease publication-title: J. Psychiatr. Res doi: 10.1016/j.jpsychires.2017.04.003 – volume: 6 start-page: 5739 year: 2021 ident: 10.1016/j.arr.2023.102003_bib129 article-title: Computational analysis indicates that PARP1 acts as a histone deacetylases interactor sharing common lysine residues for acetylation, ubiquitination, and SUMOylation in Alzheimer's and Parkinson's disease publication-title: ACS Omega doi: 10.1021/acsomega.0c06168 – volume: 30 start-page: 964 year: 2020 ident: 10.1016/j.arr.2023.102003_bib303 article-title: The molecular etiology of Alzheimer's disease publication-title: Brain Pathol. doi: 10.1111/bpa.12879 – volume: 205 start-page: 2781 year: 2008 ident: 10.1016/j.arr.2023.102003_bib271 article-title: Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models publication-title: J. Exp. Med doi: 10.1084/jem.20081588 – volume: 5 start-page: 537 year: 2010 ident: 10.1016/j.arr.2023.102003_bib145 article-title: Abundance of tRNA-derived small RNAs in phosphate-starved Arabidopsis roots publication-title: Plant Signal Behav. doi: 10.4161/psb.11029 – volume: 5 year: 2013 ident: 10.1016/j.arr.2023.102003_bib23 article-title: Nucleosome remodeling and epigenetics publication-title: Cold Spring Harb. Perspect. Biol. doi: 10.1101/cshperspect.a017905 – volume: 380 start-page: 73 year: 2023 ident: 10.1016/j.arr.2023.102003_bib217 article-title: Alzheimer's disease: FDA approves lecanemab amid cost and safety concerns publication-title: Bmj doi: 10.1136/bmj.p73 – ident: 10.1016/j.arr.2023.102003_bib247 – volume: 21 start-page: 1038 year: 2018 ident: 10.1016/j.arr.2023.102003_bib311 article-title: Pathogenic tau-induced piRNA depletion promotes neuronal death through transposable element dysregulation in neurodegenerative tauopathies publication-title: Nat. Neurosci. doi: 10.1038/s41593-018-0194-1 – volume: 275 start-page: 214 year: 2014 ident: 10.1016/j.arr.2023.102003_bib259 article-title: Mild cognitive impairment: a concept in evolution publication-title: J. Intern Med doi: 10.1111/joim.12190 – volume: 24 year: 2023 ident: 10.1016/j.arr.2023.102003_bib252 article-title: An ELOVL2-based epigenetic clock for forensic age prediction: a systematic review publication-title: Int J. Mol. Sci. doi: 10.3390/ijms24032254 – start-page: 7 year: 2018 ident: 10.1016/j.arr.2023.102003_bib144 article-title: OGT binds a conserved C-terminal domain of TET1 to regulate TET1 activity and function in development publication-title: Elife – volume: 22 start-page: 1124 year: 2018 ident: 10.1016/j.arr.2023.102003_bib309 article-title: Learning and age-related changes in genome-wide H2A.Z binding in the mouse hippocampus publication-title: Cell Rep. doi: 10.1016/j.celrep.2018.01.020 – volume: 27 start-page: 2072 year: 2013 ident: 10.1016/j.arr.2023.102003_bib127 article-title: Calorie restriction and sirtuins revisited publication-title: Genes Dev. doi: 10.1101/gad.227439.113 – volume: 58 start-page: 1791 year: 2002 ident: 10.1016/j.arr.2023.102003_bib320 article-title: Phases of A beta-deposition in the human brain and its relevance for the development of AD publication-title: Neurology doi: 10.1212/WNL.58.12.1791 – year: 2022 ident: 10.1016/j.arr.2023.102003_bib341 article-title: Alzheimer's disease and progressive supranuclear palsy share similar transcriptomic changes in distinct brain regions publication-title: J Clin Invest. – volume: 3 start-page: Cd009628 year: 2020 ident: 10.1016/j.arr.2023.102003_bib206 article-title: Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment publication-title: Cochrane Database Syst. Rev. – volume: 153 start-page: 362 year: 2020 ident: 10.1016/j.arr.2023.102003_bib289 article-title: Hippocampal long-term synaptic depression and memory deficits induced in early amyloidopathy are prevented by enhancing G-protein-gated inwardly rectifying potassium channel activity publication-title: J. Neurochem doi: 10.1111/jnc.14946 – volume: 11 start-page: 1176 year: 2009 ident: 10.1016/j.arr.2023.102003_bib229 article-title: NURD keeps chromatin young publication-title: Nat. Cell Biol. doi: 10.1038/ncb1009-1176 – volume: 63 start-page: 110 year: 2018 ident: 10.1016/j.arr.2023.102003_bib2 article-title: Regulation of ADAM10 by miR-140-5p and potential relevance for Alzheimer's disease publication-title: Neurobiol. Aging doi: 10.1016/j.neurobiolaging.2017.11.007 – volume: 78 start-page: 1345 year: 2021 ident: 10.1016/j.arr.2023.102003_bib335 article-title: Effect of levetiracetam on cognition in patients with alzheimer disease with and without epileptiform activity: a randomized clinical trial publication-title: JAMA Neurol. doi: 10.1001/jamaneurol.2021.3310 – volume: 19 start-page: 435 year: 2022 ident: 10.1016/j.arr.2023.102003_bib16 article-title: Current progress of miRNA-derivative nucleotide drugs: modifications, delivery systems, applications publication-title: Expert Opin. Drug Deliv. doi: 10.1080/17425247.2022.2063835 – volume: 11 year: 2021 ident: 10.1016/j.arr.2023.102003_bib302 article-title: Alzheimer's disease: an evolving understanding of noradrenergic involvement and the promising future of electroceutical therapies publication-title: Clin. Transl. Med doi: 10.1002/ctm2.397 – year: 2020 ident: 10.1016/j.arr.2023.102003_bib39 article-title: The therapeutic potential of epigenetic modifications in Alzheimer’s disease – volume: 11 start-page: 290 year: 2019 ident: 10.1016/j.arr.2023.102003_bib315 article-title: Systemic immune dyshomeostasis model and pathways in Alzheimer's disease publication-title: Front Aging Neurosci. doi: 10.3389/fnagi.2019.00290 – volume: 58 start-page: 329 year: 2021 ident: 10.1016/j.arr.2023.102003_bib97 article-title: The relation of the brain-derived neurotrophic factor with MicroRNAs in neurodegenerative diseases and ischemic stroke publication-title: Mol. Neurobiol. doi: 10.1007/s12035-020-02101-2 – volume: 15 start-page: 3251 year: 2006 ident: 10.1016/j.arr.2023.102003_bib301 article-title: C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1 publication-title: Hum. Mol. Genet doi: 10.1093/hmg/ddl398 – volume: 31 start-page: 764 year: 2011 ident: 10.1016/j.arr.2023.102003_bib226 article-title: HDAC3 is a critical negative regulator of long-term memory formation publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.5052-10.2011 – volume: 55 start-page: 131 year: 2016 ident: 10.1016/j.arr.2023.102003_bib255 article-title: Neural stem cells injured by oxidative stress can be rejuvenated by GV1001, a novel peptide, through scavenging free radicals and enhancing survival signals publication-title: Neurotoxicology doi: 10.1016/j.neuro.2016.05.022 – volume: 34 start-page: 805 year: 2014 ident: 10.1016/j.arr.2023.102003_bib354 article-title: Valproate improves memory deficits in an Alzheimer's disease mouse model: investigation of possible mechanisms of action publication-title: Cell Mol. Neurobiol. doi: 10.1007/s10571-013-0012-y – volume: 731 year: 2020 ident: 10.1016/j.arr.2023.102003_bib331 article-title: Targeting tau: clinical trials and novel therapeutic approaches publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2020.134919 – volume: 13 start-page: 1994835 year: 2021 ident: 10.1016/j.arr.2023.102003_bib91 article-title: Effects of anti-aging interventions on intestinal microbiota publication-title: Gut Microbes doi: 10.1080/19490976.2021.1994835 – volume: 24 start-page: 598 year: 2018 ident: 10.1016/j.arr.2023.102003_bib288 article-title: PM20D1 is a quantitative trait locus associated with Alzheimer's disease publication-title: Nat. Med doi: 10.1038/s41591-018-0013-y – volume: 15 year: 2021 ident: 10.1016/j.arr.2023.102003_bib365 article-title: The association between folate and Alzheimer's disease: a systematic review and meta-analysis publication-title: Front. Neurosci. – volume: 5 start-page: 61 year: 2018 ident: 10.1016/j.arr.2023.102003_bib112 article-title: The continuum of aging and age-related diseases: common mechanisms but different rates publication-title: Front Med (Lausanne) doi: 10.3389/fmed.2018.00061 – volume: 55 start-page: 1 year: 2022 ident: 10.1016/j.arr.2023.102003_bib173 article-title: Histochemistry, cytochemistry and epigenetics publication-title: Acta Histochem Cytochem doi: 10.1267/ahc.21-00095 – volume: 167 start-page: 125 year: 2021 ident: 10.1016/j.arr.2023.102003_bib340 article-title: Nanodelivery of natural isothiocyanates as a cancer therapeutic publication-title: Free Radic. Biol. Med doi: 10.1016/j.freeradbiomed.2021.02.044 – volume: 11 start-page: 171 year: 2020 ident: 10.1016/j.arr.2023.102003_bib286 article-title: DNA methylation biomarkers in aging and age-related diseases publication-title: Front Genet doi: 10.3389/fgene.2020.00171 – volume: 85 start-page: 1383 year: 2015 ident: 10.1016/j.arr.2023.102003_bib327 article-title: A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease publication-title: Neurology doi: 10.1212/WNL.0000000000002035 – volume: 7 year: 2022 ident: 10.1016/j.arr.2023.102003_bib338 article-title: Epigenetic regulation of aging: implications for interventions of aging and diseases publication-title: Signal Transduct. Target Ther. – volume: 10 start-page: 116 year: 2018 ident: 10.1016/j.arr.2023.102003_bib31 article-title: PLD3 epigenetic changes in the hippocampus of Alzheimer's disease publication-title: Clin. Epigenetics doi: 10.1186/s13148-018-0547-3 – volume: 13 start-page: 41 year: 2020 ident: 10.1016/j.arr.2023.102003_bib164 article-title: Oxidative stress in cognitive and epigenetic aging: a retrospective glance publication-title: Front Mol. Neurosci. doi: 10.3389/fnmol.2020.00041 – volume: 81 start-page: 1135 year: 2021 ident: 10.1016/j.arr.2023.102003_bib157 article-title: Current Status of Clinical Trials on Tau Immunotherapies publication-title: Drugs doi: 10.1007/s40265-021-01546-6 – ident: 10.1016/j.arr.2023.102003_bib248 – volume: 275 start-page: 89 year: 1999 ident: 10.1016/j.arr.2023.102003_bib323 article-title: The methylation status of cytosines in a tau gene promoter region alters with age to downregulate transcriptional activity in human cerebral cortex publication-title: Neurosci. Lett. doi: 10.1016/S0304-3940(99)00731-4 – ident: 10.1016/j.arr.2023.102003_bib272 doi: 10.1101/2022.10.05.22280735 – volume: 7 year: 2021 ident: 10.1016/j.arr.2023.102003_bib162 article-title: MicroRNAs as candidate biomarkers for Alzheimer's disease publication-title: Nanocoding RNA – volume: 32 start-page: 8270 year: 2012 ident: 10.1016/j.arr.2023.102003_bib329 article-title: Contrasting pathology of the stress granule proteins TIA-1 and G3BP in tauopathies publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.1592-12.2012 – volume: 14 start-page: 1 year: 2017 ident: 10.1016/j.arr.2023.102003_bib238 article-title: Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease publication-title: J. Neuroinflamm. doi: 10.1186/s12974-016-0779-0 – volume: 10 year: 2021 ident: 10.1016/j.arr.2023.102003_bib377 article-title: DNA methylation in genetic and sporadic forms of neurodegeneration: lessons from Alzheimer's, related tauopathies and genetic tauopathies publication-title: Cells doi: 10.3390/cells10113064 – volume: 134 start-page: 486 year: 2013 ident: 10.1016/j.arr.2023.102003_bib37 article-title: Epigenetic changes in the progression of Alzheimer's disease publication-title: Mech. Ageing Dev. doi: 10.1016/j.mad.2013.08.005 – volume: 20 start-page: 407 year: 1999 ident: 10.1016/j.arr.2023.102003_bib106 article-title: The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms☆ publication-title: Neurobiol. Aging doi: 10.1016/S0197-4580(99)00053-6 – volume: 15 year: 2022 ident: 10.1016/j.arr.2023.102003_bib28 article-title: DNA methylation and establishing memory publication-title: Epigenet Insights doi: 10.1177/25168657211072499 – volume: 15 year: 2020 ident: 10.1016/j.arr.2023.102003_bib215 article-title: Modulation of KDM1A with vafidemstat rescues memory deficit and behavioral alterations publication-title: PLoS One doi: 10.1371/journal.pone.0233468 – volume: 11 start-page: 6114 year: 2020 ident: 10.1016/j.arr.2023.102003_bib362 article-title: Epigenome-wide meta-analysis of DNA methylation differences in prefrontal cortex implicates the immune processes in Alzheimer's disease publication-title: Nat. Commun. doi: 10.1038/s41467-020-19791-w – volume: 396 start-page: 413 year: 2020 ident: 10.1016/j.arr.2023.102003_bib203 article-title: Dementia prevention, intervention, and care: 2020 report of the Lancet Commission publication-title: Lancet doi: 10.1016/S0140-6736(20)30367-6 – volume: 12 start-page: 3208 year: 2021 ident: 10.1016/j.arr.2023.102003_bib281 article-title: Restoration of energy homeostasis by SIRT6 extends healthy lifespan publication-title: Nat. Commun. doi: 10.1038/s41467-021-23545-7 – volume: 57 start-page: 1049 year: 2017 ident: 10.1016/j.arr.2023.102003_bib163 article-title: Therapeutics of neurotransmitters in Alzheimer's Disease publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-161118 – volume: 12 start-page: 84 year: 2020 ident: 10.1016/j.arr.2023.102003_bib332 article-title: Harnessing peripheral DNA methylation differences in the Alzheimer's Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease publication-title: Clin. Epigenetics doi: 10.1186/s13148-020-00864-y – volume: 13 year: 2021 ident: 10.1016/j.arr.2023.102003_bib257 article-title: A meta-analysis of Brain DNA methylation across sex, age, and Alzheimer's disease points for accelerated epigenetic aging in neurodegeneration publication-title: Front Aging Neurosci. doi: 10.3389/fnagi.2021.639428 – volume: 32 start-page: 1161 year: 2011 ident: 10.1016/j.arr.2023.102003_bib225 article-title: Epigenetic mechanisms in Alzheimer's disease publication-title: Neurobiol. Aging doi: 10.1016/j.neurobiolaging.2010.08.017 – volume: 159 year: 2021 ident: 10.1016/j.arr.2023.102003_bib109 article-title: Small nucleolar RNAs in plasma extracellular vesicles and their discriminatory power as diagnostic biomarkers of Alzheimer's disease publication-title: Neurobiol. Dis. doi: 10.1016/j.nbd.2021.105481 – volume: 43 start-page: 1300 year: 2012 ident: 10.1016/j.arr.2023.102003_bib26 article-title: Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma publication-title: Hum. Pathol. doi: 10.1016/j.humpath.2011.10.010 – start-page: 508 year: 2021 ident: 10.1016/j.arr.2023.102003_bib295 article-title: An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study publication-title: Trials doi: 10.1186/s13063-021-05404-4 – year: 2012 ident: 10.1016/j.arr.2023.102003_bib366 article-title: Ageing and cancer: Mi-2, mTOR and metabolism publication-title: Enzym. Eng. – volume: 23 start-page: 53 year: 2022 ident: 10.1016/j.arr.2023.102003_bib113 article-title: The probabilistic model of Alzheimer disease: the amyloid hypothesis revised publication-title: Nat. Rev. Neurosci. doi: 10.1038/s41583-021-00533-w – volume: 179 start-page: 312 year: 2019 ident: 10.1016/j.arr.2023.102003_bib207 article-title: Alzheimer disease: an update on pathobiology and treatment strategies publication-title: Cell doi: 10.1016/j.cell.2019.09.001 – volume: 35 start-page: 5545 year: 2007 ident: 10.1016/j.arr.2023.102003_bib346 article-title: Defective DNA base excision repair in brain from individuals with Alzheimer's disease and amnestic mild cognitive impairment publication-title: Nucleic Acids Res doi: 10.1093/nar/gkm605 – volume: 13 start-page: 476 year: 2019 ident: 10.1016/j.arr.2023.102003_bib96 article-title: Epigenetic modifications in Alzheimer's neuropathology and therapeutics publication-title: Front Neurosci. doi: 10.3389/fnins.2019.00476 – ident: 10.1016/j.arr.2023.102003_bib66 – volume: 1805 start-page: 349 year: 2018 ident: 10.1016/j.arr.2023.102003_bib210 article-title: Remodeling and repositioning of nucleosomes in nucleosomal arrays publication-title: Methods Mol. Biol. doi: 10.1007/978-1-4939-8556-2_18 – volume: 80 start-page: 441 year: 2020 ident: 10.1016/j.arr.2023.102003_bib313 article-title: Sodium oligomannate: first approval publication-title: Drugs doi: 10.1007/s40265-020-01268-1 – volume: 6 year: 2020 ident: 10.1016/j.arr.2023.102003_bib276 article-title: Late-onset vs nonmendelian early-onset Alzheimer disease: a distinction without a difference? publication-title: Neurol. Genet doi: 10.1212/NXG.0000000000000512 – volume: 6 start-page: 37486 year: 2016 ident: 10.1016/j.arr.2023.102003_bib213 article-title: Folic acid supplementation improves cognitive function by reducing the levels of peripheral inflammatory cytokines in elderly Chinese subjects with MCI publication-title: Sci. Rep. doi: 10.1038/srep37486 – volume: 9 start-page: 140 year: 2016 ident: 10.1016/j.arr.2023.102003_bib348 article-title: The protective role of microRNA-200c in Alzheimer's disease pathologies is induced by beta amyloid-triggered endoplasmic reticulum stress publication-title: Front Mol. Neurosci. doi: 10.3389/fnmol.2016.00140 – volume: 11 start-page: 927 year: 2020 ident: 10.1016/j.arr.2023.102003_bib370 article-title: Sirtuins and their biological relevance in aging and age-related diseases publication-title: Aging Dis. doi: 10.14336/AD.2019.0820 – year: 2023 ident: 10.1016/j.arr.2023.102003_bib273 article-title: Appropriate use recommendations for lecanemab publication-title: J. Prev. Alzheimers Dis. doi: 10.14283/jpad.2023.34 – volume: 178 start-page: 1011 year: 2022 ident: 10.1016/j.arr.2023.102003_bib333 article-title: High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects publication-title: Rev. Neurol. (Paris) doi: 10.1016/j.neurol.2022.06.012 – volume: 15 year: 2020 ident: 10.1016/j.arr.2023.102003_bib27 article-title: DNA methylation clocks and their predictive capacity for aging phenotypes and healthspan publication-title: Neurosci. Insights doi: 10.1177/2633105520942221 – volume: 58 start-page: 263 year: 2017 ident: 10.1016/j.arr.2023.102003_bib352 article-title: DNA methylation and tag SNPs of the BDNF gene in conversion of amnestic mild cognitive impairment into Alzheimer's disease: a cross-sectional cohort study publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-170007 – year: 2022 ident: 10.1016/j.arr.2023.102003_bib35 article-title: Dementia risk in a diverse population: a single-region nested case-control study in the East End of London publication-title: Lancet Reg. Health Eur. doi: 10.1016/j.lanepe.2022.100321 – volume: 9 start-page: 2584 year: 2018 ident: 10.1016/j.arr.2023.102003_bib198 article-title: Sulforaphane inhibits inflammatory responses of primary human T-cells by increasing ROS and depleting glutathione publication-title: Front. Immunol. doi: 10.3389/fimmu.2018.02584 – volume: 17 start-page: 171 year: 2016 ident: 10.1016/j.arr.2023.102003_bib142 article-title: An epigenetic clock analysis of race/ethnicity, sex, and coronary heart disease publication-title: Genome Biol. doi: 10.1186/s13059-016-1030-0 – volume: 10 start-page: 573 year: 2018 ident: 10.1016/j.arr.2023.102003_bib191 article-title: An epigenetic biomarker of aging for lifespan and healthspan publication-title: Aging (Albany NY) doi: 10.18632/aging.101414 – volume: 5 year: 2010 ident: 10.1016/j.arr.2023.102003_bib308 article-title: The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide publication-title: PLoS One doi: 10.1371/journal.pone.0009505 – volume: 24 start-page: 1465 year: 2010 ident: 10.1016/j.arr.2023.102003_bib316 article-title: Confining euchromatin/heterochromatin territory: jumonji crosses the line publication-title: Genes Dev. doi: 10.1101/gad.1941010 – volume: 60 start-page: 481 year: 2003 ident: 10.1016/j.arr.2023.102003_bib88 article-title: Atrophy rates of entorhinal cortex in AD and normal aging publication-title: Neurology doi: 10.1212/01.WNL.0000044400.11317.EC – volume: 17 start-page: 2181 year: 2021 ident: 10.1016/j.arr.2023.102003_bib360 article-title: Interaction between Aβ and tau in the pathogenesis of Alzheimer's disease publication-title: Int J. Biol. Sci. doi: 10.7150/ijbs.57078 – year: 2012 ident: 10.1016/j.arr.2023.102003_bib54 – volume: 90 start-page: 695 year: 2018 ident: 10.1016/j.arr.2023.102003_bib12 article-title: Resistance vs resilience to Alzheimer disease: clarifying terminology for preclinical studies publication-title: Neurology doi: 10.1212/WNL.0000000000005303 – volume: 27 year: 2022 ident: 10.1016/j.arr.2023.102003_bib119 article-title: Influence of age and dose on the effect of resveratrol for glycemic control in type 2 diabetes mellitus: systematic review and meta-analysis publication-title: Molecules doi: 10.3390/molecules27165232 – volume: 29 start-page: 68 year: 2011 ident: 10.1016/j.arr.2023.102003_bib306 article-title: Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine publication-title: Nat. Biotechnol. doi: 10.1038/nbt.1732 – volume: 12 year: 2018 ident: 10.1016/j.arr.2023.102003_bib8 article-title: Altered regulation of KIAA0566, and katanin signaling expression in the locus coeruleus with neurofibrillary tangle pathology publication-title: Front Cell Neurosci. doi: 10.3389/fncel.2018.00131 – volume: 32 start-page: 209 year: 2015 ident: 10.1016/j.arr.2023.102003_bib95 article-title: Aging, neurodegenerative disease, and traumatic brain injury: the role of neuroimaging publication-title: J. Neurotrauma doi: 10.1089/neu.2014.3506 – volume: 24 year: 2020 ident: 10.1016/j.arr.2023.102003_bib307 article-title: Mechanical regulation of histone modifications and cell plasticity publication-title: Curr. Opin. Solid State Mater. Sci. doi: 10.1016/j.cossms.2020.100872 – volume: 99 start-page: e1402 year: 2022 ident: 10.1016/j.arr.2023.102003_bib310 article-title: Association of pace of aging measured by blood-based dna methylation with age-related cognitive impairment and dementia publication-title: Neurology doi: 10.1212/WNL.0000000000200898 – ident: 10.1016/j.arr.2023.102003_bib68 – volume: 7 year: 2021 ident: 10.1016/j.arr.2023.102003_bib233 article-title: A novel knockout mouse model of the noncoding antisense Brain-Derived Neurotrophic Factor (Bdnf) gene displays increased endogenous Bdnf protein and improved memory function following exercise publication-title: Heliyon doi: 10.1016/j.heliyon.2021.e07570 – volume: 364 start-page: 97 year: 2018 ident: 10.1016/j.arr.2023.102003_bib275 article-title: Epigenetic histone deacetylation inhibition prevents the development and persistence of temporal lobe epilepsy publication-title: J. Pharm. Exp. Ther. doi: 10.1124/jpet.117.244939 – volume: 22 year: 2021 ident: 10.1016/j.arr.2023.102003_bib263 article-title: Somatostatin, a presynaptic modulator of glutamatergic signal in the central nervous system publication-title: Int J. Mol. Sci. doi: 10.3390/ijms22115864 – volume: 37 start-page: 384 year: 2013 ident: 10.1016/j.arr.2023.102003_bib103 article-title: Resting-state functional connectivity in normal brain aging publication-title: Neurosci. Biobehav Rev. doi: 10.1016/j.neubiorev.2013.01.017 – volume: 366 start-page: 1134 year: 2019 ident: 10.1016/j.arr.2023.102003_bib244 article-title: Brain cell type-specific enhancer-promoter interactome maps and disease-risk association publication-title: Science doi: 10.1126/science.aay0793 – volume: 128 start-page: 2006 year: 2005 ident: 10.1016/j.arr.2023.102003_bib110 article-title: Implicit memory and Alzheimer's disease neuropathology publication-title: Brain doi: 10.1093/brain/awh559 – volume: 26 start-page: 5481 year: 2021 ident: 10.1016/j.arr.2023.102003_bib132 article-title: The amyloid-β pathway in Alzheimer's disease publication-title: Mol. Psychiatry doi: 10.1038/s41380-021-01249-0 – volume: 13 year: 2021 ident: 10.1016/j.arr.2023.102003_bib41 article-title: P-tau/Aβ42 and Aβ42/40 ratios in CSF are equally predictive of amyloid PET status publication-title: Alzheimers Dement (Amst. ) – volume: 72 start-page: 733 year: 2019 ident: 10.1016/j.arr.2023.102003_bib256 article-title: Genome-wide methylation of mild cognitive impairment in mexican americans highlights genes involved in synaptic transport, Alzheimer's disease-precursor phenotypes, and metabolic morbidities publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-190634 – volume: 25 start-page: 610 year: 2019 ident: 10.1016/j.arr.2023.102003_bib78 article-title: Review: the bile acids urso- and tauroursodeoxycholic acid as neuroprotective therapies in retinal disease publication-title: Mol. Vis. – volume: 11 start-page: 188 year: 2021 ident: 10.1016/j.arr.2023.102003_bib90 article-title: Role of FoxO transcription factors in aging and age-related metabolic and neurodegenerative diseases publication-title: Cell Biosci. doi: 10.1186/s13578-021-00700-7 – volume: 23 start-page: 648 year: 2014 ident: 10.1016/j.arr.2023.102003_bib154 article-title: Altered CpG methylation in sporadic Alzheimer's disease is associated with APP and MAPT dysregulation publication-title: Hum. Mol. Genet doi: 10.1093/hmg/ddt451 – volume: 6 start-page: 24797 year: 2015 ident: 10.1016/j.arr.2023.102003_bib319 article-title: Dissecting tRNA-derived fragment complexities using personalized transcriptomes reveals novel fragment classes and unexpected dependencies publication-title: Oncotarget doi: 10.18632/oncotarget.4695 – volume: 12 start-page: 129 year: 2019 ident: 10.1016/j.arr.2023.102003_bib99 article-title: LSD1/KDM1A inhibitors in clinical trials: advances and prospects publication-title: J. Hematol. Oncol. doi: 10.1186/s13045-019-0811-9 – volume: 596 start-page: 43 year: 2021 ident: 10.1016/j.arr.2023.102003_bib125 article-title: The role of retrotransposable elements in ageing and age-associated diseases publication-title: Nature doi: 10.1038/s41586-021-03542-y – volume: 14 start-page: 412 year: 2017 ident: 10.1016/j.arr.2023.102003_bib82 article-title: Targeting tumor necrosis factor alpha for Alzheimer's disease publication-title: Curr. Alzheimer Res doi: 10.2174/1567205013666160930110551 – volume: 78 start-page: 141 year: 2021 ident: 10.1016/j.arr.2023.102003_bib240 article-title: Possible consequences of the approval of a disease-modifying therapy for Alzheimer disease publication-title: JAMA Neurol. doi: 10.1001/jamaneurol.2020.4478 – volume: 9 year: 2019 ident: 10.1016/j.arr.2023.102003_bib167 article-title: Elevated plasma microRNA-206 levels predict cognitive decline and progression to dementia from mild cognitive impairment publication-title: Biomolecules doi: 10.3390/biom9110734 – ident: 10.1016/j.arr.2023.102003_bib67 – volume: 114 start-page: E9645 year: 2017 ident: 10.1016/j.arr.2023.102003_bib221 article-title: Neuron-specific methylome analysis reveals epigenetic regulation and tau-related dysfunction of BRCA1 in Alzheimer's disease publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.1707151114 – volume: 10 start-page: 77 year: 2020 ident: 10.1016/j.arr.2023.102003_bib369 article-title: MicroRNA-7: expression and function in brain physiological and pathological processes publication-title: Cell Biosci. doi: 10.1186/s13578-020-00436-w – volume: 10 start-page: 174 year: 2022 ident: 10.1016/j.arr.2023.102003_bib186 article-title: Methylation differences in Alzheimer's disease neuropathologic change in the aged human brain publication-title: Acta Neuropathol. Commun. doi: 10.1186/s40478-022-01470-0 – volume: 61 year: 2017 ident: 10.1016/j.arr.2023.102003_bib171 article-title: Sulforaphane epigenetically enhances neuronal BDNF expression and TrkB signaling pathways publication-title: Mol. Nutr. Food Res doi: 10.1002/mnfr.201600194 – volume: 9 start-page: 70 year: 2017 ident: 10.1016/j.arr.2023.102003_bib344 article-title: Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years publication-title: Alzheimers Res. Ther. doi: 10.1186/s13195-017-0294-2 – volume: 2 start-page: a006213 year: 2012 ident: 10.1016/j.arr.2023.102003_bib160 article-title: Brain imaging in Alzheimer disease publication-title: Cold Spring Harb. Perspect. Med. doi: 10.1101/cshperspect.a006213 – volume: 15 year: 2021 ident: 10.1016/j.arr.2023.102003_bib101 article-title: Sirtuins as potential therapeutic targets for mitigating neuroinflammation associated With Alzheimer's disease publication-title: Front Cell Neurosci. doi: 10.3389/fncel.2021.746631 – volume: 6 year: 2011 ident: 10.1016/j.arr.2023.102003_bib267 article-title: CHD5, a brain-specific paralog of Mi2 chromatin remodeling enzymes, regulates expression of neuronal genes publication-title: PLoS One doi: 10.1371/journal.pone.0024515 – volume: 28 start-page: 54 year: 2013 ident: 10.1016/j.arr.2023.102003_bib3 article-title: Histone deacetylases enzyme, copper, and IL-8 levels in patients with Alzheimer's disease publication-title: Am. J. Alzheimers Dis. Other Demen doi: 10.1177/1533317512467680 – volume: 17 start-page: 721 year: 2018 ident: 10.1016/j.arr.2023.102003_bib43 article-title: The role of TREM2 in Alzheimer's disease and other neurodegenerative disorders publication-title: Lancet Neurol. doi: 10.1016/S1474-4422(18)30232-1 – volume: 7 start-page: 34 year: 2018 ident: 10.1016/j.arr.2023.102003_bib192 article-title: Amyloid, tau, pathogen infection and antimicrobial protection in Alzheimer's disease -conformist, nonconformist, and realistic prospects for AD pathogenesis publication-title: Transl. Neurodegener. doi: 10.1186/s40035-018-0139-3 – volume: 18 start-page: 2197 year: 2019 ident: 10.1016/j.arr.2023.102003_bib353 article-title: Circular RNA circ_0000950 promotes neuron apoptosis, suppresses neurite outgrowth and elevates inflammatory cytokines levels via directly sponging miR-103 in Alzheimer's disease publication-title: Cell Cycle doi: 10.1080/15384101.2019.1629773 – volume: 45 start-page: 30 year: 2016 ident: 10.1016/j.arr.2023.102003_bib262 article-title: Neurofilament-labeled pyramidal neurons and astrocytes are deficient in DNA methylation marks in Alzheimer's disease publication-title: Neurobiol. Aging doi: 10.1016/j.neurobiolaging.2016.05.003 – volume: 4 year: 2009 ident: 10.1016/j.arr.2023.102003_bib350 article-title: Human telomerase reverse transcriptase (hTERT) Q169 is essential for telomerase function in vitro and in vivo publication-title: PLoS One doi: 10.1371/journal.pone.0007176 – volume: 23 start-page: 237 year: 2019 ident: 10.1016/j.arr.2023.102003_bib180 article-title: 5-Azacytydine and resveratrol reverse senescence and ageing of adipose stem cells via modulation of mitochondrial dynamics and autophagy publication-title: J. Cell Mol. Med doi: 10.1111/jcmm.13914 – ident: 10.1016/j.arr.2023.102003_bib4 – volume: 438 start-page: 685 year: 2005 ident: 10.1016/j.arr.2023.102003_bib181 article-title: Silencing of microRNAs in vivo with 'antagomirs' publication-title: Nature doi: 10.1038/nature04303 – volume: 42 start-page: 829 year: 2021 ident: 10.1016/j.arr.2023.102003_bib117 article-title: Treatment strategies for glucose-6-phosphate dehydrogenase deficiency: past and future perspectives publication-title: Trends Pharm. Sci. doi: 10.1016/j.tips.2021.07.002 – volume: 15 start-page: 1455 year: 2016 ident: 10.1016/j.arr.2023.102003_bib330 article-title: Interaction of tau with the RNA-binding protein TIA1 regulates tau pathophysiology and toxicity publication-title: Cell Rep. doi: 10.1016/j.celrep.2016.04.045 – volume: 5 year: 2015 ident: 10.1016/j.arr.2023.102003_bib30 article-title: Biochemical genetic pathways that modulate aging in multiple species publication-title: Cold Spring Harb. Perspect. Med doi: 10.1101/cshperspect.a025114 – volume: 23 year: 2022 ident: 10.1016/j.arr.2023.102003_bib81 article-title: Applications of CRISPR-Cas9 in Alzheimer's disease and related disorders publication-title: Int J. Mol. Sci. doi: 10.3390/ijms23158714 – volume: 48 start-page: 514 year: 2018 ident: 10.1016/j.arr.2023.102003_bib79 article-title: Histone deacetylases 1 and 2 regulate microglia function during development, homeostasis, and neurodegeneration in a context-dependent manner publication-title: Immunity doi: 10.1016/j.immuni.2018.02.016 – volume: 23 start-page: S72 year: 2019 ident: 10.1016/j.arr.2023.102003_bib170 article-title: Methyl-CpG binding protein 2 in Alzheimer dementia publication-title: Int Neurourol. J. doi: 10.5213/inj.1938196.098 – volume: 31 start-page: 1120 year: 2001 ident: 10.1016/j.arr.2023.102003_bib179 article-title: Amyloid-beta: an antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer's disease publication-title: Free Radic. Biol. Med doi: 10.1016/S0891-5849(01)00688-8 – volume: 80 start-page: 1 year: 2021 ident: 10.1016/j.arr.2023.102003_bib205 article-title: Modifiable, non-modifiable, and clinical factors associated with progression of Alzheimer's disease publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-201182 – volume: 44 start-page: 1807 year: 2022 ident: 10.1016/j.arr.2023.102003_bib232 article-title: Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume publication-title: Geroscience doi: 10.1007/s11357-022-00558-8 – volume: 29 start-page: 787 year: 2019 ident: 10.1016/j.arr.2023.102003_bib342 article-title: Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression publication-title: Cell Res doi: 10.1038/s41422-019-0216-x – volume: 69 start-page: 351 year: 2019 ident: 10.1016/j.arr.2023.102003_bib111 article-title: Long Non-coding RNA BACE1-AS may serve as an Alzheimer's disease blood-based biomarker publication-title: J. Mol. Neurosci. doi: 10.1007/s12031-019-01364-2 – volume: 17 year: 2021 ident: 10.1016/j.arr.2023.102003_bib239 article-title: Results of the first‐in‐human, randomized, double‐blind, placebo‐controlled phase 1b study of lumbar intrathecal bolus administrations of antisense oligonucleotide (ISIS 814907; BIIB080) targeting tau mRNA in patients with mild Alzheimer’s disease publication-title: Alzheimers Dement. doi: 10.1002/alz.051871 – volume: 488 start-page: 96 year: 2012 ident: 10.1016/j.arr.2023.102003_bib161 article-title: A mutation in APP protects against Alzheimer's disease and age-related cognitive decline publication-title: Nature doi: 10.1038/nature11283 – volume: 154 start-page: 441 year: 2020 ident: 10.1016/j.arr.2023.102003_bib143 article-title: Correcting abnormalities in miR-124/PTPN1 signaling rescues tau pathology in Alzheimer's disease publication-title: J. Neurochem. doi: 10.1111/jnc.14961 – volume: 87 start-page: 4577 year: 2021 ident: 10.1016/j.arr.2023.102003_bib33 article-title: Recent developments of HDAC inhibitors: emerging indications and novel molecules publication-title: Br. J. Clin. Pharm. doi: 10.1111/bcp.14889 – volume: 21 start-page: 497 year: 2018 ident: 10.1016/j.arr.2023.102003_bib241 article-title: Dysregulation of the epigenetic landscape of normal aging in Alzheimer's disease publication-title: Nat. Neurosci. doi: 10.1038/s41593-018-0101-9 – volume: 6 start-page: 205 year: 2015 ident: 10.1016/j.arr.2023.102003_bib314 article-title: Multi-target pharmacology: possibilities and limitations of the "skeleton key approach" from a medicinal chemist perspective publication-title: Front Pharm. doi: 10.3389/fphar.2015.00205 – volume: 13 start-page: 655 year: 2022 ident: 10.1016/j.arr.2023.102003_bib318 article-title: Inferring protein expression changes from mRNA in Alzheimer's dementia using deep neural networks publication-title: Nat. Commun. doi: 10.1038/s41467-022-28280-1 – volume: 11 start-page: 41 year: 2018 ident: 10.1016/j.arr.2023.102003_bib120 article-title: DNA methylation analysis on purified neurons and glia dissects age and Alzheimer's disease-specific changes in the human cortex publication-title: Epigenetics Chromatin doi: 10.1186/s13072-018-0211-3 – volume: 3 year: 2008 ident: 10.1016/j.arr.2023.102003_bib15 article-title: Impaired spatial learning strategies and novel object recognition in mice haploinsufficient for the dual specificity tyrosine-regulated kinase-1A (Dyrk1A) publication-title: PLoS One doi: 10.1371/journal.pone.0002575 – volume: 107 start-page: 62 year: 2017 ident: 10.1016/j.arr.2023.102003_bib174 article-title: Oxidized C5-methyl cytosine bases in DNA: 5-Hydroxymethylcytosine; 5-formylcytosine; and 5-carboxycytosine publication-title: Free Radic. Biol. Med doi: 10.1016/j.freeradbiomed.2016.11.038 – volume: 21 start-page: 1149 year: 2014 ident: 10.1016/j.arr.2023.102003_bib251 article-title: Early-onset Alzheimer's disease: a global cross-sectional analysis publication-title: Eur. J. Neurol. doi: 10.1111/ene.12453 – volume: 459 start-page: 802 year: 2009 ident: 10.1016/j.arr.2023.102003_bib77 article-title: Histone H4 lysine 16 acetylation regulates cellular lifespan publication-title: Nature doi: 10.1038/nature08085 – ident: 10.1016/j.arr.2023.102003_bib62 – ident: 10.1016/j.arr.2023.102003_bib56 – volume: 143 start-page: 3763 year: 2020 ident: 10.1016/j.arr.2023.102003_bib298 article-title: Recalibrating the epigenetic clock: implications for assessing biological age in the human cortex publication-title: Brain doi: 10.1093/brain/awaa334 – volume: 12 start-page: 5711 year: 2021 ident: 10.1016/j.arr.2023.102003_bib291 article-title: Unraveling the functional role of DNA demethylation at specific promoters by targeted steric blockage of DNA methyltransferase with CRISPR/dCas9 publication-title: Nat. Commun. doi: 10.1038/s41467-021-25991-9 – volume: 12 start-page: 1252 year: 2021 ident: 10.1016/j.arr.2023.102003_bib115 article-title: DeepMAge: a methylation aging clock developed with deep learning publication-title: Aging Dis. doi: 10.14336/AD.2020.1202 – volume: 10 start-page: 2246 year: 2019 ident: 10.1016/j.arr.2023.102003_bib195 article-title: Epigenetic dysregulation of enhancers in neurons is associated with Alzheimer's disease pathology and cognitive symptoms publication-title: Nat. Commun. doi: 10.1038/s41467-019-10101-7 – volume: 123 year: 2020 ident: 10.1016/j.arr.2023.102003_bib197 article-title: Circular RNA expression profile of Alzheimer's disease and its clinical significance as biomarkers for the disease risk and progression publication-title: Int. J. Biochem Cell Biol. doi: 10.1016/j.biocel.2020.105747 – volume: 13 year: 2021 ident: 10.1016/j.arr.2023.102003_bib367 article-title: The role of non-coding RNAs in Alzheimer's disease: from regulated mechanism to therapeutic targets and diagnostic biomarkers publication-title: Front Aging Neurosci. – ident: 10.1016/j.arr.2023.102003_bib69 – volume: 7 start-page: 2 year: 2020 ident: 10.1016/j.arr.2023.102003_bib299 article-title: Editorial: geroscience and the role of aging in the etiology and management of Alzheimer's disease publication-title: J. Prev. Alzheimers Dis. – volume: 12 start-page: 103 year: 2020 ident: 10.1016/j.arr.2023.102003_bib10 article-title: Resveratrol derivatives as potential treatments for Alzheimer's and Parkinson's disease publication-title: Front Aging Neurosci. doi: 10.3389/fnagi.2020.00103 – volume: 8 start-page: 140 year: 2016 ident: 10.1016/j.arr.2023.102003_bib372 article-title: Over-expressed pathogenic miRNAs in Alzheimer's disease (AD) and prion disease (PrD) drive deficits in TREM2-mediated Aβ42 peptide clearance publication-title: Front. Aging Neurosci. doi: 10.3389/fnagi.2016.00140 – volume: 44 start-page: 179 year: 2019 ident: 10.1016/j.arr.2023.102003_bib324 article-title: Impact of efavirenz metabolism on loss to care in older HIV+ africans publication-title: Eur. J. Drug Metab. Pharm. doi: 10.1007/s13318-018-0507-5 – volume: 16 start-page: 164 year: 2018 ident: 10.1016/j.arr.2023.102003_bib175 article-title: Biomarkers in Alzheimer's, frontotemporal, lewy body, and vascular dementias publication-title: Focus (Am. Psychiatr. Publ. ) – volume: 65 year: 2022 ident: 10.1016/j.arr.2023.102003_bib282 article-title: Role of melatonin in Alzheimer's disease: from preclinical studies to novel melatonin-based therapies publication-title: Front. Neuroendocr. doi: 10.1016/j.yfrne.2022.100986 – volume: 191 year: 2020 ident: 10.1016/j.arr.2023.102003_bib345 article-title: DNA methylation in Alzheimer's disease: in brain and peripheral blood publication-title: Mech. Ageing Dev. doi: 10.1016/j.mad.2020.111319 – volume: 24 year: 2023 ident: 10.1016/j.arr.2023.102003_bib7 article-title: Alzheimer's disease: an updated overview of its genetics publication-title: Int J. Mol. Sci. doi: 10.3390/ijms24043754 – year: 2023 ident: 10.1016/j.arr.2023.102003_bib268 article-title: Levetiracetam increases hippocampal blood flow in Alzheimer's disease as measured by arterial spin labelling MRI publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-220614 – volume: 14 start-page: 198 year: 2022 ident: 10.1016/j.arr.2023.102003_bib189 article-title: CYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer’s disease publication-title: Alzheimers Res Ther doi: 10.1186/s13195-022-01151-z – volume: 12 start-page: 292 year: 2016 ident: 10.1016/j.arr.2023.102003_bib92 article-title: Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria publication-title: Alzheimers Dement doi: 10.1016/j.jalz.2016.02.002 – volume: 16 start-page: 1 year: 2021 ident: 10.1016/j.arr.2023.102003_bib149 article-title: Nuclear dynamics and stress responses in Alzheimer’s disease publication-title: Mol. Neurodegener. doi: 10.1186/s13024-021-00489-6 – volume: 82 start-page: 965 year: 2021 ident: 10.1016/j.arr.2023.102003_bib185 article-title: Time to diagnosis in young onset Alzheimer's disease: a population-based study from central norway publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-210090 – volume: 30 start-page: 503 year: 2016 ident: 10.1016/j.arr.2023.102003_bib222 article-title: Gain-of-function somatic mutations contribute to inflammation and blood vessel damage that lead to Alzheimer dementia: a hypothesis publication-title: Faseb J. doi: 10.1096/fj.15-282285 – year: 2022 ident: 10.1016/j.arr.2023.102003_bib258 article-title: MIB-626, an oral formulation of a microcrystalline unique polymorph of β-nicotinamide mononucleotide, increases circulating nicotinamide adenine dinucleotide and its metabolome in middle-aged and older adults publication-title: J. Gerontol. A Biol. Sci. Med Sci. – volume: 13 start-page: 197 year: 2023 ident: 10.1016/j.arr.2023.102003_bib368 article-title: Role of primary aging hallmarks in Alzheimer´s disease publication-title: Theranostics doi: 10.7150/thno.79535 – volume: 18 start-page: 153 year: 2020 ident: 10.1016/j.arr.2023.102003_bib178 article-title: Epigenetic effects mediated by antiepileptic drugs and their potential application publication-title: Curr. Neuropharmacol. doi: 10.2174/1570159X17666191010094849 – volume: 11 start-page: 80 year: 2020 ident: 10.1016/j.arr.2023.102003_bib51 article-title: Imaging biomarkers for neurodegeneration in presymptomatic familial frontotemporal lobar degeneration publication-title: Front. Neurol. doi: 10.3389/fneur.2020.00080 – volume: 9 start-page: 61 year: 2016 ident: 10.1016/j.arr.2023.102003_bib200 article-title: Altered DNA base excision repair profile in brain tissue and blood in Alzheimer’s disease publication-title: Mol. Brain doi: 10.1186/s13041-016-0237-z – volume: 73 start-page: 355 year: 2009 ident: 10.1016/j.arr.2023.102003_bib80 article-title: Histone deacetylase inhibition activity and molecular docking of (e)-resveratrol: its therapeutic potential in spinal muscular atrophy publication-title: Chem. Biol. Drug Des. doi: 10.1111/j.1747-0285.2009.00781.x – volume: 52 start-page: 24 year: 2019 ident: 10.1016/j.arr.2023.102003_bib188 article-title: Sirtuin signaling in cellular senescence and aging publication-title: BMB Rep. doi: 10.5483/BMBRep.2019.52.1.290 – volume: 361 start-page: 493 year: 2006 ident: 10.1016/j.arr.2023.102003_bib93 article-title: Linker histone H1 binds to disease associated amyloid-like fibrils publication-title: J. Mol. Biol. doi: 10.1016/j.jmb.2006.06.038 – volume: 20 start-page: 417 year: 2019 ident: 10.1016/j.arr.2023.102003_bib84 article-title: Regulation of transposable elements by DNA modifications publication-title: Nat. Rev. Genet doi: 10.1038/s41576-019-0106-6 – volume: 4 year: 2021 ident: 10.1016/j.arr.2023.102003_bib204 article-title: Effect of the histone deacetylase inhibitor FRM-0334 on progranulin levels in patients with progranulin gene haploinsufficiency: a randomized clinical trial publication-title: JAMA Netw. Open doi: 10.1001/jamanetworkopen.2021.25584 – volume: 14 year: 2022 ident: 10.1016/j.arr.2023.102003_bib270 article-title: The association between Alzheimer's disease and epilepsy: a narrative review publication-title: Cureus – volume: 34 start-page: 14919 year: 2014 ident: 10.1016/j.arr.2023.102003_bib361 article-title: Synaptic and cognitive improvements by inhibition of 2-AG metabolism are through upregulation of microRNA-188-3p in a mouse model of Alzheimer's disease publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.1165-14.2014 – volume: 14 start-page: 1580 year: 2018 ident: 10.1016/j.arr.2023.102003_bib305 article-title: Elevated DNA methylation across a 48-kb region spanning the HOXA gene cluster is associated with Alzheimer's disease neuropathology publication-title: Alzheimers Dement doi: 10.1016/j.jalz.2018.01.017 – volume: 9 start-page: 221 year: 2022 ident: 10.1016/j.arr.2023.102003_bib76 article-title: Aducanumab: appropriate use recommendations update publication-title: J. Prev. Alzheimers Dis. – volume: 5 year: 2020 ident: 10.1016/j.arr.2023.102003_bib83 article-title: Human endogenous retrovirus HERV-K(HML-2) RNA causes neurodegeneration through Toll-like receptors publication-title: JCI Insight doi: 10.1172/jci.insight.131093 – volume: 120 start-page: 9936 year: 2019 ident: 10.1016/j.arr.2023.102003_bib193 article-title: miR-219-5p inhibits tau phosphorylation by targeting TTBK1 and GSK-3β in Alzheimer's disease publication-title: J. Cell Biochem doi: 10.1002/jcb.28276 – volume: 91 start-page: 135 year: 2013 ident: 10.1016/j.arr.2023.102003_bib38 article-title: Alzheimer's disease: an evolutionary approach publication-title: J. Anthr. Sci. – start-page: 228 year: 2022 ident: 10.1016/j.arr.2023.102003_bib155 article-title: Prevalence estimates of amyloid abnormality across the alzheimer disease clinical spectrum publication-title: JAMA Neurol doi: 10.1001/jamaneurol.2021.5216 – volume: 32 start-page: 796 year: 2019 ident: 10.1016/j.arr.2023.102003_bib374 article-title: (De)Toxifying the epigenetic code publication-title: Chem. Res Toxicol. doi: 10.1021/acs.chemrestox.9b00013 – volume: 111 start-page: 57 year: 2020 ident: 10.1016/j.arr.2023.102003_bib266 article-title: Memory and neuromodulation: a perspective of DNA methylation publication-title: Neurosci. Biobehav Rev. doi: 10.1016/j.neubiorev.2019.12.022 – volume: 9 start-page: 114 year: 2016 ident: 10.1016/j.arr.2023.102003_bib349 article-title: Aberrant expression of histone deacetylases 4 in cognitive disorders: molecular mechanisms and a potential target publication-title: Front Mol. Neurosci. doi: 10.3389/fnmol.2016.00114 – volume: 13 year: 2018 ident: 10.1016/j.arr.2023.102003_bib138 article-title: Defensive effect of microRNA-200b/c against amyloid-beta peptide-induced toxicity in Alzheimer's disease models publication-title: PLoS One doi: 10.1371/journal.pone.0196929 – volume: 161 year: 2023 ident: 10.1016/j.arr.2023.102003_bib363 article-title: Therapeutic potential of natural molecules against Alzheimer's disease via SIRT1 modulation publication-title: Biomed. Pharm. doi: 10.1016/j.biopha.2023.114474 – ident: 10.1016/j.arr.2023.102003_bib58 – volume: 96 start-page: 115 year: 2017 ident: 10.1016/j.arr.2023.102003_bib371 article-title: Apolipoprotein E4 impairs neuronal insulin signaling by trapping insulin receptor in the endosomes publication-title: Neuron doi: 10.1016/j.neuron.2017.09.003 – ident: 10.1016/j.arr.2023.102003_bib64 – volume: 23 start-page: 2874 year: 2018 ident: 10.1016/j.arr.2023.102003_bib128 article-title: Tau activates transposable elements in Alzheimer's disease publication-title: Cell Rep. doi: 10.1016/j.celrep.2018.05.004 – volume: 7 start-page: 294 year: 2015 ident: 10.1016/j.arr.2023.102003_bib141 article-title: The cerebellum ages slowly according to the epigenetic clock publication-title: Aging (Albany NY) doi: 10.18632/aging.100742 – volume: 24 start-page: 183 year: 2009 ident: 10.1016/j.arr.2023.102003_bib177 article-title: CYP46A1 variants influence Alzheimer's disease risk and brain cholesterol metabolism publication-title: Eur. Psychiatry doi: 10.1016/j.eurpsy.2008.12.005 – volume: 157 start-page: 68 year: 2021 ident: 10.1016/j.arr.2023.102003_bib211 article-title: How the US Food and Drug Administration’s approval of aducanumab for Alzheimer’s disease has implication for oncology and beyond publication-title: Eur J Cancer doi: 10.1016/j.ejca.2021.08.012 – volume: 93 year: 2022 ident: 10.1016/j.arr.2023.102003_bib48 article-title: Multiple roles of short-chain fatty acids in Alzheimer disease publication-title: Nutrition doi: 10.1016/j.nut.2021.111499 – volume: 154 start-page: 1246 year: 2013 ident: 10.1016/j.arr.2023.102003_bib356 article-title: SWR-C and INO80 chromatin remodelers recognize nucleosome-free regions near +1 nucleosomes publication-title: Cell doi: 10.1016/j.cell.2013.08.043 – volume: 14 start-page: 25 year: 2021 ident: 10.1016/j.arr.2023.102003_bib253 article-title: Losing DNA methylation at repetitive elements and breaking bad publication-title: Epigenetics Chromatin doi: 10.1186/s13072-021-00400-z – volume: 11 year: 2020 ident: 10.1016/j.arr.2023.102003_bib34 article-title: Advances and challenges in understanding MicroRNA function in tauopathies: a case study of miR-132/212 publication-title: Front Neurol. doi: 10.3389/fneur.2020.578720 – volume: 6 start-page: 10 year: 2013 ident: 10.1016/j.arr.2023.102003_bib261 article-title: 5-hydroxymethylcytosine and its potential roles in development and cancer publication-title: Epigenetics Chromatin doi: 10.1186/1756-8935-6-10 – volume: 14 year: 2022 ident: 10.1016/j.arr.2023.102003_bib123 article-title: Multi-targets: an unconventional drug development strategy for Alzheimer's disease publication-title: Front Aging Neurosci. doi: 10.3389/fnagi.2022.837649 – volume: 521 year: 2021 ident: 10.1016/j.arr.2023.102003_bib358 article-title: The bile acid TUDCA improves glucose metabolism in streptozotocin-induced Alzheimer's disease mice model publication-title: Mol. Cell Endocrinol. doi: 10.1016/j.mce.2020.111116 – volume: 11 start-page: 303 year: 2019 ident: 10.1016/j.arr.2023.102003_bib208 article-title: DNA methylation GrimAge strongly predicts lifespan and healthspan publication-title: Aging (Albany NY) doi: 10.18632/aging.101684 – volume: 1 start-page: 63 year: 2013 ident: 10.1016/j.arr.2023.102003_bib152 article-title: miRNa-based therapeutic strategies publication-title: Curr. Anesth. Rep. – volume: 9 start-page: 258 year: 2018 ident: 10.1016/j.arr.2023.102003_bib274 article-title: Aging hallmarks: the benefits of physical exercise publication-title: Front. Endocrinol. doi: 10.3389/fendo.2018.00258 – volume: 37 start-page: 501 year: 2022 ident: 10.1016/j.arr.2023.102003_bib11 article-title: Experience with subcutaneous levetiracetam in palliative care patients: prognostic and pharmacological considerations publication-title: Neurol. (Engl. Ed. ) – volume: 12 year: 2020 ident: 10.1016/j.arr.2023.102003_bib169 article-title: Propionate and Alzheimer's disease publication-title: Front Aging Neurosci. – volume: 7 start-page: 1198 year: 2015 ident: 10.1016/j.arr.2023.102003_bib190 article-title: Epigenetic age of the pre-frontal cortex is associated with neuritic plaques, amyloid load, and Alzheimer's disease related cognitive functioning publication-title: Aging (Albany NY) doi: 10.18632/aging.100864 – volume: 85 start-page: 573 year: 2022 ident: 10.1016/j.arr.2023.102003_bib50 article-title: 5-hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for late-onset Alzheimer's disease publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-215217 – volume: 22 year: 2021 ident: 10.1016/j.arr.2023.102003_bib297 article-title: Complement system in Alzheimer's disease publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms222413647 – volume: 12 year: 2020 ident: 10.1016/j.arr.2023.102003_bib168 article-title: Alzheimer's gone viral: could herpes simplex virus type-1 be stealing your memories? publication-title: Cureus – volume: 41 start-page: 587 year: 2018 ident: 10.1016/j.arr.2023.102003_bib29 article-title: Epigenetic regulation in neurodegenerative diseases publication-title: Trends Neurosci. doi: 10.1016/j.tins.2018.05.005 – volume: 8 start-page: 262 year: 2014 ident: 10.1016/j.arr.2023.102003_bib328 article-title: Apolipoprotein E, gender, and Alzheimer's disease: an overlooked, but potent and promising interaction publication-title: Brain Imaging Behav. doi: 10.1007/s11682-013-9272-x – volume: 25 start-page: 1078 year: 2011 ident: 10.1016/j.arr.2023.102003_bib32 article-title: DNA methylation in repetitive elements and Alzheimer disease publication-title: Brain Behav. Immun. doi: 10.1016/j.bbi.2011.01.017 – ident: 10.1016/j.arr.2023.102003_bib57 – ident: 10.1016/j.arr.2023.102003_bib63 – volume: 1839 start-page: 728 year: 2014 ident: 10.1016/j.arr.2023.102003_bib312 article-title: Chromatin dynamics: interplay between remodeling enzymes and histone modifications publication-title: Biochim Biophys. Acta doi: 10.1016/j.bbagrm.2014.02.013 – volume: 13 start-page: 98 year: 2021 ident: 10.1016/j.arr.2023.102003_bib75 article-title: Aducanumab produced a clinically meaningful benefit in association with amyloid lowering publication-title: Alzheimers Res. Ther. doi: 10.1186/s13195-021-00838-z – volume: 26 start-page: 3806 year: 2021 ident: 10.1016/j.arr.2023.102003_bib139 article-title: An epigenetic predictor of death captures multi-modal measures of brain health publication-title: Mol. Psychiatry doi: 10.1038/s41380-019-0616-9 – volume: 72 start-page: 91 year: 2022 ident: 10.1016/j.arr.2023.102003_bib14 article-title: The adaptive aging brain publication-title: Curr. Opin. Neurobiol. doi: 10.1016/j.conb.2021.09.009 – volume: 72 year: 2021 ident: 10.1016/j.arr.2023.102003_bib156 article-title: Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: a systematic review publication-title: Ageing Res Rev. doi: 10.1016/j.arr.2021.101496 – volume: 65 start-page: 283 year: 2018 ident: 10.1016/j.arr.2023.102003_bib228 article-title: PICALM gene methylation in blood of Alzheimer's disease patients is associated with cognitive decline publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-180242 – volume: 1 year: 2022 ident: 10.1016/j.arr.2023.102003_bib236 article-title: Blood MAPT expression and methylation status in Alzheimer's disease publication-title: Psychiatry Clin. Neurosci. Rep. – volume: 13 start-page: 4852 year: 2022 ident: 10.1016/j.arr.2023.102003_bib300 article-title: Cross-tissue analysis of blood and brain epigenome-wide association studies in Alzheimer's disease publication-title: Nat. Commun. doi: 10.1038/s41467-022-32475-x – volume: 776 year: 2022 ident: 10.1016/j.arr.2023.102003_bib196 article-title: Circular RNA AXL increases neuron injury and inflammation through targeting microRNA-328 mediated BACE1 in Alzheimer's disease publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2022.136531 – volume: 25 start-page: 8490 year: 2021 ident: 10.1016/j.arr.2023.102003_bib194 article-title: Lamivudine improves cognitive decline in SAMP8 mice: Integrating in vivo pharmacological evaluation and network pharmacology publication-title: J. Cell Mol. Med. doi: 10.1111/jcmm.16811 – volume: 16 year: 2022 ident: 10.1016/j.arr.2023.102003_bib52 article-title: Epigenetic regulation of synaptic disorder in Alzheimer's disease publication-title: Front Neurosci. – volume: 17 start-page: 1666 year: 2022 ident: 10.1016/j.arr.2023.102003_bib279 article-title: Amyloid-beta peptide and tau protein crosstalk in Alzheimer's disease publication-title: Neural Regen. Res doi: 10.4103/1673-5374.332127 – volume: 9 year: 2020 ident: 10.1016/j.arr.2023.102003_bib284 article-title: Alzheimer's disease, a lipid story: involvement of peroxisome proliferator-activated receptor α publication-title: Cells doi: 10.3390/cells9051215 – volume: 24 start-page: 6721 year: 2015 ident: 10.1016/j.arr.2023.102003_bib304 article-title: miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo publication-title: Hum. Mol. Genet doi: 10.1093/hmg/ddv377 – volume: 10 start-page: 153 year: 2019 ident: 10.1016/j.arr.2023.102003_bib339 article-title: MicroRNAs in Alzheimer's disease publication-title: Front Genet doi: 10.3389/fgene.2019.00153 – volume: 32 start-page: 10879 year: 2012 ident: 10.1016/j.arr.2023.102003_bib172 article-title: An essential role for histone deacetylase 4 in synaptic plasticity and memory formation publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.2089-12.2012 – volume: 11 year: 2021 ident: 10.1016/j.arr.2023.102003_bib243 article-title: Epigenetics of Alzheimer's disease publication-title: Biomolecules doi: 10.3390/biom11020195 – volume: 6 start-page: a018713 year: 2014 ident: 10.1016/j.arr.2023.102003_bib296 article-title: Erasers of histone acetylation: the histone deacetylase enzymes publication-title: Cold Spring Harb. Perspect. Biol. doi: 10.1101/cshperspect.a018713 – volume: 13 start-page: 126 year: 2021 ident: 10.1016/j.arr.2023.102003_bib357 article-title: Prediction of differentially expressed microRNAs in blood as potential biomarkers for Alzheimer's disease by meta-analysis and adaptive boosting ensemble learning publication-title: Alzheimers Res Ther. doi: 10.1186/s13195-021-00862-z – volume: 82 start-page: 239 year: 1991 ident: 10.1016/j.arr.2023.102003_bib36 article-title: Neuropathological stageing of Alzheimer-related changes publication-title: Acta Neuropathol. doi: 10.1007/BF00308809 – volume: 2 start-page: 135 year: 2014 ident: 10.1016/j.arr.2023.102003_bib237 article-title: Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease publication-title: Acta Neuropathol. Commun. – year: 2023 ident: 10.1016/j.arr.2023.102003_bib364 article-title: Distinct CSF biomarker-associated DNA methylation in Alzheimer's disease and cognitively normal subjects publication-title: Res Sq. – volume: 16 start-page: 76 year: 2021 ident: 10.1016/j.arr.2023.102003_bib336 article-title: The promise of microRNA-based therapies in Alzheimer's disease: challenges and perspectives publication-title: Mol. Neurodegener. doi: 10.1186/s13024-021-00496-7 – volume: 12 start-page: 150 year: 2020 ident: 10.1016/j.arr.2023.102003_bib355 article-title: APOE alleles and diet in brain aging and Alzheimer's disease publication-title: Front Aging Neurosci. doi: 10.3389/fnagi.2020.00150 – volume: 74 start-page: 3347 year: 2017 ident: 10.1016/j.arr.2023.102003_bib148 article-title: Nicotinamide is an inhibitor of SIRT1 in vitro, but can be a stimulator in cells publication-title: Cell Mol. Life Sci. doi: 10.1007/s00018-017-2527-8 – volume: 40 start-page: 113 year: 2018 ident: 10.1016/j.arr.2023.102003_bib235 article-title: Complement in the pathogenesis of Alzheimer's disease publication-title: Semin Immunopathol. doi: 10.1007/s00281-017-0662-9 – ident: 10.1016/j.arr.2023.102003_bib5 – volume: 172 start-page: 656 year: 2020 ident: 10.1016/j.arr.2023.102003_bib108 article-title: Benefits and harms of prescription drugs and supplements for treatment of clinical alzheimer-type dementia publication-title: Ann. Intern Med doi: 10.7326/M19-3887 – volume: 30 start-page: 992 year: 2020 ident: 10.1016/j.arr.2023.102003_bib293 article-title: Applying gene-editing technology to elucidate the functional consequence of genetic and epigenetic variation in Alzheimer's disease publication-title: Brain Pathol. doi: 10.1111/bpa.12881 – volume: 4 start-page: 976 year: 2012 ident: 10.1016/j.arr.2023.102003_bib21 article-title: Sex hormones, aging, and Alzheimer's disease publication-title: Front Biosci. (Elite Ed. ) – volume: 98 year: 2021 ident: 10.1016/j.arr.2023.102003_bib260 article-title: Dietary supplementation with sulforaphane ameliorates skin aging through activation of the Keap1-Nrf2 pathway publication-title: J. Nutr. Biochem doi: 10.1016/j.jnutbio.2021.108817 – volume: 10 start-page: 418 year: 2011 ident: 10.1016/j.arr.2023.102003_bib347 article-title: Phenylbutyric acid reduces amyloid plaques and rescues cognitive behavior in AD transgenic mice publication-title: Aging Cell doi: 10.1111/j.1474-9726.2011.00680.x |
| SSID | ssj0016962 |
| Score | 2.4813972 |
| SecondaryResourceType | review_article |
| Snippet | So far, the search for a cure for Alzheimer Disease (AD) has been unsuccessful. The only approved drugs attenuate some symptoms, but do not halt the progress... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 102003 |
| SubjectTerms | Aging Alzheimer’s Clinical trials Epigenetics Mild cognitive impairment |
| Title | Targeting epigenetics: A novel promise for Alzheimer’s disease treatment |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1568163723001629 https://dx.doi.org/10.1016/j.arr.2023.102003 https://www.ncbi.nlm.nih.gov/pubmed/37422087 https://www.proquest.com/docview/2835280329 |
| Volume | 90 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEA6iFy_i2_VFBPEg1E2TbNJ6K4uyPhEf4K2kaYora3fZXQU9iH_Dv-cvMZM-QEQFT6VlhoSZYWbSzHyD0DYYbpglgRdoxT3OEuYFLU09X0umZGjdo0PXPzsXnRt-fNu6nUDtqhcGyipL31_4dOetyy_NUprNQbfbvPIBO0swaZNom7dQaOLjXIKV773WZR6-CN1QUSD2gLq62XQ1XmoIkKCUAYABqeZmfY9NP-WeLgYdzqKZMnnEUbG_OTRh8nm0EOX24PzwjHewK-d0_8kX0PG1q_G2kQmbAUBuQrfiaB9HOO8_mR62i1kVG2yTVhz1Xu5M98EMP97eR7i8s8F1Dfoiujk8uG53vHJwgqc5YWNPKpUEAtr-aUhSlfk0ZS1fK2oymCtmo7YkyqTMUJoBQp-v7LGBkFSkRgAdW0KTeT83Kwj7gU44SbUEpDw_MIoZlYhE8kQILUXWQKQSWaxLVHEYbtGLq_Kxe0CvjkHKcSHlBtqtWQYFpMZvxLTSQ1z1ilrvFluH_xsTr5m-GNNfbFuVomOrAbg5UbnpP45iAKWDMV40bKDlwgLqrTPJKSWBXP3fomtoGt6KsrV1NDkePpoNm-eMk01nyJtoKmpfnl7A8-ikc_4JATj7xQ |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LTxsxEB5RemgvCEofgdK6UtVDpW28tmPvcotQUXheGiRultfrFamSTZQEJDgg_gZ_r78Ej_chVQgq9bo7I1szszPj9cw3AF_RcNMiS6LEGhEJnvEo6VkWxVZxo1LvHgO6_smpHJyJw_Pe-QrsNb0wWFZZ-_7KpwdvXT_p1tLszkaj7q8YsbMkVz6J9nkLS1_AS-E_Xxxj8OO2rfOIZRqmiiJ1hOTN1WYo8jJzxARlHBEMaDM463Fweir5DEFofx3W6uyR9KsNbsCKK9_AZr_0J-fJNflGQj1n-FG-CYfDUOTtQxNxM8TcxHbFxS7pk3J65cbEL-Z17IjPWkl_fHPhRhM3_3N3vyD1pQ1pi9Dfwtn-z-HeIKonJ0RWUL6MlDFZIrHvn6U0N0XMct6LrWGuwMFiPmwralzOHWMFQvTFxp8bKM1l7iTS8XewWk5L9wFInNhM0NwqhMqLE2e4M5nMlMiktEoWHaCNyLStYcVxusVYN_VjvxG-WqOUdSXlDnxvWWYVpsZzxKzRg26aRb17097jP8ckWqa_rOlfbF8aRWuvAbw6MaWbXi40otLhHC-WduB9ZQHt1rkSjNFEbf3fop_h1WB4cqyPD06PtuE1vqlq2D7C6nJ-6XZ80rPMPgWjfgDabvu- |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Targeting+epigenetics%3A+A+novel+promise+for+Alzheimer%E2%80%99s+disease+treatment&rft.jtitle=Ageing+research+reviews&rft.au=Jeremic%2C+Danko&rft.au=Jim%C3%A9nez-D%C3%ADaz%2C+Lydia&rft.au=Navarro-L%C3%B3pez%2C+Juan+D.&rft.date=2023-09-01&rft.pub=Elsevier+B.V&rft.issn=1568-1637&rft.volume=90&rft_id=info:doi/10.1016%2Fj.arr.2023.102003&rft.externalDocID=S1568163723001629 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1568-1637&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1568-1637&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1568-1637&client=summon |